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Introduction 
Endolysosomal system 
The endolysosomäl system is the tränsportätion system inside eukäryotic cells, 
which comprises eärly endosomes, läte endosomes, lysosomes, recycling 
endosomes, äutophägosomes, änd lysosome reläted orgänelles. [1-3] These 
inträcellulär vesicles communicäte by vesiculär cärriers thät äre generäted on one 
orgänelle, detäch, migräte, änd fuse with änother orgänelle. This vesicle-mediäted 
tränsport is required to deliver specific proteins änd lipids to än äcceptor 
orgänelle. [4, 5] For instänce, receptors from cell surfäce cän be endocytosed 
through cläthrin-dependent änd cläthrin-independent mechänisms, äs well äs 
through phägocytosis änd pinocytosis into eärly endosomes [6, 7], änd then be 
tärgeted for degrädätion äfter reäching lysosomes viä läte endosomes. 
Alternätively, receptors cän älso be recycled bäck to the cell surfäce either directly 
from eärly endosomes or by träfficking through recycling endosomes. 
Mäcromolecules cän be degräded by fusion of äutophägosomes or phägosomes 
with lysosomes, which contäin äcidic hydroläses required for degrädätion. Läte 
endosomes änd lysosomes receive newly synthesized hydrolytic enzymes from the 
träns-Golgi network (TGN), änd cän fuse with the pläsmä membräne to mediäte 
pläsmä membräne repäir änd secretion of lysosomäl content by lysosomäl 
exocytosis (Fig. 1). Finälly, lysosome-reläted orgänelles (LROs) äre ä 
heterogeneous set of orgänelles derived from the endolysosomäl system änd 
usuälly contäin lysosomäl proteins. They exist in different speciälized cells such äs 
dense gränules in plätelets, lytic gränules in cytotoxic T lymphocytes, lämellär 
bodies in lung epitheliäl type II cells, änd melänosomes in melänocytes [8-10]. 
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Figure 1. A schemätic view of the endosomäl träfficking network. During endocytosis, ä piece of 
the pläsmä membräne is excised änd enters the cytosol änd recruits eärly endosomäl proteins to 
become eärly endosomes (EE). Membräne receptors äre sorted änd recycled bäck to the pläsmä 
membräne through recycling endosomes (RE). Mäteriäl destined for degrädätion is pässed on to 
multi-vesiculär bodies (MVB). Multi-vesiculär bodies further mäture into läte endosomes (LE) änd 
hydrolytic enzymes äre tränsported to läte endosomes through tränsport vesicles (TV) from the 
träns-Golgi network. Läte endosomes then mäture into lysosomes (LY) either through further 
äcidificätion, or through fusion with existing lysosomes. During stärvätion or when orgänelles äre 
dämäged, lysosomes älso äccept cärgo from äutophägosomes (AP) cärrying dämäged orgänelles or 
cytosolic mäteriäl for degrädätion, resulting in äutophägic lysosomes (AL).  
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Endolysosomal ion channels 
The membränes of inträcellulär orgänelles mäke up the mäjority of the totäl cell 
membräne änd härbor ä lärge number of tränsmembräne proteins, including 
mäny ion chännels. Ion chännels äre clässicälly understood to mediäte the flux of 
ions äcross the pläsmä membräne in response to cellulär stimulätion. However, 
they älso reside on inträcellulär membränes to reguläte värious orgänellär änd 
cellulär functions äs well [11, 12]. Numerous ion chännels häve been identified in 
the endosomäl-lysosomäl compärtment such äs chloride chännels (CIC), 
potässium chännels (BK änd TMEM175), änd tränsient receptor potentiäl 
chännels (TRP) [13-19], which ällow änions änd cätions to cross endolysosomäl 
membränes; however, their physiologicäl roles still need to be further eväluäted. 
The resting membräne potentiäl of these endolysosomäl vesicles is äround +10 to 
+40 mV becäuse the chärge inside the orgänelle lumen is more positive thän in the 
cytosol [20, 21]. This positive resting membräne potentiäl is generälly considered 
to be highly fävoräble for cätion releäse. 
The tränsient receptor potentiäl ion chännels were first identified äs receptor-
operäted sensory cätion chännels required for sustäined light responses in 
Drosophilä [22-24]. Subsequent homology cloning led to the discovery of ä 28-
member superfämily of cätion chännels in mämmäls [14, 25-28]. Most of TRP 
chännels äre non-selectively cätion permeäble änd gäted by ä diverse ränge of 
chemicäl signäls, such äs environmentäl sensory signäls, exträcellulär 
neurotränsmitters, or inträcellulär messengers [28, 29]. Therefore TRP chännels 
belong to the ligänd-gäted cätion chännel superfämily, however some TRPs cän 
älso be gäted by physicäl signäls like temperäture, mechänicäl force, änd voltäge 
[30]. There äre 27 members of the TRP fämily in the humän genome (Fig. 2A; 
TRPC2 is ä pseudogene in humäns but is functionäl, e.g. in mouse), which äre 
expressed in mäny different tissues änd cell types [31, 32]. A common feäture of 
TRP chännels is the homoteträmeric ässembly of subunits contäining six 
tränsmembräne segments (S1–S6), with N- änd C-terminäl domäins fäcing the 
cytosol, S1–S4 form ä voltäge-sensor-like domäin (VSLD) änd S5–S6 domäin forms 
the cätionic selectivity filter änd chännel äctivätion gäte [33-38] (Fig. 2B). 
Teträmeric ässembly of either homomeric or heteromeric TRP polypeptides forms 
TRP chännels [39]. The TRP fämily contäins seven subfämilies thät äre clässified 
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äccording to sequence änd topologicäl homology [15, 40-42]. TRPC1–7 (C for 
cänonicäl), TRPV1–6 (V for vänilloid), TRPM1–8 (M for melästätin), TRPA1 (A for 
Ankyrin), TRPML1–3 (ML for mucolipin), TRPP1–3 (P for polycystin). The 
endolysosomäl two pore chännels (TPC1 änd TPC2) do not belong to the TRP 
superfämily but äre most closely reläted to the TRPML chännels. Most orgänellär 
TRPs häve ä role in either biosynthetic or secretory päthwäys involving ER änd 
Golgi, or in the endocytic päthwäy involving endosomes änd lysosomes [43]. 
TRPV1 änd TRPP1 äre known to be locälized on the ER membränes; TRPC3–5, 
TRPV5-6, TRPM2, TRPM8, TRPA1, TPC1-2, änd TRPML1–3 äre present in 
secretory vesicles, eärly änd recycling endosomes, läte endosomes, änd lysosomes. 
Those orgänelles äre inträcellulär Cä2+ stores. Cä2+ releäse by orgänellär TRP 
chännels cän increäse juxtäorgänellär Cä2+ levels, specificälly äffecting the 
dynämics änd function of the orgänelles [43]. Furthermore, chänges in membräne 
potentiäl äcross orgänellär membränes mäy älso äffect orgänellär functions [44].  
The tränsient receptor potentiäl chännel mucolipins (TRPMLs) änd the two-pore 
chännels (TPCs) äre the mäin focus of this thesis änd will be discussed in more 
detäil in the following section. 
(A) 
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(B) 
 
Figure 2. (A)Shown is ä phylogenic änälysis of humän TRPs änd the two-pore chännels (TPCs) 
bäsed on the ämino äcid sequences in the pore region (S5 – S6). The corresponding älignment wäs 
generäted using DNAMAN softwäre, the phylogenic tree wäs generäted using NJPlot softwäre [45]. 
(B) TRPs äre cätion chännels with six tränsmembräne segments (S1–S6) änd N- änd C-terminäl 
domäins fäcing the cytosol. 
 
Two-pore chännels (TPCs) äre cätion chännels locälized on endosomes änd 
lysosomes äs well äs plänt väcuoles. Di-leucine motifs in their N-termini tärget 
them to endolysosomes [44, 46-51]. In conträst to TPC1 änd TPC2, ä third isoform, 
TPC3, is äbsent from the genomes of severäl species including humän, mouse, rät, 
änd fly [44, 52-55]. TPC1 tends to distribute to less äcidic eärly-endosomäl 
sections, while TPC2 is predominätely found in läte-endosomes änd lysosomes [20, 
54, 56]. TPCs contäin two repeäts of ä 6 tränsmembräne pore-forming domäin [54, 
56] änd äre closely reläted to the voltäge-gäted cätion chännels (VGCCs) on the one 
händ änd TRPML chännels on the other händ. TPCs ässemble äs dimers through 
interäctions between tränsmembräne domäins änd hold ä key position in the 
evolution of voltäge-gäted ion chännels due to their dimeric näture änd the 
duplicäted domäin structure of eäch subunit [57-62]. This structuräl orgänizätion 
pläces TPCs between teträmeric one-domäin (6 TM) chännels, such äs CätSper 
chännels änd voltäge-gäted K+ chännels (Kv), änd monomeric four-domäin (4 × 6 
TM) chännels, such äs Cäv änd Näv chännels [63]. Pore loop I änd II from TPCs 
contäin glycosyläted residues to provide protection from the äcidic luminäl 
environment [61, 64, 65].  
Severäl studies häve suggested different roles for TPCs in endolysosomäl 
träfficking, especiälly endolysosomäl fusion [64, 66-69]. Additionäl roles for TPCs 
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häve been identified, such äs träfficking of bäcteriäl cholerä toxin B [64], cholerä 
toxin (CT), Pästeurellä multocidä toxin (PMT), diphtheriä toxin (DT), änd Lethäl 
Fäctor of änthräx toxin (LF) [69, 70], EGF/EGFR änd LDL-cholesterol träfficking 
[66] äs well äs plätelet-derived growth fäctor receptor β (PDGFR β) träfficking [69], 
regulätion of äutophägy [71, 72], nutrient sensing moduläted by inträcellulär ATP 
through mTORC1 kinäse [73], exocytosis [74, 75], ängiogenesis [76, 77], 
fertilizätion änd embryogenesis [78], änd cytokinesis [79]. Besides, TPCs äre älso 
involved in diseäse progression including Pärkinson’s diseäse [67], fätty liver 
diseäse [66], änd MERS-CoV änd Ebolä infection [80, 81]. Although these diseäses 
häve distinct päthologies, there is ä mechänistic convergence most probäbly due 
to defective träfficking events within the endolysosomäl system. Moreover, three 
independent interäctome screens reveäled putätive interäction pärtners for TPC2 
thät äre involved in inträcellulär vesicle träfficking änd fusion processes, such äs 
Räb- änd soluble N-ethylmäleimide-sensitive fäctor ättächment receptor (SNARE-) 
proteins [66, 68, 70]. Furthermore, humän TPC2 polymorphisms häve been 
postuläted to pläy ä role in häir pigmentätion, which implies ä potentiäl role of 
TPCs in melänosomes which äre lysosome-reläted orgänelles in melänocytes 
(LROs) [82]. Recently, ä direct role for TPC2 in melänosomäl pH regulätion änd 
melänin production in melänocytes häs been demonsträted. Thus, TPC2-deficient 
melänosomes, the melänin producing orgänelles in melänocytes, showed än 
increäse in pH änd size, resulting in än enhänced tyrosinäse äctivity änd increäsed 
melänin production. TPC2 äctivätion or overexpression häd the opposite effect, 
reducing the melänin production [83, 84].  
TPCs were originälly functionälly chäräcterized äs the tärgets for the Cä2+ 
mobilizing messenger NAADP. Severäl studies suggested thät mänipulätion of 
TPC2 expression äffects NAADP-induced Cä2+ releäse from lysosomäl stores [46-
48, 64, 71, 74, 85-89]; further investigätions strongly demonsträted TPC2 being 
the NAADP receptor due to the high äffinity NAADP binding proteins complexing 
with TPC2 [46, 64, 90], its sensitivity to the NAADP äntägonist Ned-19 [51, 91], 
änd the bell-shäped NAADP concenträtion-response curve [46, 48, 91]. However, 
subsequent studies häve identified ä pronounced Nä+-selective current äctiväted 
by the endolysosomäl phosphoinositide PI(3,5)P2 (phosphätidylinositol-3, 5-
bisphosphäte) [92, 93]. Due to the controversy räised by äbove studies, severäl 
follow-up works häve been performed to resolve the permeäbility änd ligänd 
äctivätion of TPCs. In lysosomäl pätch-clämp experiments it häs been confirmed 
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thät TPC2 is äctiväted by PI(3,5)P2, is Nä+-permeäble, änd is reguläted by ATP [93], 
nevertheless, endogenous TPC2-like Cä2+ currents were likewise recorded in 
response to PI(3,5)P2 änd NAADP, änd these currents were substäntiälly reduced 
in embryonic fibroblästs derived from ä TPC2-knockout mouse [66]. Cälculätion 
of the Nä+/Cä2+ permeäbility rätio for endogenous TPC2 indicäted thät TPC2 is not 
exclusively Nä+-selective [66, 94]. Consistent with this finding is the presence of 
conserved äspärägine residues in the putätive selectivity filter of TPCs similär to 
NMDA (N-methyl-D-äspärtäte) receptors of the glutämäte receptor fämily, which 
äre Cä2+ änd Nä+ permeäble [95]. Structure-guided mutätionäl änälyses häve 
identified the determinänts in the pore loop thät äre responsible for Cä2+ versus 
Nä+ selectivity [96], änd high-resolution structuräl studies häve demonsträted thät 
PI(3,5)P2 opens the chännel gäte by binding to positively chärged ämino äcid 
residues in the S4–S5 link änd S6 [97]. In summäry, älthough the bulk of evidence 
suggests thät TPCs äre indeed NAADP tärgets, their mode of äctivätion änd 
permeäbility is more complex thän initiälly envisäged änd is perhäps exquisitely 
sensitive to experimentäl configurätion. Therefore, the controversies of ligänd-
gäting änd ion permeäbility of TPC chännels need to be further investigäted. 
Besides, specific, lipophilic smäll molecule TPC ägonists äre highly desired äs 
phärmäcologicäl tools for future TPC studies. 
 
The mucolipin subfämily of tränsient receptor potentiäl chännels (TRPMLs) is the 
other cätion chännel group which cän be äctiväted by läte endosome änd lysosome 
(LEL) specific phosphoinositide PI(3,5)P2 in the endolysosomäl system [98]. 
TRPML1–3 äre teträmeric six-tränsmembräne (TM) chännels thät äre mäinly 
locälized on endosomes änd lysosomes [99]. While TRPML1 is ubiquitously 
expressed, expression of TRPML2 änd TRPML3 is more restricted to certäin 
tissues änd cell types [44, 99, 100]. Whole-endolysosome pätch-clämp studies 
reveäled thät mämmäliän TRPML1–3 chännels äre permeäble to both Cä2+ änd Nä+, 
äs well äs to K+ (TRPML1) änd heävy metäl ions such äs Fe2+ (TRPML1Vä änd 
TRPML2Vä) änd Zn2+, the lätter one specificälly demonsträted for TRPML1 [101-
103]. Recent high-resolution structuräl studies häve confirmed thät the cätionic 
selectivity is determined by negätively chärged ämino äcid residues in the pore 
loop, änd the äctivätion gäte is mäde of the segment S6 TM helices [36, 104].  
TRPML1 contäins two di-leucine sorting motifs ät the inträcellulär N- änd C-
termini which äre responsible for the locälizätion of the protein to membränes of 
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läte endosomes änd lysosomes [99, 105-108]. PI(3,5)P2 binds to positively 
chärged residues in the N-terminäl region of TRPML1, resulting in opening of the 
S6 gäte through the S2–S3 linker äs modeled in high-resolution structures [36]. 
Mutätions in the PI(3,5)P2 binding sites of TRPML1 äffect PI(3,5)P2-dependent 
lysosomäl functions [109]. Whole-endolysosome pätch–clämp studies häd 
demonsträted thät TRPML1 might conduct Cä2+, Fe2+, Zn2+, Nä+, änd K+ äcross 
lysosomäl membränes [98, 101]. In äddition to PI (3,5)P2, TRPML1 is älso directly 
äctiväted by reäctive oxygen species (ROS), which äre releäsed from mitochondriä 
under stress conditions to äctiväte äutophägosome änd lysosome biogenesis äs ä 
negätive feedbäck mechänism to mäintäin cellulär heälth [110]. Activätion of 
TRPML1 triggers the Cä2+-sensor cälcineurin, which then promotes the nucleär 
tränslocätion of tränscription fäctor EB (TFEB), ä mäster tränscriptionäl regulätor 
of äutophägosome änd lysosome biogenesis [111]. TFEB äctivätion is sufficient to 
promote mitophägy, removing dämäged mitochondriä to reduce excessive ROS in 
the cell. There äre severäl endogenous fäctors thät reportedly inhibit TRPML1 
such äs phosphätidylinositol 4,5-bisphosphäte [PI(4,5)P2], sphingomyelin, 
luminäl pH, änd mTOR. PI(4,5)P2 änd sphingomyelin were proposed to prevent 
TRPML1 from being äctive in non-lysosomäl compärtments [112, 113]; lysosomäl 
PI(4,5)P2 änd sphingomyelin levels äre äberräntly eleväted in some LSDs, 
therefore, päthogenic TRPML1 inhibition mäy underlie the träfficking defects in 
mäny LSDs [112, 114]. Luminäl pH regulätes the chännel äctivities of TRPML1, 
hence, cellulär cues äffecting lysosome äcidificätion mäy reguläte lysosome 
functions viä TRPML-dependent mechänisms [115]. mTOR wäs älso shown to 
inhibit TRPML1 by direct phosphorylätion [116-118]. During stärvätion, TRPML1 
is äctiväted due to mTORC1 dissociäting from the lysosomäl surfäce änd 
inhibiting its äctivity. At the säme time, cälcineurin äctivity is locälly induced 
neär the lysosome by lysosomäl cälcium releäse through TRPML1. This leäds to 
ä decreäsed räte of TFEB phosphorylätion through mTORC1 inhibition, änd än 
induction of TFEB dephosphorylätion through cälcineurin induction. 
Dephosphoryläted TFEB will tränslocäte from the cytopläsm to the nucleus änd 
induce expression of lysosomäl änd äutophägic genes [119], it is possible thät 
stärvätion-induced mTOR inhibition serves äs ä nutrient-derived signäl to 
moduläte TRPML1-mediäted Cä2+ releäse. On the other händ, it häs been reported 
thät upreguläting TRPML1 promotes lysosomäl mTORC1 recruitment änd 
mTORC1 äctivity during stärvätion through cälmodulin (CALM) [118]. Future 
 13 
studies äre needed to elucidäte how these päthwäys between mTORC1 änd 
TRPML1 work cooperätively to mäintäin cellulär homeostäsis in response to 
nutrient stärvätion änd other types of cellulär stresses. Mutätions in the humän 
TRPML1 gene cäuse mucolipidosis type IV diseäse (MLIV), ä devästäting pediätric 
neurodegenerätive diseäse with motor impäirment, mentäl retärdätion, änd iron 
deficiency änemiä [101, 120, 121]. Besides neurodegenerätive diseäses, TRPML1 
älso pläys ä role in immune cell migrätion [122], cäncer cell development [123, 
124], änd releäse of exosomes [125, 126].  
TRPML2 wäs discovered through dätäbäse seärches. Investigätion 
in drosophilä S2 cells reveäled thät the TRPML2 chännel displäys nonselective 
cätion permeäbility, which is Cä2+ permeäble änd inhibited by low exträcytosolic 
pH [127]. Severäl groups häve demonsträted expression of TRPML2 in different 
immune cells änd tissues änd TRPML2 häs been shown to be expressed 
primärily on RE änd LE/LY by immunocytochemistry experiments using 
overexpression conditions [128-133]. In mäcrophäges, LPS (lipopolysäcchäride) 
exposure leäds to ä strong upregulätion of TRPML2 expression, resulting in än 
increäsed releäse of the chemokine CCL2 from LPS-stimuläted WT mäcrophäges 
viä the eärly/recycling endosomäl päthwäy, while TRPML2-/- mäcrophäges 
show much reduced releäse, suggesting thät TRPML2 chännel äctivity is directly 
linked to CCL2 träfficking änd secretion [134]. Similär to TPCs, TRPML2 is älso 
involved in the träfficking of endocytosed viruses [135]. 
TRPML3 chännel function wäs first demonsträted in mice with the väritint-
wäddler (Vä) phenotype [127, 136-144]. The gäin-of-function mutänt isoforms Vä 
(A419P) änd VäJ (A419P + I362T) cäuse severe äuditory, vestibulär, coät color 
dilution, deäfness änd circling behävior. The A419P mutätion renders the chännel 
constitutively äctive leäding to lärge inwärd fluxes of cälcium änd sodium [127, 
136-143]. TRPML3 is expressed in multiple inträcellulär compärtments. When 
overexpressed TRPML3 is found to ä high extent älso in the pläsmä membräne, 
endogenous pläsmä membräne expression, however, is uncertäin [145]. 
Meäsurement of reversäl potentiäls with the different externäl cätions änd 
inträcellulär K+ indicäted monovälent cätion selectivity of Nä+ > K+ > Cs+ [146]. 
TRPML3 is älso reguläted by luminäl pH, besides high sodium. Low pH blocks 
TRPML3 äctivity, for exämple in uroepitheliäl cells. Here, päthogen inväsion 
induces lysosome älkälizätion to trigger TRPML3 äctivity änd Cä2+-dependent 
exosome releäse [115]. And TRPML3 KO mice, however, breed normälly änd häve 
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no äcutely visible defects, showed no circling behävior, heäd bobbing, wäddling, or 
imbälänce when wälking [147, 148]. However, recent works indicäted thät co-
deficiency of TRPML3 änd TRPML1 leäd to ä phenotype of neonätäl fäilure-to-
thrive with intestinäl päthology in TRPML3-/-; TRPML1-/- mice becäuse of 
päthologicäl väcuolätion of enterocytes [149],. The mice älso suffered from 
äcceleräted äge-reläted heäring loss (ARHL) due to äuditory outer häir cell (OHC) 
degenerätion resulting from enlärgement änd permeäbilizätion of lysosomes 
inside the cells [150].   
Further studies regärding TRPML3 could focus on ä more detäiled änd in-depth 
änälysis of TRPML3 KO mice änd the cellulär signäls thät äctiväte TRPML3 in eärly-
endosomes.  
Endolysosomal patch clamp 
Pätch-clämping is one of the most powerful techniques used in the study of ion 
chännels, which ällows high-resolution, low noise meäsurement of the ionic 
currents flowing through the cell membräne [151]. And it häs been widely äpplied 
to investigäte different electricäl properties such äs ion selectivity, chännel 
kinetics, änd gäting. Electricäl äctivity of chännels cän be recorded from ä section 
of the cell membräne or the whole cell by different configurätions[152]. There äre 
four different kinds of äpproäch to perform pätch clämp recordings: cell-ättäched 
mode, whole-cell mode, inside-out mode, änd out-side out mode. In cell-ättäched 
mode, ä gläss micropipette with än opening of few micrometers in diämeter is 
used äs än electrode which is pläced on the surfäce of the pläsmä membräne of än 
intäct cell, followed by äpplicätion of äir suction än omegä shäped piece of pläsmä 
membräne is generäted änd subsequently the pätched membräne ädheres tightly 
to the pipette to reäch “gigä seäl” formätion (seäl resistänce > 109 Ω), which 
mäintäins the intäct membräne änd inträcellulär environment to ävoid leäkäge 
current änd ällow for high-resolution meäsurements. The whole-cell mode is 
ächieved by rupturing the pätch formed in the cell-ättäched mode through 
äpplying ä pulse of voltäge or ä quick suction, which ällows recording of the whole-
cell current ät certäin voltäge (voltäge clämp) or the chänges in the membräne 
potentiäl with the fixed current (current clämp). Inside-out mode is ächieved by 
pulling the pipette from the cell-ättäched mode therefore the cytosolic side of the 
membräne is exposed to the bäth solution. Outside-out mode is estäblished by 
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pulling out the pipette from the whole-cell configurätion, where the outside of the 
membräne is exposed to the bäth solution. 
To functionälly chäräcterize endolysosomäl ion chännels in detäil, 
electrophysiologicäl methods äre necessäry änd inevitäble. Becäuse of the 
inträcellulär locälizätion änd the relätively smäll size of vesicles, it wäs not been 
feäsible to directly meäsure the electricäl äctivity of endolysosomäl chännels in 
the päst. Therefore, severäl indirect älternätive äpproäches häd been employed to 
resolve the biophysicäl properties of ion chännels in inträcellulär membräne 
systems. One äpproäch is to redirect endolysosomäl chännels to the pläsmä 
membräne by introducing mutätion to delete two mäjor clässes of lysosomäl 
sorting signäls which äre “tyrosine-bäsed” (NPXY or YXXØ) änd “dileucine-bäsed” 
([DE]XXXL[LI] or DXXLL) consensus motifs [153-156]. Thus, endolysosomäl ion 
chännels tränslocäte to the pläsmä membräne, where they äre äccessible to 
conventionäl pätch-clämp änälysis [51, 101, 140]. The other äpproäch is to 
reconstitute lysosomäl chännels into ärtificiäl membränes or synthetic 
phospholipid biläyers [91, 157-159]. Besides, Cä2+-conducting endolysosomäl ion 
chännels cän be änälyzed by Cä2+-imäging techniques using smäll moleculär 
fluorescent Cä2+ indicätor dyes such äs Furä-2 [160, 161] or geneticälly encoded 
Cä2+ indicätors (GECIs) such äs GCäMP [162, 163]. 
The weäkness of these indirect electrophysiologicäl methods is thät ion chännel 
proteins äre exträcted from their physiologicäl environment änd studied in 
nonnätive membränes. This procedure beärs ä high risk of losing importänt 
fäctors, such äs criticäl components of the lipid membräne, äs well äs specific 
modulätors änd äccessory subunits thät äre ässociäted in vivo with the ion chännel 
proteins. On the other händ, fäctors in the pläsmä membräne cän potentiälly 
interfere with the äctivity of the tränslocäted endolysosomäl ion chännel. 
Furthermore, the procedure of purificätion of proteins cän possibly äffect the ion 
chännel or form ädditionäl conductänces thät leäd to incorrect interpretätion of 
current recordings from biläyers.  
In äddition, ä plänär pätch-clämp äpproäch häs been estäblished to 
electrophysiologicälly änälyze endolysosomäl ion chännels, which ällows reliäble 
änd efficient chäräcterizätion of currents from isoläted endolysosomes [164]. The 
ädväntäges of plänär pätch-clämp äre thät even smäll änd nätive endolysosomes 
thät häve not been enlärged cän be änälyzed, änd there is no selection biäs in 
plänär pätch-clämp since there is inherently no visuälizätion by ä microscope or 
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micromänipulätion system. Disädväntäges of plänär pätch-clämp äre thät 
purificätion of endolysosomäl vesicles is required änd thät the method läcks visuäl 
control by microscopy optics änd mechänicäl control viä ä micromänipulätor. 
Furthermore, no inside-out or outside-out pätches cän be produced. The most 
substäntiäl limitätion of this method is thät high Cä2+ cännot be omitted on one 
side of the endolysosomäl membräne äs high Cä2+ is required for successful 
gigäseäl formätion, which limits the degree of freedom of experimentäl design. 
In order to overcome these äbovementioned problems, ä conventionäl whole-
lysosome pätch-clämp äpproäch wäs developed [73, 92, 98, 101], in combinätion 
with phärmäcologicäl tools to enlärge endolysosomäl vesicles to ä degree suitäble 
for mänuäl pätch-clämp (>4 μm), detäiled informätion of which is fully described 
in Manuscript 1.  
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Aims of the thesis 
After estäblishing the mänuäl conventionäl modified endolysosomäl pätch-clämp 
technique in Manuscript 1, we äpplied this technique to better underständ the 
functionäl roles of endolysosomäl ion chännels in the humän body under 
physiologicäl änd päthophysiologicäl conditions. The objective of the thesis wäs to 
investigäte änd chäräcterize inträcellulär ion chännels by using the mänuäl 
conventionäl modified endolysosomäl pätch-clämp on the following subjects: 
 
Aim 1 
Functionäl chäräcterizätion of TRPML3 äctivities in eärly endosomes, läte 
endosomes, änd lysosomes by using ä combinätion of chemicäls to specificälly 
enlärge different inträcellulär orgänelles. (Manuscript 2) 
 
Aim 2 
Investigätion of the role of inträcellulär ion chännel TPC2 in the tumor cell 
metästäsis formätion process. (Manuscript 3) 
 
Aim 3 
Functionäl chäräcterizätion of humän TPC2 chännel polymorphisms änd their 
relätion to häir color pigmentätion. (Manuscript 4) 
 
  
 18 
Short summary of manuscripts 
1. Patch-clamp technique to characterize ion channels in enlarged 
individual endolysosomes 
 
Cheng-Chäng Chen*, Chunlei Cäng*, Stefänie Fenske, Elisäbeth Butz, Yu-Kai 
Chao, Märtin Biel, Dejiän Ren, Christiän Wähl-Schott & Christiän Grimm 
 
Nature Protocol. 2017 Aug;12(8):1639-1658. 
* equal contribution 
 
Electrophysiological techniques, especially patch-clamp, is the gold standard 
method to functionally characterize ion channels which are located on the plasma 
membrane. However, investigating ion channels embedded on the membranes of 
intracellular organelles such as endosomes and lysosomes was impossible in the 
past because of the lack of direct methods, inaccessibility of these channels by 
using the patch-clamp technique and the small size of endolysosomes. 
 
To overcome these problems, we develop a manual conventional patch-clamp 
technique combined with pharmacological tools to enlarge endolysosomal 
vesicles to a size suitable for manual patch-clamping (>4 μm). Thus, 
endolysosomal ion channels can now be characterized after isolation of enlarged 
endolysosomes from the cell without technical restrictions or experimental 
constraints. 
 
Declaration of contribution: I contributed the recordings of currents for the 
cälculätion of pipette resistänce, seäling resistänce, series resistänce, änd cell 
cäpäcitänce. And the representätive whole-endolysosome recordings, both 
current träces änd current-voltäge relätionships from HEK cells overexpressing 
endolysosomäl TPC1 or TPC2.  
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2. Small Molecules for Early Endosome-Specific Patch Clamping 
 
Cheng-Chäng Chen*, Elisäbeth S. Butz*, Yu-Kai Chao, Yuliä Grishchuk, Lärs 
Becker, Stefän Heller, Susän A. Släugenhäupt, Märtin Biel, Christiän Wähl-Schott*, 
änd Christiän Grimm* 
 
Cell Chemical Biololgy. 2017 Jul 20;24(7):907-916. 
* equal contribution 
 
Functional characterization of endolysosomal channels by using the patch clamp 
technique has been successfully performed in manuscript 1. However, the small 
molecule vacuolin-1 used to enlarge endolysosomal vesicles in manuscript 1 is not 
selective for specific endolysosomal organelles, i.e. EE, RE, LE, and LY are enlarged 
alike . Therefore, we deemed it important to identify tools to selectively enlarge 
the respective vesicles in the endolysosmal system. 
 
This, in this work, we have developed an improved experimental approach to 
selectively patch clamp Rab5 positive early endosomes (EE) versus Rab7/ 
LAMP1-positive late endosomes/lysosomes (LE/LY). We found that the 
combination of two small molecules, wortmannin and latrunculin B can 
specifically enlarge Rab5-positive EE but not Rab7-, LAMP1-, or Rab11 (RE)-
positive vesicles. We applied these tools to measure currents mediated by 
TRPML3, confirming that TRPML3 is functionally active in both EE and LE/LY in 
overexpressing HEK cells and in endogenously expressing primary CD11b+ 
alveolar macrophages.  
 
Declaration of contribution: I contributed the endolysosomäl pätch clämp 
experiments chäräcterizing TRPML3 chännel function in both EE änd LE/LY under 
different ion änd pH conditions in HEK cells overexpressing TRPML3.  
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3. Two-Pore Channel Function Is Crucial for the Migration of Invasive 
Cancer Cells 
 
Ong Näm Phuong Nguyen*, Christiän Grimm*, Linä S. Schneider, Yu-Kai Chao, 
Cärinä Atzberger, Kärin Bärtel, Annä Wätermänn, Melänie Ulrich, Doris Mäyr, 
Christiän Wähl-Schott, Märtin Biel, änd Angelikä M. Vollmär 
 
Cancer Research. 2017 Mär 15;77(6):1427-1438. *equal contribution 
 
Metastatic invasion is the key feature that distinguishes cancer cells from all other 
cells. Metastases formation is the major cause of cancer-related deaths. The ability 
of cancer cells to migrate from primary disease sites is attributed to the mutation 
of genes that regulate the production of proteins that normally tether cells to their 
surrounding tissues. Decreased synthesis in cancer cells of a number of substances 
that bind them to neighboring cells, together with the abnormal synthesis of 
enzymes capable of degrading the bonds between cells and tissues, allow cancer 
cells to escape the primary tumor site. 
 
In this study, we report the NAADP and PI(3,5)P2 sensitive Ca2+-permeable cation 
channels in the endolysosomal system of these cells, two-pore channels (TPC), as 
candidate targets for the treatment of invasive cancers because inhibition of TPCs 
was found to abrogates metastatic cancer cell migration. Disrupting TPC function 
halted träfficking of β1-integrin and resulted in its accumulation in EEA1-positive 
early endosomes, therefore metastatic invasive cancer cells were rendered unable 
to form leading edges that are required for migration. Our findings link TPC to 
cancer cell migration and provide a preclinical proof of concept for their candidacy 
as targets to treat metastatic cancers. 
 
Declaration of contribution: I performed endolysosomäl pätch clämp experiments 
chäräcterizing TPC2 chännel function änd the inhibitory effect of teträndrine on 
TPC2 in T24 cäncer cell.  
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4. TPC2 polymorphisms associated with a hair pigmentation 
phenotype in humans result in gain of channel function by 
independent mechanisms 
 
Yu-Kai Chao*, Verenä Schludi*, Cheng-Chäng Chen, Elisäbeth Butz, O. N. Phuong 
Nguyen, Märtin Mu ller, Jens Kru ger, Cläudiä Kämmerbäuer, Mänu Ben-Johny, 
Angelikä M. Vollmär, Cärolä Berking, Märtin Biel, Christiän A. Wähl-Schottä, änd 
Christiän Grimm 
 
PNAS. 2017 Oct 10;114(41):E8595-E8602. 
* equal contribution 
 
Two polymorphisms (M484L and G734E) in the endolysosomal ion channel TPC2 
have been reported to be associated with a shift in hair color from brown to blond 
in a genome-wide association study. Later on the role of TPC2 in hair color 
pigmentation had also been described showing that TPC2 regulates the pH and 
size of melanosomes inside the melanocytes and that loss of TPC2 activity by 
knockout or knockdown leads to a strong increase of melanosomal pH, resulting 
in the higher melanin production. However functional, i.e. electrophysiological 
data of how TPC2 polymorphisms affect channel function was still missing. 
 
In this study, we characterized these two TPC2 polymorphisms by using the 
endolysosomal patch-clamp technique and found that both polymorphisms result 
in TPC2 channel gain-of-function by different mechanisms. TPC2 M484L 
polymorphic variant shows increased sensitivity to the endogenous ligand 
PI(3,5)P2 because of a channel pore dilation; besides, TPC2 G734E polymorphic 
variant shows less sensitivity to ATP-Mg inhibition due to the weaker interaction 
between mTOR complex and the TPC2 channel. Electrophysiological data from 
fibroblast cell lines isolated from human donors carrying the different 
polymorphic variants further validated our findings in HEK cells expressing the 
different TPC2 polymorphisms.  
 
Declaration of contribution: In this study I contributed the lysosomäl pätch clämp 
recordings on HEK cells expressing hTPC2 with different polymorphic väriänts. In 
äddition I performed recordings on different humän fibrobläst cell lines isoläted 
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from donors with distinct TPC2 polymorphisms, contributed dose response 
curves of PI(3,5)P2 änd ässessed ATP-Mg äs well äs mTOR inhibitor effects on TPC2 
in HEK cells.  
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IntroDuctIon
The membranes of intracellular organelles make up the majority 
of the total cell membrane and harbor a large number of trans-
membrane proteins, including many ion channels. Among these 
intracellular channels, ion channels localized in endolysosomal 
membranes have recently generated particular interest. They are 
fundamental to the control of numerous physiological functions, 
including endolysosomal ion and pH homeostasis, regulation of 
endolysosomal resting membrane potential, catabolic export 
of amino acids, vesicle trafficking and vesicle fusion1–7. Loss of 
function or dysfunction of endolysosomal ion channels under-
lies human metabolic diseases such as nonalcoholic fatty liver 
disease and hyperlipoproteinemia, affects the development of 
certain infectious diseases and is implicated in the development 
of congenital lysosomal storage disorders and neurodegenerative 
diseases such as Alzheimer’s disease and Parkinson’s disease1,6–11. 
For example, Hockey et al. recently demonstrated that defects 
such as enlarged and aggregated lysosomes in fibroblasts from 
Parkinson’s disease patients with the common G2019S muta-
tion in LRRK2 (leucine-rich repeat kinase 2) could be corrected 
by molecular silencing of TPC2 (two-pore channel 2), phar-
macological inhibition of TPC regulators (Rab7, NAADP and 
PtdIns(3,5)P2) and buffering local Ca2+ increases11. The strong 
link between dysfunction or loss of function of these channels 
and the pathophysiology of human disease indicates that these 
ion channels have a high potential to become clinically relevant 
drug targets. In addition, organelle proteomic studies suggest that 
there is a plethora of other putative ion channels and transport-
ers (>70) in endolysosomes that remain to be characterized12,13.
Development of the protocol
To functionally characterize endolysosomal ion channels in 
detail, electrophysiological methods are inevitable. In the past, 
these channels could not be analyzed in detail because of the 
lack of direct methods, in particular because of the inaccessibil-
ity of these channels by the patch-clamp method. In addition to 
technical problems arising from the intracellular localization of 
these channels per se, the small sizes (~0.5 µm) of endosomes 
and lysosomes preclude the use of standard patch-clamp elec-
trodes. To circumvent this, endolysosomal channel proteins can 
be purified and reconstituted in artificial membranes or bilay-
ers14–17. Alternatively, Ca2+-conducting endolysosomal ion 
channels can be analyzed by Ca2+-imaging techniques. However, 
all these methods suffer from methodological drawbacks (see 
‘Comparison with alternative approaches’ section). Recently, 
we used a planar patch-clamp approach that is well suited to 
direct analysis of endolysosomal ion channels such as TRPML 
channels (also called MCOLN channels or mucolipins) and 
TPCs18–22, and also to characterization of bacterial and mito-
chondrial ion channels. Although the planar patch-clamp method 
is technically straightforward to perform even at high efficiency, 
the most substantial limitation of this method is that Ca2+ can-
not be omitted on one side of the endolysosomal membrane 
(a high Ca2+ concentration is required for successful gigaseal 
formation, as described previously23), which limits the degree 
of freedom of experimental design. Here, we describe a method 
that overcomes this problem by using the conventional patch-
clamp technique. In combination with pharmacological tools 
to enlarge endolysosomal vesicles to a degree suitable for man-
ual patch-clamp (>4 µm), this method is very powerful. In this 
protocol, a set of techniques is provided that is well suited to 
the characterization of ionic currents from endolysosomes 
and that does not have major technical restrictions or experimen-
tal restraints. The protocol assumes basic knowledge of patch-
clamp methods.
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according to proteomics analyses, more than 70 different ion channels and transporters are harbored in membranes of intracellular 
compartments such as endosomes and lysosomes. Malfunctioning of these channels has been implicated in human diseases such as 
lysosomal storage disorders, neurodegenerative diseases and metabolic pathologies, as well as in the progression of certain infectious 
diseases. as a consequence, these channels have engendered very high interest as future drug targets. Detailed electrophysiological 
characterization of intracellular ion channels is lacking, mainly because standard methods to analyze plasma membrane ion channels, 
such as the patch-clamp technique, are not readily applicable to intracellular organelles. Here we present a protocol detailing how to 
implement a manual patch-clamp technique for endolysosomal compartments. In contrast to the alternatively used planar endolysosomal 
patch-clamp technique, this method is a visually controlled, direct patch-clamp technique similar to conventional patch-clamping.  
the protocol assumes basic knowledge and experience with patch-clamp methods. Implementation of the method requires up to 1 week, 
and material preparation takes ~2–4 d. an individual experiment (i.e., measurement of channel currents across the endolysosomal 
membrane), including control experiments, can be completed within 1 h. this excludes the time for endolysosome enlargement,  
which takes between 1 and 48 h, depending on the approach and cell type used. Data analysis requires an additional hour.
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Overview of the procedure
In our recent studies1,8, we adopted a robust methodology that 
has recently been used by other groups2,24. This approach per-
mits efficient endolysosomal patch-clamping of ion channels 
from heterologous expression, as well as from native cells such as 
cardiomyocytes, hippocampal neurons or macrophages. Initially, 
a suitable cell system for endolysosomal patch-clamping must be 
selected. Then, the specific expression of the ion channel in ques-
tion must be confirmed in the endolysosomal system. This can 
be done by standard molecular biology and cell culture methods, 
and will not be described in this protocol. Once a suitable cell 
system is selected and the expression of the ion channels in ques-
tion is verified, the actual patch-clamp experiment can be per-
formed. The following five stages, most of which are also applied 
in conventional patch-clamping, have been specifically optimized 
(see Fig. 1 for an overview of the PROCEDURE): enlargement of 
endolysosomal vesicles using one of the described approaches 
(Steps 11 and 12), the design and production of high-end glass 
electrodes (Steps 13–27), the dissection and release of endolyso-
somal vesicles from the cells into the culture dish (Steps 28–38) 
and the actual patch-clamp experiment (39–55). As a whole, 
the technique provides a valuable tool for high-efficiency state-
of-the-art recordings from endolysosomal ion channels. In the 
‘Experimental design’ section, we outline the key modifications 
that are central to the optimal performance of the protocol.
Applications of the assay and target audience
This protocol is dedicated to scientists working on endolyso-
somal ion channels. Using endolysosomal patch-clamp technol-
ogy, known endolysosomal ion channels can be analyzed, and 
novel channels and transporters can be discovered and character-
ized. The technique outlined in this protocol will open a broad 
spectrum of novel applications dealing with endolysosomal ion 
channel function and dysfunction. The method can also com-
plement drug screening to identify new drugs for lysosomal ion 
channels. Compounds identified in such a screen could be vali-
dated individually using the robustness of lysosomal patch-clamp. 
Our protocol provides the scientific framework that enables the 
experimenter to establish direct methodologies for electrophysi-
ological recordings of endolysosomal ion channels and to directly 
address related scientific questions. The technology can be modi-
fied for recordings of other endolysosomal-like organelles, such 
as phagosomes25 or melanosomes26, and, potentially, of other 
intracellular vesicles and organelles, such as secretory granules 
or Golgi-derived vesicles. However, the technique might not be 
applicable to very large organelles with a more complex architec-
ture—in particular, endoplasmic reticulum (ER).
Advantages and limitations of the assay
The key advantages of this method for recording endolysosomal 
ion channels are as follows:
The method is direct. It allows for direct measurements of 
endolysosomal ion channels in their quasi-native environment. 
There is no need for biochemical isolation or purification of 
endolysosomal vesicles. The method is suitable for studies of 
already-known endolysosomal ion channels and, more impor-
tantly, for the discovery and characterization of new ones.
The method is very robust. It is possible to control most param-
eters just as in conventional patch-clamp.
•
•
The protocol has broad applications in cell lines such as HEK293 
cells and native cells.
The level of technical challenge is comparable to that of conven-
tional patch-clamp.
The protocol generally does not require specific equipment (requires 
only standard electrophysiological equipment); one exception is the 
electrode puller. We recommend using a Sutter model P-97.
Visual control allows identification of specific target vesicles 
expressing fluorescent-protein-tagged channel variants using epi-
fluorescence microscopy. Enlarged lysosomes are fragile spheri-
cal vesicles that can be discriminated from other intracellular 
organelles. Visual control is vital for selecting the correct vesicles and 
for monitoring during the subsequent patch-clamp experiment.
The method also has some potential drawbacks and pitfalls:
Enlargement of endolysosomes using small molecules or expres-
sion of mutant Rab variants bears the risk of potential artifacts. 
First, artifacts could result from changes in endolysosomal mem-
brane structure and/or composition of lipids and proteins. Sec-
ond, small molecules could directly interact with the ion channel 
in question and affect the properties. The mechanisms regarding 
how vacuolin-1 and the other molecules enlarge endolysosomes 
are still not fully understood.
Similar to conventional patch-clamp in general, there is a poten-
tial risk for selection bias. Given that dissection, seal formation 
and recording of large lysosomes are much easier as compared 
with those of small ones with this protocol, the experimenter 
might be tempted to preferentially select very large endolyso-
somes (as opposed to planar patch-clamp).
It is difficult to exchange the electrode solution with this protocol 
(as opposed to planar patch-clamp).
Production of patch pipettes is difficult, and optimization of the 
protocol for the P-97 puller is time-consuming.
It is quite probable that cytosolic factors such as small molecules 
or proteins associated with endolysosomal membranes are altered 
or lost when cells are sliced and endolysosomes are dissected and 
released from the cytosol. This loss of factors could lead to a change 
or lack in regulation of properties of the channel in question.
Comparison with alternative approaches
A limited number of methods are currently available for the char-
acterization of endolysosomal and other intracellular ion channels. 
The standard method used is to reconstitute purified ion channel 
•
•
•
•
•
•
•
•
•
Preparation of HEK293 cells for endolysosomal recordings
Enlargement of endolysosomal vesicles
Preparation of recording glass pipettes
Isolation of endolysosome from cell
Formation of configuration of whole-endolysosomal recording
Timing 3–12 min
Timing 1–10 min
Timing 1–10 min
Timing 2–4 d
Timing 1–48 h
Steps 12–26
Steps 27–37
Step 11
Steps 1–10
Steps 38–55
Figure 1 | Overview of the Procedure: whole-organelle patch-clamp approach.
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proteins or membranes of isolated cell organelles into synthetic 
phospholipid bilayers14,15. Alternatively, purified channel proteins 
or membrane vesicles can be reconstituted into liposomes that are 
quite large and can be analyzed by means of conventional patch-
clamp16,17. The main conceptual drawback of these methods is 
that the ion channel proteins are extracted from their physiological 
environment. This procedure bears a high risk of losing important 
factors, such as critical components of the lipid membrane, as 
well as specific modulators and accessory subunits that are associ-
ated in vivo with the ion channel protein. Other approaches for 
investigating intracellular ion channels in organelles include Ca2+ 
imaging27. This technique is an option only for ion channels per-
meable to Ca2+. For these experiments, either Ca2+ indicators or 
better genetically encoded Ca2+ sensors can be used. One option 
is to design fusion proteins that combine genetically encoded Ca2+ 
sensor proteins with endolysosomal ion channels. Most endolyso-
somal ion channels’ N and C termini face the cytosolic side of the 
lysosomal membrane. Therefore, attaching genetically encoded 
Ca2+ channels to either the N or the C terminus resolves Ca2+ 
signals in the ultimate proximity of the cytoplasmic opening of 
the channel in question. However, these methods lack some advan-
tages of patch-clamp analysis, including the ability to directly 
access ion channels. Furthermore, disrupting lysosomal targeting 
motifs has been shown to effectively (mis)target endolysosomal 
ion channels to the plasma membrane, where they are accessible to 
conventional patch-clamp experimentation28. Finally, we recently 
applied a planar patch-clamp approach to electrophysiologically 
analyze endolysosomal ion channels. It is possible to efficiently 
obtain electrophysiological recordings using this approach. The 
planar patch-clamp method allows reliable and efficient charac-
terization of currents from isolated endolysosomes. Furthermore, 
a direct side-by-side comparison of electrophysiological experi-
ments using planar patch-clamp and endolysosomal patch-clamp 
(using the protocol described here) revealed similar functional 
properties for TRPML1, TRPML3, TPC1 and TPC2, which cross-
validates these methods. The advantages of planar patch-clamp 
are that even small and native endolysosomes that have not been 
enlarged can be analyzed. Furthermore, in planar patch-clamp 
there is no selection bias, as there is inherently no visualization 
by a microscopy or micromanipulation system. Disadvantages 
of planar patch-clamp are that purification of endolysosomal 
vesicles is required and that the method lacks visual control by 
microscopy optics and mechanical control via a micromanipu-
lator. Furthermore, no inside-out or outside-out patches can be 
produced. The most noteworthy drawback of planar patch-clamp 
is the low degree of freedom in the design of solutions—for exam-
ple, it is not possible to record in Ca2+-free solution.
Experimental design
Here, we present a comprehensive protocol for endolysosomal 
patch-clamp. There are technical challenges in the experimental 
aspect of the protocol (expression of endolysosomal channels 
in heterologous systems, preparation of native cells, enlarge-
ment of endolysosomes, design of patch electrodes, dissection of 
endolysosomes), as well as in the acquisition and the analysis of 
patch-clamp data.
Generation and validation of heterologous and native cell 
systems suitable for endolysosomal patch-clamp. In general, 
any cell type, such as HEK293 cells, transiently or stably express-
ing endolysosomal ion channels, as well as native cells prepared 
from wild-type or genetically modified mouse lines, can be used 
for endolysosomal patch-clamp. For rules and considerations 
in regard to how to generate, express and validate expression 
of tagged and nontagged ion channel variants in different cell 
lines, we refer to standard literature for detailed protocols on 
transfection, generation of stable cell lines and preparation and 
cultivation of native cells from mice. In this protocol, we will 
focus on HEK293 cells expressing endolysosomal ion channels to 
describe the endolysosomal patch-clamp approach.
Cell lines transiently or stably expressing channel variants 
tagged by fluorescent proteins attached to the N- or C-terminal 
cytosolic part of the channel protein are useful because the specific 
expression in the correct vesicle system can be confirmed by con-
focal imaging in living cells. This can be done by coexpressing 
marker proteins such as Rab5 for early/sorting endosomes, Rab11 
for recycling endosomes, and Rab7 or LAMP1 for late endosomes 
and lysosomes. Here, it should be taken into consideration that 
overexpression of channel proteins or marker proteins may 
change endolysosomal morphology (e.g., diameter). Cells can 
also be fixed and immunocytochemistry can be performed 
to find out which specific vesicle type expresses the desired ion 
channel. There are excellent commercially available antibodies 
that selectively stain early/sorting endosomes (Rab5), recycling 
endosomes (Rab11) or late endosomes/lysosomes (Rab7/LAMP1). 
For these experiments, either tagged or untagged channel proteins 
can be used. If specific antibodies are available to reliably detect 
the desired endolysosomal channel, immunocytochemistry can 
be performed in cells expressing untagged channel variants or 
in native cells.
It is reasonable to start with cell lines stably expressing 
tagged channel variants. As soon as it is clear in which vesicle 
the channel is expressed, the tag can be omitted and cell lines 
stably expressing the untagged channel variant can be used for 
further experiments. The advantage is that potential artifacts 
associated with fusion of fluorophores to channels can be ruled 
out. Alternatively, bicistronic expression plasmids can be used, 
which lead to expression of the untagged channel protein in 
one reading frame and a fluorophore in another reading frame. 
By this approach, cells expressing the channel are marked by 
the fluorophore.
We also use native cell lines for endolysosomal patch-clamp 
experiments. For example, immortalized mouse embryonal 
fibroblasts (MEF cells) are very convenient cell lines for endolyso-
somal research in general. We produced and patch-clamped MEF 
cells from wild-type mice and genetically modified mouse models 
lacking TRPML channels or TPCs. These lines can be cultured for 
4–8 passages for endolysosomal patch-clamp experiments. Mutant 
MEFs can also be engineered using the CRISPR/Cas system or 
standard shRNA-mediated knockdown approaches. In addition to 
MEFs, we use primary cells such as cardiomyocytes, hippocampal 
neurons, glial cells, peritoneal and other tissue macrophages, hepa-
tocytes, and kidney and bladder epithelial cells. For native cells, 
specific expression of the desired ion channel in distinct endolyso-
somal vesicles is determined as described above for cell lines.
We will outline five important stages that must be optimized 
for endolysosomal patch-clamp. These stages are described in 
step-by-step detail in the PROCEDURE.
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Enlargement of endolysosomal vesicles. For manual endolyso-
somal patch-clamp experiments, it is very important to enlarge 
endolysosomes to a degree sufficient for manual experimentation. 
To enlarge late endosomes and lysosomes, either PIKfyve inhibitor 
YM201636 (ref. 9) or vacuolin-1 (ref. 2) can be used. However, 
the latter is less specific because it also increases the size of early 
endosomes and possibly other vesicle populations29. Transient 
transfection of mutated marker proteins such as Rab5Q79L (for 
early endosomes) can also be applied to enlarge distinct endolyso-
somal vesicles. However, one noteworthy advantage of pharma-
cological tools is that they are acutely applied and can lead to 
substantial vesicle enlargement within a few hours. Furthermore, 
these compounds do not seem to have an impact on membrane 
proteins and membrane components during measurements.
Results of effective treatment are shown in Figure 2. A video dem-
onstrating the enlargement process over a period of 1 h is shown 
for vacuolin-1 (Supplementary Video 1 and Supplementary 
Fig. 1; scale bar, 10 µm). It is very important to determine the opti-
mal concentration and time required to enlarge specific vesicles 
in different cell types. These parameters must be optimized for 
individual cell types. We recommend starting with testing more 
than one method for enlarging endolysosomes. Begin with cell 
lines expressing tagged channel variants and analyze the effect 
of the procedure by live-cell confocal microscopy. Confirm the 
identity of enlarged vesicles either by coexpression of tagged ion 
channels or by measurement of marker proteins. Alternatively, 
use immunocytochemistry and specific antibodies that detect the 
tagged or native ion channel along with antibodies that specifically 
detect marker proteins for early endosomes, recycling endosomes 
or late endosomes/lysosomes. In patch-clamp experiments, results 
obtained with different methods of enlarging endolysosomes 
should be compared to ensure that there are no artifacts relating 
to a particular substance.
Design and fabrication of glass pipettes for endolyso-
somal patch-clamp. The greatest challenge with endolyso-
somal patch-clamp is the production of suitable electrodes. 
In fact, in our experience 65% of the time required for endolyso-
somal patch-clamp is spent on the production of these electrodes. 
Several puller systems are available that can reliably be used for 
the production of high-end patch-clamp electrodes. We use a 
Sutter model P-97 puller. Alternatively, pipettes may be produced 
using other pullers such as the Narishige puller (PC-10). However, 
we have used this puller with very limited success, and there-
fore we cannot recommend this puller to generate pipettes for 
endolysosomal patch-clamping. To patch large or medium-sized 
native endolysosomes, the DMZ puller, in combination with 
thick-walled glass electrodes with a very small opening diameter, 
may be used. Optimal pipette geometry and pipette resistance are 
essential to the formation of high-resistance seals (gigaseals) with 
the membrane of the lysosome or organelle of interest. The opti-
mal geometry of patch pipettes for endolysosomal patch-clamp 
is shown in Figures 3 and 4. To obtain highly efficient pipettes, 
we use a six-cycle pulling program (Table 1; Fig. 3c). On the basis 
of our experience, patch electrodes optimal for endolysosomal 
recordings have a pipette resistance of 5–8 MΩ (Table 2). The 
resistance of the pipette used for recordings is mainly the result 
of the geometry of the pipette, the characteristics of the glass and 
the internal solution used. Thick-walled glass capillaries should 
be used for pipette fabrication. In comparison with pipettes used 
for whole-cell recording, pipettes used for endolysosomal patch-
clamp have much higher resistance.
Dissection and release of endolysosomal vesicles. The next 
important stage is the dissection and release of enlarged 
endolysosomes using glass electrodes and patch-clamp micro-
manipulators. For successful dissection, it is important that cells 
be tightly attached to the coverslip. This is done by coating the 
coverslips with poly-l-lysine. The entire procedure is shown in 
Supplementary Videos 2 and 3. Figure 5 gives an overview of the 
dissection procedure in two planes.
Patch-clamp experiments in whole-endolysosome configura-
tion.  After dissection of lysosomes, the dissection electrode is 
exchanged for a recording electrode. As in whole-cell patch-clamp, 
the pipette is attached to the endolysosomal membrane using 
micromanipulators. We recommend using a water objective with 
40× or 60× magnification to visualize endolysosomes. Seal forma-
tion is monitored in a manner similar to whole-cell patch-clamp 
by applying a voltage step pulse of 5 mV (pulse duration 5 ms) 
from a holding potential of 0 mV. During this step, slight suction 
is applied via a plastic pipette pressure system connected to the 
pipette holder (the pipette pressure system includes plastic three-
way blood transfusion taps and 1-ml syringes). Successful gigaseal 
formation is indicated by a decrease to <10 pA of the current 
amplitude evoked by the voltage pulse of 5 mV. Endolysosome-
attached configuration is established once a stable gigaseal has 
been reached. From this configuration, the whole-endolysosomal 
configuration can be established by rupturing the membrane by a 
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Figure 2 | Enlargement of intracellular organelles in HEK293 cells upon 
treatment. (a) Representative confocal images showing the effects 
of YM201636 (800 nM; 5 h) and vacuolin-1 (1 µM, overnight) on the 
enlargement of intracellular vesicles in HEK293 cells transfected with Rab5-
mCherry (red) and Rab7-GFP (green). Scale bars, 5 µm. (b) Zoom-in images 
of the areas within the white squares shown in a. Note that a subpopulation 
of organelles increases to a size allowing successful patch-clamp 
experimentation. Scale bars, 5 µm. All cells were transfected for at least  
24 h before application of reagents and incubated in a 10% CO2 atmosphere 
and at 37 °C during the time of treatment. 
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ZAP pulse (fast voltage pulse—i.e., 0.1–50 ms with −200 to −1,000 
mV). In our experience, suction pulse applied via the mouthpiece, 
similar to that used in whole-cell patch-clamp, does not work.
To conduct the protocol, we assume a basic understanding of 
and as well as experience in performing patch-clamp experiments. 
Details in regard to performance of patch-clamp recordings and 
data analysis are not described (for details see, e.g., The Axon 
Guide for Electrophysiology & Biophysics Laboratory Techniques30). 
Only steps specific to recording endolysosomal preparations are 
described in detail. Conventions for endolysosomal current pres-
entation are as in standard patch-clamp experimentation. Inward 
cationic currents are defined as currents flowing out of the vesi-
cle lumen into the cytosol; outward cationic currents are those 
flowing from the cytosol into the organelle lumen. Therefore, 
current value reads from the amplifier for endolysosomal patch-
clamp must be inverted (invert the y axes by multiplying by −1). 
Furthermore, endolysosomal membrane voltage is defined as 
cytosolic potential with respect to luminal (conventional: extra-
cellular) potential (Supplementary Fig. 2). Therefore, the voltage 
axes must also be inverted. Thus, endolysosomal data are handled 
in the same way as inside-out patch data (for details see ref. 30).
Voltage-clamp mode. In endolysosomal voltage-clamp patch 
experiments, current flowing across the endolysosomal membrane 
is recorded as a function of the controlled input voltage deliv-
ered by either voltage steps or voltage ramps. For endolysosomal 
voltage-clamp experiments, a large range of input voltages 
(e.g., −100 mV to +100 mV) are used.
Passive current components may be present in endolysosomes 
from leak conductance and specific ion-channel-dependent 
background currents. Leak currents are characterized by linear 
current (I)–voltage (V) relations crossing the origin. Leak cur-
rents of endolysosomes isolated from nontransfected HEK293 
cells are in the range of <50 pA (at 100 mV); the underlying ion 
channels are most likely potassium/sodium conductance channels 
and chloride channels.
In case of voltage-activated ion channels, leak current compo-
nents could be subtracted from the measured currents by recording 
a series of scaled voltage pulses just before or after the voltage 
pulse used to elicit voltage-gated endolysosomal currents. These 
scaled pulses are typically one-fourth or one-fifth of the ampli-
tude of the experimental pulses, and the subtraction process is 
referred to as P/4 or P/5 leak subtraction (for details see Cummins 
et al.31). Because of the very small amplitude of leak currents, 
we normally do not use P/4 or P/5 subtraction.
Once high-quality seals are established and background sig-
nals are minimized, specific endolysosomal conductance can 
be recorded. Several ion channels and transporters have been 
reported to be expressed in intracellular vesicles or endolysosomes 
(Fig. 6; Table 3), including TRPML1-3, TRPM2, TRPV2, TPC1-2, 
the potassium channel TMEM175, BK (big potassium) potassium 
channels, P2X4, CAX and chloride channels (CLCs)1,3,5,6,20,22,32–43. 
Although most of these proteins have been reported to be localized 
in certain subsets of endolysosomal vesicles, it is not clear whether 
they are restricted to these vesicles or are more broadly distributed 
and also present in LROs (lysososome related organelles) or other 
vesicles and vice versa. In addition, the distribution of these chan-
nels may differ from one specific cell type to the other.
Whole-cell
patch pipette
Whole-organelle
patch pipette
Heat+
cycles ≤ 5
Heat++
cycles ≤ 4
Cycle 0
Cycle 1
Cycle 2
Cycle 3
Cycle 4
Cycle 5
Cycle 6
Contamination Unbalance
Too narrow
and thin
Too wide
and thick
a b
c d
Figure 3 | Equipment used for the fabrication of optimal patch pipette tips. 
(a) A commercially available pipette puller. (b) Diagram of a conventional 
whole-cell patch-clamp pipette (left) and a whole-endolysosomal  
patch-clamp pipette. (c) Pipettes for endolysosomal patch-clamp after  
each individual pulling cycle are shown. (d) Examples of failed pipettes  
after pulling process are shown. Too much HEAT during the pulling process 
results in too-sharp tips (upper panel), which break the endolysosomal 
membrane. Pipettes may also be contaminated or unbalanced (middle  
panel). Suboptimal pulling conditions can result in pipette tips that are  
too wide or too narrow (lower panel). Heat+ and Heat++, too much heat.
Too wide
and thick
Too narrow
and thin
No gigaseal
Closed end
Perfect
geometry
0.5–0.9 µm <0.3 µm
>
2 
µm
a b
c d
Figure 4 | Fire-polishing of patch-clamp pipettes. (a) Comparison of 
geometrical properties of recording pipettes for patch-clamp before polishing 
(left column) and after polishing (middle and right columns). Pipettes that 
are too wide and thick can result in no gigaseal formation (first row). Closed-
end tip pipettes are produced from tips that are too narrow (second row) or 
by overpolishing. Third row shows ideal pipette geometry. (b) A commercially 
available fire polisher is shown. (c,d) Ideal pipette seen in the vision field 
of the 35× objective microscope lens of the fire polisher before polishing (c) 
and after polishing (d).
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To establish the method and to familiarize yourself with 
endolysosomal ion channels present in the cell and vesicle types 
of interest, we recommend starting with native endolysosomes 
dissected from HEK293 or MEF cells. To monitor total currents 
present in endolysosomes, voltage ramps are useful. We start with 
ramps of different durations, ranging from 100 to 500 ms, and 
different time intervals between the application of individual 
ramps to account for dynamic activation and inactivation gating 
of endolysosomal ion channels. Typical shapes of I–V relations for 
endolysosomal ion channels are shown in Figure 6. TPC1 chan-
nels are voltage-dependent, with an I–V relationship resembling 
those of voltage-gated Ca2+ channels and Na+ channels37. TPC2 
channels do not display voltage-dependent gating and therefore 
display linear I–V relations that can be distinguished from non-
selective linear leak currents by a positive reversal potential of 
~+60–80 mV for standard recording solutions1. There are also 
outwardly rectifying channels such as the BK43 channel and CLC5 
channel currents, and inwardly rectifying ion channels such as 
TRPML1-3 (ref. 6; Fig. 6). Protocols with a family of voltage steps 
separated by a pause interval can also be used. Using these proto-
cols, specific aspects of channel gating, such as I–V characteris-
tics, kinetics and voltage dependence of activation, deactivation 
and inactivation of channels in question, can be examined (see 
the Supplementary Note and Supplementary Table 1 for basic 
theoretical information and equations for patch-clamp).
Depending on the ion channels of interest, intra- and extra-
luminal patch-clamp solutions and voltage-clamp protocols must 
be designed. The specific composition of patch-clamp solutions 
must be adapted to the current of interest. If anionic conductance 
is not the major focus, the currents can be reduced by replacing 
chloride with impermeable anions such as aspartate, gluconate 
or methane sulfonate. In this case, agar bridges, instead of AgCl 
wire, may be used. With anionic conductance reduced, cationic 
currents of interest can be isolated from contaminating currents 
by removal of individual cations. If pharmacological activators or 
blockers of the conductance of interest are available, these can be 
used to dissect currents from contaminating currents. For such 
experiments, initial measurements of the total current are per-
formed, after which the endolysosome is exposed to a drug that 
selectively blocks or activates the current of interest. The current 
of interest is then extracted by calculating the difference between 
currents obtained before and after the exposure to drug. Finally, 
current recordings obtained from cell lines or primary native cells 
prepared from wild-type or knockout mouse lines lacking the 
channel of interest can be compared.
For endolysosomal current recordings, configurations similar 
to those used in whole-cell patch-clamp experiments can be 
used. Endolysosome-attached, whole-endolysosome, inside-out 
and outside-out configurations can be used2. In the first two 
configurations, total current passing through all the channels in 
a particular intracellular vesicle can be measured. By contrast, 
in inside-out and outside-out patches, only currents through 
channels contained in the patch are measured.
Single-channel voltage-clamp recording. In voltage-clamp 
mode, single-channel activity can be recorded using the avail-
able configurations. The typical low density of endolysosomal 
ion channels can make it difficult to obtain patches containing a 
single channel. Thick-walled pipette glass seems to work best for 
manufacturing electrodes with small pipette tips and low capaci-
tance. Coating of the glass with Sylgard or wax can be used to 
lower the pipette capacitance.
Potential experimental problems and specific considerations. 
Current recordings with whole-endolysosomal configuration are 
problematic because of the potential loss of factors from either 
side of the endolysosomal membrane, which could lead to changes 
in gating properties over the time course of the recording period. 
table 1 | Comparison of pulling programs for endolysosomal patch pipettes and conventional patch pipettes.
cycle
endolysosomal patch pipette Whole-cell patch pipette
Heat pull Vel tIMe Heat pull Vel tIMe
1 Value determined by ramp protocol Blank 30 150 Value determined by ramp protocol +10 Blank 40 150
2 25 150 40 150
3 25 150 40 150
4 25 150 40 150
5 25 150 –* –
6 16 150 – –
Air jet P = 400 was applied in all cases. *Polishing is not necessary for conventional patch pipettes.
table 2 | Common ranges of electrical parameters for endolysosomal patch-clamp.
parameter Rpipette Raccess Rseal capacitance leak currents
Range 5–8 MΩ 15–90 MΩ 1–20 GΩ 0.1–5 pF <50 pA
Ω, ohm, F, farad.
©
20
17
 
M
ac
m
ill
an
 P
ub
lis
he
rs
 L
im
ite
d,
 
pa
rt
 
o
f S
pr
in
ge
r 
N
a
tu
re
.
 
A
ll 
rig
ht
s 
re
se
rv
ed
.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. © 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
protocol
nature protocols | VOL.12 NO.8 | 2017 | 1645
First, the pipette solution could dilute or lead to a loss of specific 
modulators (small molecules or other factors) on the luminal 
side of the lysosome lumen and cause time-dependent changes 
in current properties. In addition, components of the pipette or 
cytosolic solution could activate or inhibit specific second mes-
senger pathways regulating endolysosomal ion channels. Using 
the endolysosome-attached mode in conjunction with perforated 
patch would be well suited to solving specific problems arising 
from the luminal side of the endolysosomal membrane. Second, in 
endolysosomal patch-clamp there is the possibility of washout of 
small molecules or factors associated with the cytosolic side of the 
endolysosomal membrane, as this side of the membrane faces the 
recording solution (cytosolic solution). This possibility has been 
shown for ATP, which blocks TPCs from the cytosolic side of the 
membrane. This particular problem can be minimized by careful 
design of bath solutions (e.g., make sure not to include ATP in 
the cytosolic recording solution)1 or controlled for by running 
time-dependent controls and starting specific protocols at con-
sistent times after establishing the whole-endolysosome recording 
configuration. Another problem could be loss because of washout 
of regulatory proteins associated with endolysosomal ion chan-
nels. If these regulatory factors are part of signaling cascades, the 
physiological regulation of the endolysosomal channel is lost. For 
example, the regulation of TPCs by NAADP may depend on such 
a factor that is lost in some preparations whereas it is present in 
other preparations, which could potentially explain the presence 
of NAADP responses in some preparations and not others.
Current-clamp mode. Changes in membrane voltage of endolyso-
somal vesicles can be recorded using current-clamp experiments. 
In this recording mode, changes in the membrane potential are 
recorded as a function of the size of currents injected into the 
endolysosome. It is important to note that the endolysosomal 
membrane potential is defined as the outside potential (i.e., 
cytosolic potential) minus the luminal potential facing the inside 
of the intracellular vesicle (∆Ψ = Vm = Vcytosol – Vlumen (ref. 44)). 
Endolysosomal current-clamp recordings can be used to study the 
resting membrane potential, dynamic changes of the endolyso-
somal membrane potential and the contribution of distinct ion 
channels to this potential. In addition, active changes of endolyso-
somal membrane potential upon opening or closing of the channel 
by specific activators or inhibitors can be analyzed. Furthermore, 
spontaneous and evoked active firing patterns can be recorded 
using current-clamp experiments. Recently, it has been shown that 
in endolysosomes action potential-like firing can be evoked10.
For current-clamp experiments we use MEFs or native cells 
generated from wild-type and genetic mouse lines lacking specific 
endolysosomal ion channels. It is important to use native cells or 
MEFs directly after preparation.
30°
CoverslipIsolationpipette
a
b
c
d
Figure 5 | Dissection procedure for preparation of individual enlarged 
endolysosomes from a single cell. Left panels show the top view of the target 
cell (view via eyepiece). Right panels show the section of the target cell 
along the red dotted line. (a) The glass pipette is pressed against the edge 
of a cell that is close to the enlarged target endolysosome. (b) The pipette 
is quickly pulled away to cut open the cell membrane. (c) The top of the cell 
is pushed with the same glass pipette. (d) The enlarged endolysosome is 
squeezed out through the incision.
TPC1 TPC2
Transporters (e.g., CAX)
H+Ca2+
TMEM175
ClCs
Cl–
K+
pH 4.6
Na+, Ca2+TRPML1/2/3
Ca2+, Fe2+
Zn2+, K+
Na+
P2X4
BK
K+
V-ATPase
Figure 6 | Schematic showing ion channels that have been measured with 
the endolysosomal patch-clamp technique. The cross-shaped graphs show 
the IV curves (current–voltage plots; x axis = voltage, y axis = current)  
of six types of endolysosomal ion channels (TPCs, TRPMLs, P2X4, ClCs,  
TMEM175 and BK) measured with this technique. H+ and Ca2+ gradients in 
endolysosomes are established and maintained by V-ATPases and putative 
Ca2+ transporters (e.g., CAX). Inward current stands for cation flux from the 
lysosomal lumen to the cytosol. ClC, chloride channel; V, vacuolar-type.
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table 3 | Ion channels in intracellular vesicles, the endolysosomal system or lysosome-related organelles.
Ion channel expression Function Human disease
TRPM1  
(ref. 32)
Skin and eyes Tumor suppressor; potential  
role in mediating synaptic  
transmission in bipolar cells
Mutations in TRPM1 are associated  
with congenital stationary night  
blindness, metastasis and poor prognosis 
in melanoma
TRPM2  
(ref. 33)
Brain Oxidant stress sensor,  
mediates H2O2-dependent cell 
death; potential role in lysosomes 
(ADP-ribose-evoked calcium 
release from intracellular  
calcium stores)
Guamanian amyotrophic lateral 
sclerosis/parkinsonism dementia  
complex
TRPM7  
(ref. 34)
Broad Synaptic vesicle function,  
Anoxia-induced cell death
Guamanian amyotrophic lateral 
sclerosis/parkinsonism dementia  
complex
TRPML1  
(refs. 2,4,6, 
7,9,10, 
15,20–22,25)
Broad PI(3,5)P2 activation; PI(4,5)P2 
and sphingomyelin inhibition; 
role in sorting/transport in  
late endocytic pathway;  
regulates lysosomal lipid and  
cholesterol trafficking;  
endolysosomal pH regulation  
and cation/heavy-metal (iron) 
homeostasis; lysosomal  
exocytosis; phagocytosis
Mucolipidosis type IV (MLIV)  
is associated with mutations in  
TRPML1; symptoms include severe  
psychomotor retardation and  
retinal degeneration
TRPML2  
(refs. 6,22)
Highest expression in lymphoid 
 and myeloid lineage
Found in recycling endosomes; 
upregulation in macrophages in 
response to TLR activation
ND
TRPML3  
(refs. 6,10,22,35)
Hair cells of the inner ear, organ  
of corti, utricle, stria vascularis, 
(skin) melanocytes, kidney,  
bladder, lung, liver, olfactory  
bulb, nasal cavity, thymus,  
colon, trachea, brain
Senses lysosome neutralization  
by pathogens to trigger their 
expulsion
Deafness, circling behavior, head  
bobbing and coat-color dilution is  
associated with mutations in MmTRPML3 
(Varitint-waddler mutations Va and VaJ), 
bacterial uropathogenic Escherichia coli 
(UPEC) infection
TRPA1  
(ref. 36)
Primary afferent somatosensory  
neurons present in sensory  
ganglia-containing nociceptors
Thermosensation and  
inflammatory pain; role in  
lysosomes?
Episodic pain syndrome
TRPV2 
 (ref. 37)
Central nervous system, spleen  
and lung
Thermosensation and nociception; 
role in early endosomes?
ND
TRPV5  
(ref. 37)
Intestine, kidney, placenta Ca2+ reabsorption; found in  
early/recycling endosomes;  
interaction with TRPML  
channels?
Osteoporosis, hypercalciuria
TRPV6  
(ref. 37)
Kidney, intestine Ca2+ reabsorption; found in  
early/recycling endosomes;  
interaction with TRPML  
channels?
Alopecia, dermatitis, decreased  
intestinal Ca2+ reabsorption
TRPC3  
(ref. 37)
Heart tissue BDNF-induced chemoattractive 
turning; regulation of  
mitochondrial calcium  
uptake?
Cerebellar ataxia (moonwalker mouse)
(continued)
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Analysis of patch-clamp data. Data obtained by endolysosomal 
patch-clamp experiments are analyzed in the same way as data 
from conventional patch-clamp. We assume that the reader 
is experienced in analyzing data obtained by this method. For 
table 3 | Ion channels in intracellular vesicles, the endolysosomal system or lysosome-related organelles (continued).
Ion channel expression Function Human disease
TRPC5  
(ref. 37)
Cerebral vascular tissue Regulation of growth cone  
extension
Susceptibility to pyloric stenosis
TPC1  
(refs. 2,38)
Broad; highest expression in  
heart and kidney
PI(3,5)P2 activation;  
ATP-sensor; vesicle fusion and 
transport; endolysosomal pH and 
Ca2+ regulation
Virus (Ebola) infection
TPC2  
(refs. 
1,7,8,24,39,40)
Broad NAADP and PI(3,5)P2 activation; 
ATP-sensor; vesicle fusion and 
transport; endolysosomal pH?  
and Ca2+ regulation;  
melanosomal pH regulation?
Virus (Ebola) infection, LDL-cholesterol 
and serum cholesterol accumulation, 
neurodegenerative diseases  
(e.g., Parkinson’s disease)
ClC3 (ref. 5) Broad Acidification of synaptic  
vesicles, endosomes
ClC4 (ref. 5) Broad ND
ClC5 (refs. 5,41) Kidney, intestine Acidification of endosomes Dent’s disease (proteinuria,  
kidney stones)
ClC6 (ref. 5) Nervous system Acidification of late endosomes
ClC7 (ref. 5) Broad Acidification of osteoclast  
resorption lacuna
Osteopetrosis, retinal degeneration, 
lysosomal storage
P2X4 (ref. 42) Broad ATP activation; pH and Ca2+  
regulation
Neuropathic pain
BK (ref. 43) Neuron, smooth muscle, cochlea Ca2+ regulation Epilepsy, neurological disorders
TMEM175 (ref. 3) Nervous system Regulation of lysosomal  
membrane potential and pH
Parkinson’s disease
Tissue expression, function and associated human diseases are summarized from recent studies. Some of these ion channels are also present in other organelles and/or in the plasma membrane.  
BK, big potassium channel; ClC, chloride channel; ND, not determined; P2X4, P2X purinoreceptor subunit 4; TMEM175, transmembrane protein 175; TRP, transient receptor potential channel;  
TRPC, TRP canonical channel; TRPM, TRP melastatin channel; TRPV, TRP vanilloid channel.
detailed information on basic patch-clamp and analysis, we refer 
to—e.g., ref. 30. Analysis depends on the properties of the ion 
channels of interest. Some examples how data are analyzed and 
graphically displayed are given in the ANTICIPATED RESULTS.
MaterIals
REAGENTS
Chemicals
Boric acid (VWR, cat. no. 20185.360) ! cautIon Boric acid is a  
dangerous chemical. Avoid skin contact. Avoid inhalation and contact  
with skin or eyes. Wear protective gear while handling.
Borax decahydrate, sodium borate decahydrate (Sigma-Aldrich,  
cat. no. B9876) ! cautIon Borate may damage fertility or the  
unborn child.
Calcium methanesulfonate (Ca-MSA; Tokyo Chemical Industry,  
cat. no. M0549)
Calcium chloride (CaCl2; VWR, cat. no. 22317.297)
EGTA (Sigma-Aldrich, cat. no. E4378)
HEPES (Carl Roth, cat. no. 6763)
Hydrochloric acid (HCl; VWR, cat. no. 470301) ! cautIon Hydrochloric 
acid is a corrosive acid. Avoid contact with eyes and skin. Wear protective 
gear while handling it.
•
•
•
•
•
•
•
2-(N-Morpholino)-ethane sulfonic acid (MES; Carl Roth, cat. no. 4256)
Poly-l-Lysine hydrobromide (Sigma-Aldrich, cat. no. P1399)
Potassium methanesulfonate (K-MSA; Sigma-Aldrich, cat. no. 83000)
Potassium hydroxide (KOH; Carl Roth, cat. no. 6751) ! cautIon KOH is 
toxic if swallowed. Avoid direct contact, which may cause severe skin burns 
and eye damage. KOH is harmful to aquatic life.
Potassium chloride (KCl; Sigma-Aldrich, cat. no. p9333)
Potassium phosphate monobasic (KH2PO4; Sigma-Aldrich,  
cat. no. P5655)
Sodium chloride (NaCl; VWR, cat. no. 27810.295)
Sodium phosphate dibasic anhydrous (Na2HPO4; VWR,  
cat. no. 470302-660)
Sodium methanesulfonate (Na-MSA; Sigma-Aldrich, cat. no. 304506)
Drugs
Vacuolin-1 (Santa Cruz, cat. no. sc-216045)
PI(3,5)P2 (AG Scientific, cat. no. P-1123)
•
•
•
•
•
•
•
•
•
•
•
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Cell culture
Human embryonic kidney (HEK) 293 cells stably overexpressing the ion 
channels under investigation (DSMZ, cat. no. ACC 305) ! cautIon The 
cell lines used in your research should be regularly checked to ensure that 
the cells are authentic and that they are free from contamination such as 
mycoplasma.
Dulbecco’s modified Eagle medium containing 25 mM glucose (DMEM 
supplemented with 4.5 g/l glucose, pyruvate and GlutaMax; Invitrogen,  
cat. no. 31966-021)
FBS (Biochrom, cat. no. S0615)
Penicillin–streptomycin (penicillin 10,000 units/ml; streptomycin  
10,000 µg/ml; Biochrom, cat. no. A2213)
0.5% Trypsin–EDTA (10×; Gibco, cat. no. 1699348)
TurboFect transfection reagent (Thermo Fisher Scientific, cat. no. R0531)
EQUIPMENT
Cell Culture
Humidified cell culture incubator set to 37 °C, 10% CO2
Water bath, 37 °C
Pipette preparation
Capillary glass and filament (borosilicate glass with filament,  
fire polished, o.d. 1.5 mm, i.d. 0.75 mm, length 10 cm; Sutter Instrument, 
cat. no. BF150-75-10)  crItIcal The correct glass type is essential  
to producing good patch pipettes. 
 crItIcal The protocol is optimized for use in combination with the 
following equipment.
Flaming/Brown-type micropipette puller (Sutter Instrument, cat. no. P-97)
Trough filament, 3.0 mm wide (World Precision Instruments,  
cat. no. FT330B)  crItIcal It is not possible to produce good patch 
pipettes with a box filament.
Microforge with platinum heater (Narishige, cat. no. MF-830)
Patch-clamp setup
Inverted microscope system (Olympus, model no. IX73)
Light source (LEJ, model no. LQ-HXP 120)
Patch-clamp amplifier. For single-channel recordings and whole-endolyso-
some recordings in voltage-clamp mode, it is possible to use a  
HEKA EPC10 (HEKA Instruments, cat. no. 895000) or an Axopatch 200B 
(Molecular Devices). For current-clamp recordings, it is possible to use a 
HEKA EPC10 (HEKA Instruments, cat. no. 895000) or a Multiclamp 700B 
Amplifier (Molecular Devices, model no. 700B)
Multi-micromanipulator systems (Sutter Instrument,  
model no. MPC-200-ROE)
TMC 63-500 Series high-performance lab tables (TMC, model no. 63-500)
Type II Faraday cage (AMETEK)
MicroFil for glass pipette filling (28 gauge, 97 mm long; World Precision 
Instruments, cat. no. MF28G-5)
Syringe for pressure monitoring (1 ml; B. Braun, cat. no. 9166017V)
Stopcock for pressure monitoring (Discofix C; B. Braun, cat. no. 16494C)
Polyethylene tubing (PE-160/10) for pressure monitoring (1 foot; 1.57 mm 
o.d. × 1.14 mm i.d.; Warner Instruments, cat. no. 64-0755)
Data analysis
OriginPro v8.0 (OriginLab, http://www.originlab.com/index.
aspx?go=Products/Origin)
PatchMaster v2×90 (HEKA Instruments, http://www.heka.com/downloads/
downloads_main.html)
pClamp v10 (Molecular Devices, https://www.moleculardevices.com/systems/
conventional-patch-clamp/pclamp-10-software)
Other
24-Well cell culture plate (Cellstar, cat. no. 662160)
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Microscope glass coverslip (12 mm; VWR, cat. no. 631-1577)
Conical tube, 15 and 50 ml (Sarstedt, cat. nos. 62.554.001, 62.548.004)
Eppendorf Research Plus pipette (1,000 µl; Eppendorf, cat. no. 3120000062)
Eppendorf Research Plus pipette (200 µl; Eppendorf, cat. no. 3120000054)
Eppendorf Research Plus pipette (20 µl; Eppendorf, cat. no. 3120000038)
Eppendorf Research Plus pipette (2.5 µl; Eppendorf, cat. no. 3120000011)
Needle (0.9 × 40 mm, 20 gauge; B. Braun, cat. no. 4657519)
Cell culture flask, 25 cm2 (50 ml; Greiner Bio-One, cat. no. 690160)
Pipette tips (1,000 µl; Sarstedt, cat. no. 70.762)
Pipette tips (200 µl; Sarstedt, cat. no. 70.760.001)
Pipette tips (10 µl; Sarstedt, cat. no. 70.1130)
Reaction tube (1.5 and 2.0 ml; Eppendorf Safe-Lock tubes; Eppendorf,  
cat. nos. 0030120086, 0030120094)
Syringe filter, sterile (0.2 µm; VWR, cat. no. 10708S1G43BD)
REAGENT SETUP
Pipette solution (lysosome luminal) Prepare the solution with the  
following reagents (in mM): 140 Na-MSA, 5 K-MSA, 2 Ca-MSA, 1 CaCl2,  
10 HEPES and 10 MES. Adjust the pH to 4.6 with MSA. Adjust the osmolarity 
to 310 mosm/liter with glucose. Sterilize the solution by passing it through  
a 0.2-µm filter, prepare aliquots of 45 ml in 50-ml conical tubes and store  
them at 4 °C for up to 2–4 weeks.
! cautIon Unless otherwise stated, for TPCs the recording pipette  
solution consists of high Na+ and Ca2+ to mimic physiological luminal  
conditions of the lysosome.
 crItIcal To isolate lysosomal cation currents, MSA or gluconate variants 
of chemicals are used instead of chloride salts as impermeable anions.
 crItIcal MES, which is characterized by a midrange pKa (pH ~5 to 6), is 
applied to buffer the pH range between 2.5 and 5.
Bath solution (cytosolic) Prepare the bath solution with the following  
reagents (in mM): 140 K-MSA, 5 KOH, 4 NaCl, 0.39 CaCl2, 1 EGTA and  
10 HEPES. Adjust the pH to 7.2 with KOH. Adjust the osmolarity to  
300 mosm/l with glucose. Sterilize the solution by passing it through  
a 0.2-µm filter, prepare aliquots of 45 ml in 50-ml conical tubes and store 
them at 4 °C for up to 2–4 weeks.
Poly-l-lysine coating solution Poly-l-lysine coating solution is  
0.1 mg/ml of poly-l-lysine in 80 mM boric acid and 10 mM borate,  
sterilized by passing it through a 0.2-µm filter. Freshly prepare the solution 
before use.
Supplemented DMEM Supplement DMEM with 10% (vol/vol) FBS and 
100 U of penicillin–streptomycin per ml. Store it at 4 °C for up to 2–4 weeks; 
warm it to 37 °C in a water bath before use.
PBS Buffer Prepare PBS buffer with the following reagents (in mM):  
137 NaCl, 2.7 KCl, 10 Na2HPO4 and 2 KH2PO4. Adjust the pH to 7.4 with 
HCl. Prepare 500-ml aliquots, heat-sterilize them and store them at room 
temperature (21–23 °C) for up to 6 months.
0.05% (vol/vol) Trypsin Dilute 0.5% (vol/vol) trypsin at a 1:10 ratio with 
distilled sterile H2O, prepare 10-ml aliquots in 15-ml conical tubes and store 
them at −20 °C for up to 2–4 months; warm the aliquots to 37 °C in a water 
bath before use.
Preparation of coated coverslips Microscope glass coverslips are autoclaved 
and exposed to poly-l-lysine coating solution for at least 24 h. Aspirate off 
the poly-l-lysine solution, rinse the coverslips five times with dH2O and store 
them in dH2O at room temperature for up to one month. Before plating cells, 
place one coverslip into each well of a 24-well plate. Spread 0.5–1 ml of PBS 
on each coverslip and aspirate. Allow the coverslips to dry completely under a 
laminar flow hood for at least 15 min.
•
•
•
•
•
•
•
•
•
•
•
•
•
proceDure
preparation of HeK293 cells for endolysosomal recordings ● tIMInG 2–4 d
1| Maintain HEK293 cells (passages 1–16) in supplemented DMEM and keep them at 37 °C in a humidified atmosphere  
of 10% CO2-containing air.
2| Treat HEK293 cells cultured in a 25-cm2 flask with 0.5 ml of 0.05% (vol/vol) trypsin for 5 min in a 37 °C  
incubator (10% CO2).
3| Typically, after 5 min cells are detached; otherwise, incubate for another 5 min.
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4| Add 4.5 ml of supplemented DMEM to dilute the trypsin.
5| Pipette the cell suspension up and down several times.
6| Add 0.5 ml of cell suspension to a new cell culture flask (8 × 105 per flask), add 4.5 ml of supplemented DMEM and  
incubate at 37 °C in a humidified atmosphere of 10% CO2-containing air for 2–3 d, then split the cells again.
7| Add 400 µl of cell suspension (2–4 × 105 cells) to 8 ml of supplemented DMEM in a 15-ml conical tube.
8| Gently turn the tube upside down 2–3 times. Next, add 1 ml of supplemented DMEM with cells to eight wells of  
a 24-well plate containing poly-L-lysine-coated 12-mm glass coverslips.
9| One or two days before patch-clamp experiments, transfect the cells with Turbofect according to the manufacturer’s 
protocol to generate cells transiently expressing TPC2 or TRPML1.
 crItIcal step Fluorophore-tagged endolysosomal channel proteins are very helpful in identifying channel-protein-
expressing endolysosomes used for whole-endolysosome patch-clamp recordings.
10| Grow the cells until they are 40–70% confluent (1–5 × 105 cells per well).
enlargement of endolysosomal vesicles ● tIMInG 1–48 h, depending on the option followed
11| Add the precise concentration of pharmacological tool(s) to cell culture dishes or wells and incubate at 37 °C until  
enlarged vesicles begin to form. The size of enlarged endolysosomes can reach up to 1–10 µm depending on the tool  
compound, incubation time and cell type.
12| If you are proceeding to enlarge unspecific endolysosomes for electrophysiological studies, follow option A. If you are 
preparing for specific electrophysiological measurements of late endosomes/lysosomes, follow option B.
(a) unspecific endolysosome enlargement using vacuolin-1 ● tIMInG at least 1 h
 (i)  Add vacuolin-1 to the culture medium and incubate at 37 °C and 10% CO2. 
 crItIcal step Different cell types can be treated with 1–5 µM vacuolin-1 for 1 h to multiple days in culture4,34,35. 
The optimal concentration and time of treatment should be determined experimentally. For example, we have treated 
macrophages with 1 µM vacuolin-1 for 1 h; COS-1, HEK293 and fibroblasts have been treated overnight with 1 µM 
vacuolin-1. Cardiomyocytes and skeletal muscle cells were treated with 5 µM vacuolin-1 for 24–48 h. 
 crItIcal step Perform Step 12A(i) within 1–2 h of performing Step 11.
(b) late endosome/lysosome enlargement using YM201636 ● tIMInG at least 1 h
 (i)  Add YM201636 to the culture medium and incubate at 37 °C and 10% CO2. 
 crItIcal step For HEK293 cells, use 0.4 µM YM201636 overnight or 0.8 µM YM201636 for 2 h. For macrophages, 
use 0.4 µM YM201636 for 1–3 h. 
 crItIcal step Perform Step 12B(i) within 1–2 h of performing Step 11. 
 crItIcal step YM201636 specifically enlarges Rab7- and LAMP-1-positive late endosomes and lysosomes, not 
Rab5-positive early endosomes (Fig. 2). Note, however, that on average YM201636-enlarged vesicles are slightly 
smaller than vacuolin-1-enlarged vesicles (3–8 µm). 
 crItIcal step Most cells are detached after prolonged treatment (>24 h for HEK293/ >4 h for macrophages)  
with a high concentration of YM201636 (>800 nM). YM201636-enlarged vacuoles shrink and vanish after 6–12 h  
when treated with a low concentration (<400 nM).
pulling glass pipettes ● tIMInG 1–5 min per pipette
 crItIcal Pipette production is critical because the intracellular organelle membranes of the endolysosomes are fragile. 
The 6-cycle pulling procedure is validated for the Sutter Instrument P-97 puller with trough filament in combination with  
the Sutter Instrument BF150-75-10 glass pipette. Pulling procedures using other pullers and different glass pipettes will 
require individual optimization (for the critical procedure of pipette fabrication, see Steps 19–26).
13| Mount the glass capillary onto the puller for the fabrication of the patch pipette as described in the manufacturer’s protocol.
14| Run a RAMP test with the puller to determine a heat value (HEAT) that will melt the glass capillaries under your  
experimental conditions (e.g., room temperature, filament, glass) without burning out the heater filament.
 crItIcal step Parameters may need to be varied to produce desired pipettes if the filament of the puller is aged. Refer to 
the Sutter Instrument Pipette Cookbook (https://www.sutter.com/MICROPIPETTE/p-97.html).
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15| Design a new pulling program for the Sutter Instrument puller with six individual pulling cycles using the HEAT,  
velocity (VEL) and time (TIME) parameters given in table 1. Set the HEAT to the value determined in Step 14.
! cautIon The parameters in table 1 may require individual optimization.
16| Press the green ‘Pull’ key on the keypad.
 crItIcal step The capillary should be separated during the sixth cycle to produce two patch pipettes. Separation during 
earlier cycles will produce pipettes tips that are too sharp for seal formation (Fig. 3d, upper panel).
17| Loosen the clamping knobs and remove the pipettes from the puller.
18| Inspect the pipette tips with the eyepiece of a microforge and determine the opening diameter, sharpness and geometry. 
The tip opening should be 0.5–0.9 µm in diameter (Fig. 4a, left).
If the tip of the pipette is too wide (>1 µm) or too thick (Fig. 3d, lower panel; Fig. 4a, left), increase HEAT parameter of 
the sixth pull by 5 units or increase the VEL parameter by 1 unit for the fabrication of the next pipette. If the tip is too  
narrow and thin, decrease the parameters accordingly.
 crItIcal step Optimal HEAT and VEL parameters for the sixth cycle must be determined after each pulling process.  
The VEL parameter for the fifth cycle is used to further adjust, if required.
19| Discard pipettes that are too sharp, too wide or too thin. Also discard pipettes with dust or protruding pieces of glass 
and pipettes with rough and unbalanced ends (Fig. 3d).
 Pipettes with suboptimal geometry can be used to produce dissection pipettes in Steps 28–38.
 crItIcal step At this stage, ~50% of the generated pipettes are not suitable for use in whole-endolysosomal  
patch-clamp experimentation.
 crItIcal step Immediately polish pipettes with the correct tip size with a microforge (Fig. 4b).
Fire polishing patch-clamp pipettes using a microforge ● tIMInG 1–3 min per pipette
20| Place the patch pipette in the pipette holder of the microforge according to the manufacturer’s protocol.
21| Use the 35× objective lens to inspect the pipette tip (in combination with the 15× eyepiece lens, this results  
in a 525-fold magnification).
22| Move the patch pipette close to the filament with the micromanipulator.
! cautIon The filament will expand during the process of heating.
 crItIcal step Always place the pipette tip in the same area of the vision field of the microforge. 3/4 to 9/10 of the  
heat filament should be at a lower position and in the bottom of the vision field. Place the tip slightly higher than the  
center of the scale.
23| Set the temperature wheel to graduation level 80.
 crItIcal step Adjust the temperature level according to your experimental conditions (e.g., room temperature,  
glass type, distance to pipette tip).
24| Turn the heater on with the foot switch and apply a brief heat pulse (1–2 s).
25| Monitor the polishing process through the eyepiece of the microforge.
 crItIcal step The aim is to briefly melt the tip so that the glass can flow, resulting in a final tip geometry that is not  
too sharp, so that the pipette does not penetrate the membrane of the vesicle against which it is pressed and can efficiently 
promote seal formation. After final polishing, the inner path of the pipette tip should be very narrow, straight and linear 
(Fig. 4a; supplementary Video 4). A steep taper, which corresponds to a blunt tip, leads to lower pipette resistance for  
the same opening diameter. The final resistance also depends on recording solutions in the different experimental designs.  
The optimal recording pipettes usually had resistances of 5–8 MΩ after fire polishing. The tip opening diameter should  
be <0.3 µm, and the parallel inner pipette should be >2 µm (Fig. 4a,c and d).
26| Place the finished pipette in a closed box to protect it from dust.
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27| Repeat Steps 13–26 until the desired number of pipettes have been fabricated.
 crItIcal step Recording pipettes should be used within 6 h after polishing. Pipettes not used within 6 h or with  
tips that are too narrow can be used as isolation or dissection pipettes.
? troublesHootInG
Dissection and release of endolysosomal vesicles ● tIMInG ~1–10 min
28| Remove one coverslip from the 24-well plate that contains cells with enlarged vesicles from Step 12 and transfer it to 
the microscope chamber (supplementary Videos 2 and 3).
29| Add 1 ml of bath solution.
 Cells can be stored in bath solution for ~1 h for whole-endolysosomal patch-clamp experimentation, which includes 
endolysosome isolation, sealing and recording steps. After 1 h, HEK293 cells tend to detach from the coverslip during 
endolysosome extraction and enlarged endolysosomes will become smaller, adhesive (i.e., sticking to the pipette)  
and difficult to isolate.
30| Using a MicroFil or a self-made plastic filling needle, fill an isolation pipette with luminal solution and mount the  
pipette onto the headstage of the patch-clamp setup.
31| Set the angle of the diagonal mode movement of the micromanipulator. The angle should be close to 30°  
(factory default).
32| Inspect the cells under the microscope (40× objective lens and 10× eyepiece) and search for cells with endosomes or 
lysosomes that are sufficiently enlarged and close to the edge of the cell membrane for isolation.
! cautIon The size of the endolysosome should not be larger than 1/2 the size of the cell. If it is too large, it will be  
floating around. If it is too small, it will be hard to seal.
 crItIcal step Vesicles close to cell edges are easier to isolate. Vesicles on the left side are usually difficult to control 
(assuming the pipette is approaching from the right side); in particular, dissecting the vesicle out of the cell is more difficult 
and vesicles break more easily under the pressure of the isolation pipette.
33| Set the MODE selector of micromanipulator to 0. Bring the isolation pipette into close proximity to the selected cell.
 crItIcal step A MODE selector setting of 0 to 9 is used for very fast to very slow movements. A setting of 0 brings the 
isolation pipette to the selected cell. A setting of 4–5 is used to isolate the endolysosmal vesicle (Steps 33–36). A setting of 
5–6 is used for gigaseal formation (Steps 44–46).
34| Set the MODE selector of the micromanipulator to 5. Move the isolation pipette downward until it touches the edge of 
the plasma membrane (Figs. 5 and 7).
35| Rapidly move the isolation pipette away horizontally. This will pull out a piece of plasma membrane (Fig. 7a).
36| Use the same pipette to push the endolysosome from the opposite side of the cell and press the cytoplasmic body to 
squeeze the endosome/lysosome out through the incision (Figs. 5 and 7b).
37| Using the isolation pipette, move the endolysosome away from the cell (Fig. 7c).
 crItIcal step Parts of the plasma membrane or other materials might cover or contaminate the endosome/lysosome and 
lead to failure of sealing. This can be avoided by moving the endolysosome away from the cell.
? troublesHootInG
38| Inspect the isolated endolysosome under a microscope (Fig. 7d).
 crItIcal step The membrane of endolysosomal vesicles is brighter and much thinner than the plasma membrane. 
Endolysosomal membranes are weak and almost transparent under a microscope.
? troublesHootInG
Gigaseal formation ● tIMInG 1–2 min
39| Use a freshly polished recording pipette and fill it with the appropriate luminal solution.
40| Mount the pipette to the headstage of the amplifier.
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41| Apply 20–50 mbar positive pressure to the pipette  
(or 0.03–0.05 ml of a 1-ml syringe for pressure control)  
and hold this pressure (lock the valve).
42| Set the MODE selector of the micromanipulator to 0.
43| Move the pipette tip into the bath solution and place it in the middle of the visual field. The pressure should be strong 
enough to see the liquid flow into the bath solution.
 crItIcal step It is necessary to give positive pressure to avoid dust clogging the pipette tip. With pressure exceeding  
50 mbar, it is easier to form a seal with the endolysosomal membrane, but it is not possible to break into the endolysosome 
to establish whole-endolysosome mode.
44| Apply repetitive current pulses (+5 mV; 5 ms) to determine pipette resistance, seal resistance and series resistance to  
monitor the size of the pipette tip, seal formation and establishment of whole-endolysosome configuration, respectively (Fig. 8).
45| Set the MODE selector of the micromanipulator to 6. Quickly move the pipette close to the top of the target vesicle  
(<30 s) (Fig. 7e).
46| Move the pipette close to the vesicle until you see movement of the vesicle, which is caused by liquid flow out of the pipette.
a b c
d e f
Figure 7 | Series of images illustrating the continuous process of  
isolation of a vacuolin-1-enlarged endolysosomal vesicle in a HEK293 cell 
(2-h treatment) with an ‘isolation pipette’ and gigaseal formation with the 
‘recording pipette’. (a–c) First, an isolation pipette is used to cut open the 
plasma membrane and to push the endolysosmal vesicle out of the cell.  
(a) The targeted enlarged endolysosome, located on the right side of the  
cell in the center of the image, is shown. The cell membrane is cut open  
with an ‘isolation pipette’ at a position close to the endolysosome (Step 34). 
(b) The vesicle is pushed out through the opening in the membrane with the 
same ‘isolation pipette’ (Step 35). (c) The intact vesicle is located outside 
of the cell but is still connected by a small part to the cytoskeleton of the 
cell (Step 37). (d–f) A second pipette (‘recording pipette’) is used to form 
a gigaseal and to perform whole-endolysosome recording. (d) The isolated 
endolysosome sometimes moves back to the host cell within a few seconds. 
Unexpected movements of the isolated endolysosome should be considered 
before starting the patching step (Step 41). (e) Slight positive pressure from 
the tip of the recording pipette should be applied (this can be seen when  
the vesicle is moving forward (1–5 µm) slightly because of the liquid flow). 
An appropriate positive pressure (0.03–0.05 ml) keeps the pipette tip clean 
and increases the success rate for the experiment (Step 45). (f) Release 
of the positive pressure; a small backward flow helps to patch the vesicle 
membrane within 1 s (Step 47). After gigaseal formation for 10–30 s, the 
pipette with the intact vesicle on its tip can be moved away or up 1–20 µm, 
which stabilizes the configuration of the whole-endolysosome recording. 
Scale bar, 10 µm (applies to all the panels).
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Figure 8 | Currents for calculation of pipette resistance, seal resistance, series 
resistance and cell capacitance. (a) The recording pipette is located in the 
bath solution. The rectangular voltage pulse (step: 5 ms; 5 mV; vacuolin-1-
enlarged endolysosomal vesicle isolated from a HEK293 cell 2 h after treatment) 
causes a virtually rectangular current response. The pipette resistance can be 
calculated by dividing the command voltage by the current response. (b) During 
establishment of lysosome-attached mode (gigaseal formation), the current 
response diminishes rapidly. The seal resistance can be calculated by dividing 
the command voltage by the very small remaining current. (c) Application of 
the ZAP pulse causes an immediate membrane breakdown and an increase of 
the capacitive currents that indicate the successful formation of the whole-
endolysosomal mode. For a spherical endolysosome, this current is described 
by a single exponential function of time. Series resistance can be calculated 
by dividing the amplitude of the capacitive currents by the command voltage. 
The capacity of the cell can be calculated by dividing the time constant of the 
capacitive currents by the series resistance. 
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47| Adjust the offset voltage of the pipette to 0 mV (Fig. 8a).
48| Release the positive pressure immediately. Under optimal 
conditions, the vesicle will be sucked in the direction  
of the pipette and attach to the membrane, and a gigaseal 
(1–20 GΩ) will form within 1 s (Figs. 7f and 8b).
? troublesHootInG
49| Monitor gigaseal formation by inspecting the current 
during the repetitive current pulses. It should diminish  
very quickly to 0 mV (Fig. 8b).
? troublesHootInG
50| If you are proceeding with single-channel recordings  
in endolysosome-attached mode, continue with option A.  
If you are proceeding with single-channel recordings  
in lumen-out mode, continue with option B. If you are  
proceeding with whole-endolysosome recordings in  
voltage-clamp and current-clamp mode or single-channel 
recordings in cytosol-out mode, continue with option C.
(a) single-channel recordings in lysosome-attached 
mode ● tIMInG 1–5 min, depending on the patch protocol
 (i) Form a gigaseal to establish lysosome-attached mode (Fig. 9).
 (ii)  Change the feedback resistor of the headstage to 50 GΩ in the PatchMaster software (or Multiclamp 700B Command-
er). For an Axopatch 200B amplifier, switch the ‘CONFIG’ setting to ‘PATCH’ on the front panel and turn on the ‘HEAD-
STAGE COOLING’ switch on the rear panel. These settings provide the best signal-to-noise ratio, which is important for 
the recording of small single-channel currents. 
 crItIcal step Turn on headstage cooling at least 1 h before experimentation so that the amplifier can equilibrate. 
If this is not done, the current offset will be changing throughout the course of the experiment.
 (iii)  Acquire current traces using step potentials in software such as PatchMaster (or Clampex, for Axon amplifiers)  
and check whether single-channel events were detected (Fig. 10). If not, abandon this recording and try  
a new one. 
 crItIcal step In lysosome-attached mode, the voltage across the attached membrane patch (Vpatch) is determined 
by the resting membrane potential of the endolysosome (VRMP) and the voltage applied through the amplifier (Vamp). 
As the VRMP is not known, the voltage dependence calculated from Vamp does not represent the true voltage  
dependence of the channel. The direction of currents in lysosome-attached recordings is opposite to those in  
whole-endolysosomal recordings.
(b) single-channel recordings in lumen-out mode ● tIMInG 1–5 min, depending on the patch protocol
 (i)  After forming a gigaseal, pull off a membrane patch by moving the pipette away from the endolysosome quickly  
(>3 µm/s) with the manipulator (Fig. 9). 
 crItIcal step After pulling off the membrane patch, the membrane surrounding the pipette tip often seals up to 
form a vesicle. In this case, the lumen-out mode can be achieved by taking the pipette tip out of the bath solution 
briefly to break the outer face of the vesicle.
 (ii)  Change the feedback resistor of the headstage to 50 GΩ in the PatchMaster software (or Multiclamp 700B Command-
er). For an Axopatch 200B amplifier, switch the ‘CONFIG’ setting to ‘PATCH’ on the front panel and turn on the ‘HEAD-
STAGE COOLING’ switch on the rear panel. 
 crItIcal step Turn on headstage cooling at least 1 h before experimentation so that the amplifier can equilibrate. 
If this is not done, the current offset will change throughout the course of the experiment.
 (iii)  Acquire current traces using step potentials in software such as PatchMaster (or Clampex, for Axon amplifiers) and 
check whether single-channel events were detected. Keep in mind that the directions of current and voltage in  
lumen-out recordings are opposite to those of whole-endolysosomal recordings.
 (iv) Change the bath solution or add channel opener/blocker, if necessary.
(c) establishment of whole-endolysosome mode ● tIMInG 1 min
 (i) Set the ZAP command (fast voltage pulse) from the PatchMaster control to an initial value of −750 mV/0.5 ms.
 (ii) Use ZAP to break into the vesicle and to establish whole-endolysosomal mode.
Lysosome-attached
mode
Whole-lysosome
mode
Lumen-out
mode
Cytosol-out
mode
ZAP
Pull Pull
Figure 9 | Patch-clamp configurations for single-lysosome recordings. 
Single-lysosome recordings can be performed in three different modes: 
endolysosome-attached, lumen-out and cytosol-out.
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 (iii)  Observe a rapid increase of the transient currents  
during the repetitive voltage steps (Fig. 8c). 
 crItIcal step If break-in fails, increase the  
zapping time 2- to 10-fold step by step until  
break-in. If break-in still fails, apply a larger voltage, 
up to −1,000 mV. 
? troublesHootInG
recordings in whole-endolysosme mode ● tIMInG  
1–5 min, depending on the patch protocol
51| Cancel capacity transients by applying capacitance  
compensation circuitry until series resistance is <100 MΩ 
and/or capacitance remains in a reasonable range (from  
0.1 ± 0.05 to 5 ± 0.5 pF).
! cautIon If capacitance compensation fails (i.e., the 
capacitance value does not appear on the display and the 
small box in the ‘auto’ button (E) is darkened (indicating  
an error after autocompensation)), recording should not  
be continued.
? troublesHootInG
52| If you are proceeding with whole-endolysosome  
recordings in voltage-clamp mode, continue with option A. 
If you are proceeding with whole-endolysosome recordings 
in current-clamp mode, continue with option B.
(a) Voltage-clamp recordings in whole-endolysosomal 
mode ● tIMInG 1–5 min, depending on the patch protocol
 (i)  Apply a suitable holding potential, depending on  
your channel of interest or the cell type used.
 (ii)  Acquire current traces by applying a protocol  
containing the desired voltage pulses with the  
PatchMaster software (Axon amplifiers) and record  
currents at room temperature.
(b) current-clamp recordings in whole-endolysosomal 
mode ● tIMInG 1–5 min, depending on the patch protocol
 (i)  Switch the recording mode to I = 0 by clicking  
the ‘I = 0’ button on the panel of the Multiclamp  
700B Commander software. This will disconnect  
all external inputs.
 (ii)  Open or set up an appropriate protocol for the  
current-clamp recording in the Clampex software. 
! cautIon Make sure that the holding current in the protocol is set to 0 before proceeding to the next step.  
The holding current will be injected into the endolysosome immediately after switching to IC (current-clamp) mode. 
This may cause a large change in membrane potential and may disrupt the gigaseal.
 (iii) Switch to current-clamp mode by clicking the ‘IC’ button on the panel of the Multiclamp 700B Commander software.
 (iv)  Check the ‘Tuning’ checkbox and monitor the ‘Primary Output: Membrane Potential’ in the ‘Scope’ window of the  
Clampex software. Adjust the amplitude and frequency tuning parameters to generate a sawtooth pattern of voltage 
traces with ~10 mV amplitude.
 (v)  Go to ‘Options/Auto’ menu, check the ‘Reduce Rs Compensation…’ button and close this menu. Check the ‘D Reduce  
if oscillation detected’ checkbox.
 (vi)  Check the ‘Pipette Capacitance Neutralization’ checkbox and carefully increase the capacitance value until overshoot 
starts to show up in the voltage traces. 
! cautIon Overneutralizing the pipette capacitance will generate oscillations that may be harmful to the endolyso-
somes. Therefore, it is better to keep the checkbox ‘Reduce if oscillation detected’ checked and reduce the pipette 
capacitance neutralizing value slightly (e.g., to 0.5 pF) from optimal to prevent oscillation caused by capacitance 
changes during the recordings.
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Figure 10 | Representative whole-endolysosome recordings. (a) Current 
traces were recorded from a vacuolin-1-enlarged endolysosome isolated  
from a HEK293 cell expressing TPC1 in the presence of 1 µM PI(3,5)P2.  
(b) Current–voltage relationship for experiment shown in a. (c) Current 
traces were recorded from a vacuolin-1-enlarged endolysosome isolated  
from a HEK293 cell expressing TPC2 in the presence of 1 µM PI(3,5)P2.  
(d) Current–voltage relationship for experiment shown in c. (e) Currents 
recorded from a vacuolin-1-enlarged endolysosome isolated from a TRPML1−/− 
macrophage. (f) Current–voltage relationship for experiment shown in e. 
Panels a, c and e show current amplitudes obtained using a step protocol. 
Panels b, d and f show current–voltage relationships reconstructed from  
the currents in a, c and e (indicated by arrows), respectively. 
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 (vii)  Automatically compensate for the series resistance by clicking the ‘Auto’ button in the ‘Bridge balance’ box.  
This should prevent the fast voltage step from appearing at the start and finish of the current tuning step.  
In some cases, you may have to manually adjust the value to reach optimal balance.
 (viii) Acquire voltage traces using the protocols of the data acquisition software.
single-channel recordings in cytosol-out mode ● tIMInG 1–5 min, depending on the patch protocol
53| Pull the pipette slowly (~0.5–1 µm/s) away from the endolysosome with manipulator to establish cytosol-out  
mode (Fig. 9).
 crItIcal step The membrane fragments attached to the pipette tip should reseal to form a membrane patch  
whose cytosolic side is in contact with the bath solution.
54| In the PatchMaster (or MultiClamp 700B Commander) software, change the feedback resistor of the headstage to 50 GΩ. 
For an Axopatch 200B amplifier, switch the ‘CONFIG’ switch to ‘PATCH’ on the front panel and turn on the ‘HEADSTAGE  
COOLING’ switch on the rear panel to minimize the noise.
55| Acquire traces using step potentials in the PatchMaster (or Clampex, for Axon amplifiers) software and check  
whether single-channel events were detected. If not, abandon this recording and try a new one.
? troublesHootInG
Troubleshooting advice can be found in table 4.
table 4 | Troubleshooting table.
step problem possible reason solution
27 Parallel path of the 
pipette is too short 
(<2 µm)
(a)  Too-wide opening of the 
pipette tip (>1 µm) 
(b) Imbalance of the pipette tip  
(c) Tip is over-polished
(a)  Increase the HEAT +5 on the sixth cycle of the pulling  
program on the P-97 puller and pull a new pipette 
(b)  Check that the pipette position is right in the middle of  
the trough filament on the P-97 puller. If not, realign  
the filament according to the Sutter Instrument Pipette 
Cookbook and pull a new pipette 
(c) Pull a new pipette
37 Isolation of lysosome 
failed
(a)  Cell was not well attached  
to the dish  
(b)  Pipette was broken  
during isolation  
 
(c)  Plasma membrane sticks  
to the pipette tip
(a)  Optimize cell culture. Determine the optimal time window 
after harvesting the cells. Coat the coverslip with  
poly-l-lysine coating solution for a longer time period, or use 
fresh cells 
(b)  Move down the pipette when the pipette tip touches  
the bottom of the coverslip in Step 36. Watch the tip move 
slightly toward the left. Once you notice this movement,  
stop moving down 
(c)  Move the tip faster horizontally or toward the 2 or 4 o’clock 
position, or apply positive pressure to blow the membrane away
38 Isolated lysosome  
vanished
(a) Lysosome burst 
(b) Lysosome shrunk 
(c) Lysosome floated away
(a,b) Adjust the osmolality of the bath solution 
(c)  Do not move the lysosome too far away from the cell with  
the isolation pipette
48 No automatic  
gigaseal formation 
after release of  
pressure
(a)  Pressure was too low or  
there was a pressure leak 
(b)  Pipette tip was blocked  
by air or contamination 
(c)  Isolated was lysosome  
still covered by plasma  
membrane
(a)  If the lysosome does not move onto the tip of the pipette 
right after release of the positive pressure, quickly move the 
patch pipette close to the lysosome (within 3 s) 
(b)  Check that pipette resistance was not higher than 20 MΩ in 
the bath solution. Use a new recording pipette 
(c)  To prevent the plasma membrane from covering the isolated 
lysosome, Steps 33–36 of the isolation protocol are critical.  
Try to repeat. Steps 34 and 35 a few times, until the damaged 
edge is large enough to release the lysosome easily, before  
proceeding to Step 36
(continued)
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● tIMInG
Steps 1–10, preparation of HEK293 cells for endolysosomal recordings: 2–4 d
Steps 11 and 12, enlargement of endolysosomal vesicles: 1–48 h
Steps 13–27, preparation of recording glass pipettes: 1–10 min per pipette
Steps 28–38, isolation of endolysosome from the cell: 1–10 min
Steps 39–55, formation of whole-endolysosomal recording: 3–12 min 
antIcIpateD results
Typical current traces obtained after the patch pipette crosses the surface of the recording solution are shown  
in Figure 8. Optimally shaped pipettes used for lysosomal patch-clamp are characterized by a pipette resistance  
of 5–8 MΩ. After seal formation, the seal resistance typically increases to a range of 8–10 GΩ. Finally, after breaking into 
the endolysosomal vesicle, slow transients appear, indicating optimal access to the lumen of the endolysosome. From the 
transients, series resistance and endolysosomal capacitance 
are calculated (table 2). Typically, the series resistance 
ranges from 20 to 100 MΩ and the capacitance ranges  
from 0.1 to 5 pF.
Once whole-endolysosome conformation is achieved,  
specific currents can be recorded. In late endosomes  
and lysosomes TPCs can be readily recorded. Families of 
current traces obtained by applying a voltage step protocol 
(−100 mV to +100 mV, 20-mV increments, 2 s) side by side 
with the corresponding current–voltage relationships are 
shown in Figure 10. TPC1 and TPC2 currents are activated 
by applying PI(3,5)P2. As PI(3,5)P2 is a nonspecific agonist 
of TPCs and TRPML1 in late endolysosomes, TPC2-like cur-
rents are recorded from TRPML1−/− peritoneal macrophages 
(Fig. 10e,f). TMEM175 channels are constitutively  
active and therefore the activation of these channels  
does not require the application of an activator  
(data not shown).
It is also possible to record dynamical time-dependent 
changes in lysosomal membrane potential in  
table 4 | Troubleshooting table (continued).
step problem possible reason solution
49 Still no gigaseal  
when the pipette  
tip is attached  
to the lysosomal  
membrane
(a) Pressure leak 
(b)  No good connection  
between the lysosomal  
membrane and the  
pipette tip
(a)  If no gigaseal is formed within 1 s, apply an additional  
0.01–0.05 ml of negative pressure (usually not more than  
0.05 ml) and hold the potential at −30 mV; this will help 
cause sealing within 5 min. When the gigaseal is established, 
release the pressure  
If no gigaseal forms within 5 min and the lysosome is still 
intact, try to patch again 
(b)  Apply fast voltage ramp (–80 mV to +80 mV, 20 ms;  
repeat 10–100 times) for 1–3 min
50C(iii) Loss of seal or  
lysosome during  
zapping
(a)  Geometry of the pipette  
tip is not optimal 
(b)  Pressure between the  
pipette and the bath was 
unbalanced
(a) Prepare new patch pipette  
(b)  After gigaseal, slowly move the pipette with the lysosome 
vertically and horizontally away from the host cell until  
the host cell is outside the field of view. Then wait 60 s 
before zapping
51 Compensation failure (a)  Did not achieve a whole-
endolysosome configuration 
(b)  Capacitance value of the 
vesicle is smaller than 0.1 pF
(a) Go back to Step 49C(i–iii) 
 
(b) Remove the pipette and go back to Step 29
150 K 150 K15 K
10 s
�
 
(m
V)
120
100
80
60
40
20
0
–20
Figure 11 | Representative current-clamp recording from a vacuolin-1  
(5 µM overnight)-enlarged endolysosome isolated from a cortical astrocyte 
showing steady-state value and dynamic changes of lysosomal membrane 
potential. Pipette solution consists of 150 mM K-methanesulfonate,  
1 mM HCl, 10 mM HEPES and 10 mM MES, pH 5.5. Bath solution consists  
of 150 mM K-MSA (or 15 mM K-MSA + 135 mM NMDG-MSA), 1 mM HCl and  
10 mM HEPES, pH 7.2. Ψ, membrane voltage.
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current-clamp mode. Figure 11 shows the time course of 
lysosomal membrane voltage, starting with a cytosolic  
solution containing 150 mM potassium, followed by  
a change to a solution containing 15 mM potassium and 
finally by an exchange back to a solution containing 150 mM 
potassium. The experiment demonstrates that reduction of 
potassium from 150 to 15 mM induces a depolarization of 
the lysosomal membrane potential by 50 mV. Given the  
composition of the solutions, the result suggests  
that potassium conductance is present in the 
 lysosomal membrane.
Finally, single-channel activities can be recorded from  
endolysosomal membranes (Fig. 12). Using specific  
solutions, single-channel events can be recorded in cells 
expressing TRPML1 channels. For the experiment shown in 
Figure 12, a series of voltage pulses ranging from 0 mV to 
−140 mV (20-mV increments, step duration: 3 s; interstep 
interval: 2 s) was applied from a holding potential of 0 mV. The patch was recorded in endolysosome-attached mode and  
contained two single channels. From the experiment, a current–voltage relation was determined by plotting current amplitude  
of single-channel activities versus voltage. From this relation, the slope conductance was determined to be 49 pS.
Lysosome
0
–20
–40
–60
–80
–100
–120
–140
2 
pA
� (mV)
200 ms
TRPML1
–160 –120 –80 –40
–1
–2
–3
� (mV)
I (p
A)
a
b
Figure 12 | Single-channel recordings. (a) Current recordings from isolated 
endolysosomes prepared from HEK293 cells overexpressing TRPML1 channels 
(n = 1). Shown are mean current amplitudes of all single-channel events at a 
given voltage. Pipette solution consists of 145 mM K-MSA, 5 mM KCl, 10 mM 
HEPES and 1 µM PI(3,5)P2, pH 7.2. Bath solution consists of 145 mM K-MSA, 
5 mM KCl, 10 mM HEPES and 5 µM PI(3,5)P2, pH 7.2. (b) Current–voltage 
relationship for TRPML1 channels from a. The red line represents  
linear fitting of the three data points (−140, −120 and −100 mV).  
Ψ, membrane voltage.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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To resolve the subcellular distribution of endolysoso-
mal ion channels, we have established a novel
experimental approach to selectively patch clamp
Rab5 positive early endosomes (EE) versus Rab7/
LAMP1-positive late endosomes/lysosomes (LE/
LY). To functionally characterize ion channels in
endolysosomal membranes with the patch-clamp
technique, it is important to develop techniques
to selectively enlarge the respective organelles. We
found here that two small molecules, wortmannin
and latrunculin B, enlarge Rab5-positive EE when
combined but not Rab7-, LAMP1-, or Rab11 (RE)-
positive vesicles. The two compounds act rapidly,
specifically, and are readily applicable in contrast
to genetic approaches or previously used com-
pounds such as vacuolin, which enlarges EE, RE,
and LE/LY. We apply this approach here to measure
currents mediated by TRPML channels, in particular
TRPML3, which we found to be functionally active in
both EE and LE/LY in overexpressing cells as well as
in endogenously expressing CD11b+ lung-tissue
macrophages.
INTRODUCTION
For many years the best studied and characterized membrane
proteins in eukaryotic cells were those located in the plasma
membrane. Proteins in intracellular membranes, in particular
ion channels and transporters, were much less well character-
ized, and their function and physiological roles were less well
understood. In recent years, however, with the emerging tech-
nical capability to patch clamp endolysosomal organelles, a
number of ion channels in endolysosomal membranes can
be studied in more detail, e.g., TRPML channels (mucolipins
1–3 or TRPML1-3), TPCs (two-pore channels, TPC1-2), P2X4,
TMEM175, or BK (Ca2+-activated potassium channel) (CangCell Cheet al., 2013, 2014, 2015; Chen et al., 2014; Dong et al., 2008;
Grimm et al., 2014; Huang et al., 2014; Wang et al., 2015;
Zhong et al., 2016). Endolysosomal ion channels and transport
proteins are increasingly recognized as important regulators of
endolysosomal function and human health. They are highly crit-
ical for the regulation of proton and other ionic concentrations
within endolysosomal vesicles and participate in the regulation
of the numerous endolysosomal vesicle trafficking as well as
exo-, endo-, and phagocytic processes (Cheng et al., 2010;
Grimm et al., 2012a; Samie et al., 2013; Patel, 2015; Venkata-
chalam et al., 2015; Grimm et al., 2017). Endolysosomal
dysfunction can cause multiple storage disorders such as
mucolipidoses, sphingolipidoses, or neuronal ceroid lipofusci-
noses, which typically go along with fatal neurodegenerative
processes. Dysfunction of the endolysosomal and autophagic
system has also been implicated in the development of neuro-
degenerative diseases such as Parkinson’s or Alzheimer’s dis-
ease, metabolic, retinal and pigmentation disorders, infectious
diseases, and cancer (Fraldi et al., 2016; Kondratskyi et al.,
2013; Medina and Ballabio, 2015; Mole and Cotman, 2015;
Saftig and Sandhoff, 2013; Sakurai et al., 2015; Venkatachalam
et al., 2015; Zhang et al., 2009). Development and progression
of diseases, including those mentioned above, have recently
been found to be often associated with dysfunction of endo-
lysosomal ion channels or transporters such as TRPML
channels, two-pore channels, CLC transport proteins, or
the BK channel (Zhang et al., 2009; Jentsch et al., 2010; Wei-
nert et al., 2010; Stauber et al., 2012; Bae et al., 2014; Calcraft
et al., 2009; Ruas et al., 2010; Chen et al., 2014; Grimm et al.,
2014; Weinert et al., 2014; Hockey et al., 2015; Jentsch, 2015;
Medina et al., 2015; Sakurai et al., 2015; Venkatachalam et al.,
2015; De Leo et al., 2016; Favia et al., 2016; Kilpatrick et al.,
2016; Zhong et al., 2016, 2017; Nguyen et al., 2017). In this
context, it is also important to understand where the channels
are functionally expressed, i.e., in early endosomes (EE) or late
endosomes (LE), in lysosomes (LY), recycling endosomes (RE),
autophagosomes, or lysosome-related organelles. Depending
on the subcellular location, ion channels are likely to affect
different trafficking pathways, resulting in different physiolog-
ical and pathophysiological consequences when the channel
is mutated, lost, or therapeutically targeted. Until now, onemical Biology 24, 907–916, July 20, 2017 ª 2017 Elsevier Ltd. 907
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compound, a small molecule called vacuolin, has been widely
used to enlarge the size of endolysosomal vesicles, a step
that is required to enable successful endolysosomal patch-
clamp experimentation (Dong et al., 2008). However, vacuolin
is not very selective in its ability to enlarge endolysosomal
organelles as it enlarges different kinds of endolysosomal ves-
icles (Cerny et al., 2004; Lu et al., 2014). Hence, novel tools that
enable selective patch-clamp experimentation on distinct en-
dolysosomal organelles are urgently needed. Currently, only
limited biochemical evidence is available to determine in which
organelle a certain channel protein is expressed (Kim et al.,
2009; Martina et al., 2009; Sun et al., 2015). We exemplarily
confirm here the subcellular location(s) of TRPML channels, in
particular TRPML1 and TRPML3. TRPML3 had been suggested
previously to be present in both EE and LE/LY based on
biochemical analyses (Kim et al., 2009; Martina et al., 2009).
However, direct functional evidence that TRPML3 is found in
different endolysosomal organelles, i.e., from patch-clamp an-
alyses, was missing. Here, we use different small molecules,
i.e., wortmannin (Wort.) and latrunculin B (Lat.B), for EE and
YM201636 (Chen et al., 2014) for LE/LY instead of vacuolin or
genetic tools such as Rab5Q79L (for EE; Stenmark et al.,
1994; Cang et al., 2015) to selectively patch clamp EE versus
LE/LY.
RESULTS
Wortmannin and Latrunculin B Specifically Enlarge EE
when Combined
As reported previously, vacuolin-enlarged vesicles represent a
rather non-homogeneous population of endolysosomal organ-
elles as they comprise LE/LY (Rab7/LAMP1-positive vesicles)
as well as EE (Rab5-positive vesicles) and RE (Rab11-positive
vesicles) (Figure S1; Cerny et al., 2004). To identify more selec-
tive pharmacological tools for the enlargement of endolysoso-
mal vesicles for patch-clamp experimentation, we tested
several small molecules known or suggested previously in the
literature to have an effect on intracellular vesicle trafficking,
movement, or fusion/fission (Li et al., 1995; Jones et al., 1998;Figure 1. Effect of Wort./Lat.B on Organelles Expressing TRPML Chann
Experiments in TRPML3 Channel Overexpressing Cells
(A and B) Representative confocal images (time series) showing the effect of 200
while Rab7-GFP positive vesicles remained unaffected (B). Experiments were p
bar, 10 mm.
(C–E) Representative confocal images of Rab5-mCherry and TRPML1-YFP (C), R
transfected into HEK293 cells and treated for 20–30 min with 200 nM wortmann
observed only in combination. In (C), orange arrowheads point to Rab5-positi
TRPML1 negative); vesicle marked with white arrowheads in (D) is positive for Rab
positive) is unaffected by Wort./Lat.B treatment and comparable with untreated
(F) Representative currents from Wort./Lat.B-enlarged EE isolated from non-tra
elicited by applying 10 mM ML-SA1.
(G) Representative currents from Wort./Lat.B.-enlarged EE isolated from non-tra
elicited by applying 1 mM PI(3,5)P2 or 10 mM PI3P, 10 mM phosphatidylserine, 10
(H) Statistical summary of data as shown in (G). Shown are average current dens
(I) Representative currents from Wort./Lat.B-enlarged EE isolated from HEK293
phatidylserine, 10 mM PI(4,5)P2, or 10 mM PI(3,4)P2 in combination with 1 mM PI(3
(J) Statistical summary of data as shown in (I). Shown are average current densit
In all experiments, luminal pH was set to 6.7 and intracellular pH was set to 7.2
maximal TRPML3 currents. Voltage ramps of 500 ms from 100 to +100 mV we
experiments are shown as indicated. ***p < 0.001, Student’s t test, unpaired.Sheff et al., 2002; Greene and Gao, 2009). We eventually discov-
ered that Wort. (200 nM) and Lat.B (10 nM) specifically and
robustly enlarge EE (Rab5- or EEA1-positive vesicles) to a de-
gree suitable for patch-clamp experimentation (i.e., >3–4 mm
in diameter), but only when combined, while leaving LE/LY
(Rab7/LAMP1-positive vesicles) or RE (Rab11-positive vesicles)
unaffected (Figures 1A–1E, S1, and S2A, and Movies S1 and
S2). When applied alone, neither drug resulted in sufficiently
enlarged vesicular structures (Figure S3A and S3B). Importantly,
Wort./Lat.B-enlarged vesicles were generally LAMP1/Rab7/
TRPML1 or Rab11 negative (Figures 1E and S1; Movies S1
and S2).
TRPML3 Currents in EE Isolated from Overexpressing
HEK293 Cells
In a first set of experiments, we demonstrate that in Wort./Lat.B-
enlarged Rab5/TRPML3-positive organelles, large inwardly
rectifying currents could be elicited with the TRPML channel
agonist ML-SA1 (Figure 1F) (Shen et al., 2012; Wang et al.,
2015) or with PI(3,5)P2, an endolysosome-specific phosphoino-
sitide previously shown to activate TRPML channels (Figures
1G–1J; Shen et al., 2012; Chen et al., 2014; Zhang et al.,
2012). In EE isolated from non-transfected (NT) HEK293 cells,
no ML-SA1 or PI(3,4)P2 currents were detectable (Figures 1F
and 1G). Phosphoinositides or phospholipids other than PI(3,5)
P2 did not result in significant channel activation nor did they
significantly enhance PI(3,5)P2-mediated channel activation
(Figures 1G–1J). Zhang et al. (2012) have shown recently that
PI(4,5)P2 and PI(3,4)P2 suppress PI(3,5)P2-induced TRPML1
channel activity by 60%–70%. For TRPML3, we found that
only PI(4,5)P2 caused significant inhibition of PI(3,5)P2-mediated
activation, but not PI(3,4)P2 (Figures 1I and 1J).
TRPML3 Currents in LE/LY Isolated from
Overexpressing HEK293 Cells
To selectively measure TRPML channel activity in LE/LY, we
performed patch-clamp experiments by using the PIKfyve
inhibitor YM201636 to increase the size of LE/LY (Chen
et al., 2014). Treatment with YM201636 resulted in enlargedels and Endolysosomal Markers, and Early Endosomal Patch-Clamp
nM Wort. and 10 nM Lat.B on Rab5-mKate-positive vesicle enlargement (A),
erformed in HEK293 cells. Images are taken from Movies S1 and S2. Scale
ab5-mCherry and TRPML3-YFP (D), or LAMP1-mKate and TRPML1-YFP (E),
in (Wort.) and 10 nM latrunculin B (Lat.B). Significantly enlarged vesicles were
ve/TRPML1-negative enlarged vesicles (Rab5-positive vesicles were always
5 and TRPML3; in (E), it is shown that the size of the vesicles (LAMP1/TRPML1
vesicles (No Wort./Lat.B). Scale bars, 10 mm.
nsfected (NT) HEK293 cells or from HEK293 cells expressing TRPML3-YFP,
nsfected (NT) HEK293 cells or from HEK293 cells expressing TRPML3-YFP,
mM PI(4,5)P2, or 10 mM PI(3,4)P2.
ities at 100 mV (mean ± SEM).
cells expressing TRPML3-YFP, elicited by applying 10 mM PI3P, 10 mM phos-
,5)P2.
ies at 100 mV (mean ± SEM).
to mimic EE conditions. Luminal solution contained high potassium to detect
re applied every 5 s. In all statistical analyses, mean values of n independent
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B Figure 2. TRPML1 and TRPML3 Currents in
YM201636-Enlarged LE/LY
(A) Representative basal currents from YM201636-
enlarged LE/LY isolated from HEK293 cells
expressing TRPML3-YFP. High luminal sodium
decreased the average basal TRPML3 activity.
(B) Statistical summary of data as shown in (A).
Shown are average current densities at 100 mV
(mean ± SEM).
(C) Representative TRPML3 currents from
YM201636-enlarged LE/LY in the presence of
PI(3,5)P2 (1 mM). High luminal sodium as well as low
luminal pH decreased TRPML3 channel activity.
(D) Statistical summary of data as shown in (C).
Shown are average current densities at 100 mV
(mean ± SEM).
(E) Representative ML-SA1 elicited currents from
YM201636-enlarged LE/LY isolated from HEK293
cells expressing TRPML1-YFP.
(F) Representative ML-SA1 elicited currents from
YM201636-enlarged LE/LY isolated from non-
transfected (NT) HEK293 cells.
In all statistical analyses, the mean values of n in-
dependent experiments are shown as indicated.
**p < 0.01, *p < 0.05, Student’s t test, unpaired.LAMP1/TRPML1-positive vesicles but did not enlarge Rab5-
or Rab11-positive vesicles, confirming a dominant effect of
YM201636 on LE/LY (Figure S3C). Likewise, TRPML3-express-
ing vesicles positive for LAMP1 were enlarged by YM201636
(Figure S3D). TRPML3-positive YM201636-enlarged vesi-
cles were consistently negative for Rab5 (Figure S3D). In
contrast to Wort./Lat.B-enlarged TRPML3-expressing vesicles,
large basal currents were detectable in YM201636-enlarged
TRPML3-expressing vesicles, possibly due to the presence of
higher levels of PI(3,5)P2 in LE/LY compared with EE and/or
due to a higher expression level in LE/LY (Figures 2A and 2B).
This basal activity of TRPML3 in LE/LY was strongly reduced
when the luminal fluid contained high sodium (140 mM) instead
of high potassium (140 mM) (Figures 2A and 2B). Basal activity
was further enhanced by PI(3,5)P2 (Figures 2C and 2D). Like
basal currents, PI(3,5)P2-enhanced currents were strongly
reduced by replacing high luminal potassium with high luminal910 Cell Chemical Biology 24, 907–916, July 20, 2017sodium. A decrease in pH from 6.7 to 4.6
further reduced channel activity (Figures
2C and 2D). These findings are in agree-
ment with previously described features
of overexpressed TRPML3 measured us-
ing the whole-cell patch-clamp technique
(Kim et al., 2008; Grimm et al., 2010,
2012b). In YM201636-enlarged LE/LY
isolated from NT HEK293 or HEK293
cells overexpressing TRPML1, no basal
currents were detectable (Figures 2E
and 2F). ML-SA1 elicited currents in
YM201636-enlarged vesicles overex-
pressing TRPML1 but not in YM201636-
enlarged vesicles isolated from NT
HEK293 cells (Figures 2E and 2F).
In summary, these data directly demon-strate the functional presence of TRPML3 in both EE and LE/LY,
thus corroborating previously obtained data from immunofluo-
rescence studies.
TRPML Currents in EE and LE/LY Isolated from
Peritoneal Macrophages
We focused on macrophages to detect and characterize endog-
enous TRPML channel currents in intracellular organelles with
this approach. We started with peritoneal macrophages (PMF)
isolated from wild-type (WT), Trpml1/, and Trpml3/ mice
(Figure 3). RT-qPCR analyses revealed the presence of TRPML1
but the absence or very low level expression of TRPML2 and
TRPML3 in PMF (Figure 3A). Like in HEK293 cells, Wort./
Lat.B-enlarged vesicles were negative for LAMP1 but positive
for EEA1 in PMF (Figure S2A), and YM201636-enlarged vesicles
were LAMP1 positive but EEA1 or RAb11 negative (Figures S2B
and S2C). The TRPML channel agonists ML-SA1 and PI(3,5)P2
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Figure 3. Functional Expression of Endogenous TRPML Channels in Peritoneal Macrophage Organelles
(A) RT-qPCR results for TRPML1, TRPML2, and TRPML3 in PMF normalized to HPRT (N.E., normalized expression).
(B and C) Representative currents from Wort./Lat.B-enlarged EE isolated from PMF (WT and Trpml3/), elicited by an application of 10 mM ML-SA1 under
different pH and cationic conditions (conditions were set to evoke either maximal TRPML1 current activity [low luminal pH, high sodium, B] or maximal TRPML3
current activity [neutral pH, low sodium/high potassium, C]).
(D) Representative currents from vacuolin-enlarged vesicles isolated from mouse (WT or Trpml1/) primary peritoneal macrophages (PMF), elicited by an
application of 10 mM ML-SA1.
(E) Statistical summary of data as shown in (D). Shown are average current densities at 100 mV (mean ± SEM).
(F) Representative currents from YM201636-enlarged LE/LY isolated from mouse (WT or Trpml1/) primary peritoneal macrophages (PMF), elicited by an
application of 10 mM ML-SA1.
(G) Statistical summary of data as shown in (F). Shown are average current densities at 100 mV (mean ± SEM).
(H) Representative currents from YM201636-enlarged LE/LY isolated from mouse (WT or Trpml1/) primary peritoneal macrophages (PMF), elicited by an
application of 10 mM ML-SA1 under pH 7.2 and high luminal potassium conditions.
(I) Statistical summary of data as shown in (H). Shown are average current densities at 100 mV (mean ± SEM).
In all statistical analyses, mean values of n independent experiments are shown as indicated. ***p < 0.001, **p < 0.01, *p < 0.05, Student’s t test, unpaired.were applied to elicit currents in Wort./Lat.B, YM201636, as
well as vacuolin-enlarged vesicles. While neither TRPML1- nor
TRPML3-like currents were detectable in Wort./Lat.B-enlarged
vesicles (Figures 3B and 3C), TRPML1-like currents could be
detected in vacuolin-enlarged PMF vesicles (Figures 3D and
3E) as reported previously (Samie et al., 2013). Likewise,
TRPML1-like currents were detectable in YM201636-enlarged
vesicles (Figures 3F and 3G). In WT, PMF currents of compa-
rable size were measured in the vacuolin- as well as theYM201636-enlarged vesicle groups when stimulated with ML-
SA1 under pH 4.6 and high luminal sodium conditions (Figures
3D–3G). Both vacuolin- and YM201636-enlarged vesicles iso-
lated from Trpml1/ PMF showed no more TRPML-like current
activity (Figures 3D–3G). TRPML3-like channel activity was not
detectable in any vesicle population isolated from PMF. Even
replacing high luminal sodium with potassium and measuring
at neutral pH (7.2), conditions that should favor detection
of TRPML3 currents, did not reveal significant TRPML3-likeCell Chemical Biology 24, 907–916, July 20, 2017 911
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Figure 4. Functional Expression of Endogenous TRPML Channels in CD11b+ Lung-Tissue Macrophage Organelles
(A) Representative currents from Wort./Lat.B-enlarged EE isolated from Trpml1/ or Trpml3/ LMF, elicited by application of 10 mM ML-SA1.
(B) Statistical summary of data shown in (A). Shown are average current densities at 100 mV (mean ± SEM).
(C) Representative currents from YM201636-enlarged LE/LY isolated from murine (WT, Trpml1/ or Trpml3/) CD11b+ primary lung-tissue macrophages
(LMF), elicited by application of 10 mM ML-SA1.
(D) Statistical summary of data shown in (C). Shown are average current densities at 100 mV (mean ± SEM). In all experiments, conditions were set to evoke
maximal TRPML3 current activity (neutral pH, low sodium).
(E) Shown are RT-qPCR results for TRPML1, TRPML2, and TRPML3 in LMF normalized to HPRT.
In all statistical analyses mean values of n independent experiments are shown as indicated. ***p < 0.001, **p < 0.01, *p < 0.05, Student’s t test, unpaired.channel activity, either in LE/LY or in EE (Figures 3C, 3H, and 3I).
The remaining TRPML channel activity in LE/LY detectable
under these conditions completely disappeared in Trpml1/
PMF (Figures 3H and 3I). These data support previous reports
on ML-SA1 effects in WT and Trpml1/ PMF (Samie et al.,
2013; Wang et al., 2015) and demonstrate the absence of
TRPML-like currents other than TRPML1 from PMF LE/LY as
well as the complete absence of TRPML-like currents from
PMF EE.
TRPML Currents in EE and LE/LY Isolated from CD11b+
Lung-Tissue Macrophages
We next focused on different tissue macrophages and thus were
able to identify endogenous TRPML3 expression and channel
activity in CD11b+ lung-tissue macrophages (LMF). In patch-
clamp experiments, TRPML3-like currents were detected in
both EE and LE/LY isolated from LMF (Figures 4A–4D). In EE
isolated from Trpml3/ LMF, ML-SA1-induced currents were
completely absent (independent of the pH and ionic conditions
applied; Figures 4A, 4B, S4A, and S4B), while in EE isolated
from Trpml1/ orWT LMF, strong TRPML3-like channel activity
elicited by applyingML-SA1was detectable (Figures 4A and 4B).
In LE/LY, TRPML3-like currents were also detectable under
neutral pH and high luminal potassium conditions (Figures 4C
and 4D). In contrast to EE, we found also ML-SA1-induced cur-912 Cell Chemical Biology 24, 907–916, July 20, 2017rents in LE/LY isolated from Trpml3/ LMF (Figures 4C and 4D).
Under highly acidic conditions in the lumen and with high luminal
sodium (140 mM), ML-SA1-induced currents in LE/LY isolated
from Trpml3/ LMF were not significantly different from those
measured in LE/LY isolated from WT (Figures S4C–S4F). These
data suggest the presence of TRPML3 in EE and the presence
of both TRPML1 and TRPML3 in LE/LY of LMF. This is in accor-
dance with RT-qPCR analyses of LMF, confirming the presence
of TRPML1 and TRPML3 but not TRPML2 in normal, non-stimu-
lated LMF (Figure 4E).
DISCUSSION
Our data demonstrate that the simple and short-term (<20–
30 min at 37C) combined application of two pharmacological
tools, Wort. and Lat.B, can be used to specifically enlarge EE
(Figure 5A) to a degree suitable for patch-clamp experimenta-
tion (>3–4 mm). We further demonstrate here that the PIKfyve
inhibitor YM201636 is a suitable pharmacological tool to
selectively enlarge LE/LY (Figure 5A), while vacuolin enlarges
EE, RE, as well as LE/LY. We have validated our technique
by studying the subcellular expression of TRPML channels,
in particular TRPML3, in endogenously expressing macro-
phages isolated from WT and TRPML knockout mice, respec-
tively, as well as in overexpressing HEK293 cells. Our data
AB
Figure 5. Characteristics of Available Phar-
macological Tools for Endolysosomal
Patch-Clamp Analysis
(A) Cartoon showing schematically the activity
ranges of the different pharmacological tools used
for the enlargement of endolysosomal vesicles
for patch clamp. The combination of Wort. and
Lat.B is highly specific for early endosomes (EE)
excluding recycling endosomes (RE). YM201636
is selectively enlarging LE/LY. Vacuolin enlarges
EE, RE, as well as LE/LY alike.
(B) Cartoon showing schematically the subcellular
location(s) of TRPML1 and TRPML3.suggest that within the endolysosomal system, TRPML3
shows a less selective expression pattern than TRPML1 (Fig-
ure 5B). Expression of TRPML3 in EE as well as LE/LY had
been claimed before based on biochemical analyses (Kim
et al., 2009; Martina et al., 2009). The organelle-selective
patch-clamp experiments presented here essentially confirm
these findings by directly proving the functional activity of
TRPML3 in both EE and LE/LY, while TRPML1 activity was
found only in LE/LY.
The fact that Wort. and Lat.B act, when combined, so specif-
ically and rapidly on the enlargement of EE (up to >5 mm) is a
novel and surprising finding. Latrunculins are produced by
sponges such as the red sea sponge Latrunculia magnifica
(Kashman et al., 1980). Latrunculins were originally shown to
disrupt microfilament organization and to interfere with actin
polymerization (Spector et al., 1983). However, it was also found
that they disrupt endosomal sorting of transferrin (Sheff et al.,
2002), and more recently Greene and Gao (2009) postulated an
important role for actin dynamics in the internalization and endo-
somal sorting/trafficking of clathrin-mediated endocytosis.Wort.
is a fungal metabolite that was first isolated from Penicillium
wortmanni. It is a non-specific inhibitor of phosphoinositide 3-ki-
nases (PI3K) (Wymann et al., 1996; Walker et al., 2000; Kong and
Yamori, 2008). In addition to Wort., we tested a range of other
available kinase/PI3K inhibitors (Figure S5) such as stauro-
sporine, quercetin, LY294002, ZSTK474, or AS605240 (Walker
et al., 2000; Kong and Yamori, 2008). Staurosporine has a range
of affinities for different kinases. The plant-derived bioflavonoid
quercetin [2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-ben-
zopyran-4-one] is also a broad-spectrum protein kinase inhibi-
tor. Compared with quercetin, LY294002 inhibits PI3K more
selectively than protein kinases. LY294002 was the first syn-
thetic PI3K inhibitor, and its chemical structure is based on the
model compound quercetin, which was previously shown to
inhibit PI3K as well as various other protein kinases. In addition,
both Wort. and LY294002 inhibit mTOR and DNA-PK (Kong and
Yamori, 2008). While Wort. also inhibits MLCK, LY294002 in-Cell Chemichibits CK2. ZSTK474 is a specific pan-
PI3K inhibitor and shows no inhibition
against mTOR and DNA-PK (Kong and
Yamori, 2008). AS-605240 was re-
ported as a PI3Kg-selective inhibitor
that showed more than 30-fold selectivity
for PI3Kg over PI3Kd and PI3Kb, and 7.5-
fold selectivity over PI3Ka. Furthermore,AS-605240 was shown to be ineffective in inhibiting a panel
of protein kinases (Kong and Yamori, 2008). We tested these
compounds alone or in combination with Lat.B (in different con-
centrations and at different time points) and found that neither
staurosporine, quercetin, LY294002, ZSTK474, nor AS605240
had an effect on Rab5-positive EE comparable with Wort. (Fig-
ure S5). From these data, we conclude that the observed effect
is specific toWort. and unlikely to bemediated by PI3K inhibition.
This conclusion is supported by the fact that compounds that
are selective PI3K inhibitors had no effect (Figure S5).
We further demonstrate here that TRPML channels are differ-
entially expressed in different populations of macrophages.
While TRPML1 (but no other TRPML channel) is found in perito-
nealmacrophages under basal conditions, TRPML3 is only found
in specific tissue macrophages such as CD11b+ lung=tissue
macrophages. Increasing evidence suggests that TRPML chan-
nels are expressed in different macrophages (Samie et al., 2013;
Sun et al., 2015). Macrophages are quite diverse in function and
genetic composition (Davies et al., 2013; Gautier et al., 2012).
They are found in organs and tissues throughout the human
body and contribute to a rather diverse range of physiological
processes, such as clearance of cellular debris and effete eryth-
rocytes, ironprocessing, immunesurveillance, response to infec-
tion, initiation of inflammatory responses and wound healing
(Davies et al., 2013). Samie et al. (2013) have recently shown
that TRPML1 regulates red blood cell phagocytosis in macro-
phages. Sun et al. (2015) reported an upregulation of TRPML2
in activatedmacrophages such as bonemarrow-derived macro-
phages and alveolar macrophages and claimed predominant
expression in RE, and Remis et al. (2014) suggested, based on
in situ hybridization experiments, that TRPML3 is expressed in
alveolar macrophages. That ion channels such as TRPML chan-
nels are differentially expressed in macrophages is further sup-
ported by recent evidence provided by Gautier et al. (2012) who
found TRPML3 (Mcoln3) expressed in lung but not peritoneal
macrophages or microglia based on their analyses of gene
expression profiles, essentially corroborating our findings.al Biology 24, 907–916, July 20, 2017 913
The complex regulation of phagocytic and endocytic as well
as intracellular trafficking and degradation processes in different
types of tissue macrophages will become more comprehensive
if the expression of key regulators of these processes, such as
distinct ion channels, pumps, and transporters, can be resolved
down to the specific organellar level. Given the huge diversity in
function and the overall heterogeneity of tissue macrophages,
this knowledge may help to better understand how macro-
phages are able to fulfill their specialized roles in such diverse
tissues as spleen, lung, liver, skin, or bone.
Taken together, selective EE patch clamping with simple phar-
macological tools is an important step forward for the functional
characterization of endogenously expressed endolysosomal ion
channels. In the future, more specific tools will hopefully be
found to perform similar experiments, e.g., with RE, lyso-
some-related organelles, or perhaps even synaptic vesicles or
secretory organelles. Substantial progress in the selectivity of
endolysosomal patch clamping will further facilitate strategies
to exploit endolysosomal ion channels as novel therapeutic tar-
gets and will help us to understand how the differential expres-
sion of key components in the endolysosomal system, such as
ion channels and transporters, contributes to the regulation of
different trafficking pathways in healthy and diseased cells.
SIGNIFICANCE
We show here that we can selectively patch clamp subpop-
ulations of endolysosomal organelles by using distinct small
molecules for specific vesicle enlargement. Thus, we can
demonstrate where exactly ion channels such as TRPML
channels are functionally expressed within the complex en-
dolysosomal trafficking network. The endolysosomal traf-
ficking and transport machinery relies heavily on the correct
function of the specific sets of proteins, in particular ion
channels, transporters, and pumps that are expressed
in the membranes of the multiple different vesicles that
contribute to this machinery. Endolysosomal dysfunction
can cause lysosomal storage disorders such asmucolipido-
ses, sphingolipidoses, or neuronal ceroid lipofuscinoses,
which typically go along with fatal neurodegenerative pro-
cesses. Dysfunction of the endolysosomal system has also
been implicated in the development of many other diseases,
ranging from metabolic diseases, retinal and pigmentation
disorders to infectious diseases and even cancer. One
important prerequisite for a successful investigation of
endolysosomal ion channels is the availability of tools and
techniques to study them in the organellar membranes
where they are endogenously expressed. The widely used
compound vacuolin is relatively unspecific in enlarging en-
dolysosomal organelles. Here, we describe here novel tools
tomore specifically enlarge early versus late endolysosomal
vesicles for patch clamping. Wortmannin in combination
with latrunculin B specifically enlarges EE, while YM201636
specifically enlarges LE/LY. To validate this approach, we
applied these tools to measure TRPML channels, in partic-
ular TRPML1 and TRPML3, in EE versus LE/LY and demon-
strate that in contrast to TRPML1, TRPML3 is functionally
active in both EE and LE/LY in overexpressing HEK293 as
well as in endogenously expressing cells.914 Cell Chemical Biology 24, 907–916, July 20, 2017STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Animals were used under approved animal protocols and University of Munich (LMU) Institutional Animal Care Guidelines.
Trpml1-/- KO mice were obtained from Dr. Susan Slaugenhaupt (Harvard) and were generated as described in Venugopal et al.
(2007). For genotyping of Trpml1-/- KO mice the following forward and reverse primers were used: 5’-tgaggagagccaagctcatt-3’
(sense), 5’-tcatcttcctgcctccatct-3’ (antisense) and 5’-tggctggacgtaaactcctc-3’ (antisense), expected bands 400 bp (WT), 200 bp
(KO); cycling conditions: annealing temperature 58C, 35 cycles.
Trpml3-/- KO mice were generated by deleting exon11 as described previously (Jo¨rs et al., 2010). For genotyping of Trpml3-/- KO
and WT mice two primer pairs were used: 5’-gaacacactgactacccccaa-3’ (sense) and 5’-tacagttttacagatgtgtttgag-3’ (antisense), ex-
pected bands: 309 bp (WT), no band (KO); 5’-gaacacactgactacccccaa-3’ (sense) and 5’-agaggttcactagaacgaagttcctattcc-3’ (anti-
sense), expected bands: no band (WT), 374 bp (KO); cycling conditions: 35 cycles, annealing temperature 65C for both.
Cell Lines and Primary Cell Culture
All cell culture cells were cultured in a standard humidified 37C incubator, with 5% CO2. HEK293 cells were maintained in low
glucose DMEM supplemented with 10% FBS, 100 U penicillin/mL and 100 mg streptomycin/mL. HEK293 cells stably expressing
TRPML3-YFP (Grimm et al., 2010) were selected using G418 at a final concentration of 0.8 mg/mL.e2 Cell Chemical Biology 24, 907–916.e1–e4, July 20, 2017
Primary peritoneal and lung tissuemacrophageswere isolated from 6 to 10weeks old TRPML1-/-, TRPML3-/- andwildtypemice of
both gender.
For preparation of macrophages, mice were deeply anesthetized with isofluorane and killed by cervical dislocation. For harvesting
peritoneal macrophages (PMF), the outer skin of the peritoneumwas carefully opened and 10mL phosphate buffer saline (PBS) were
injected into the peritoneal cavity. After detaching macrophages by massaging the peritoneum, the cell suspension was collected
using a syringe and a 20G needle. Cells were pelleted and subsequently cultured in F12/DMEM supplemented with 20% FBS,
100 U penicillin/mL, and 100 mg streptomycin/mL. PMF were used for experiments within 2-10 days after isolation. Lung macro-
phages (LMF) were isolated from dissociated whole lung tissue by positive magnetic cell sorting (MACS) for CD11b-positive cells
using the protocol for ‘‘CD11b MicroBeads, mouse’’ (130-049-601, Miltenyi Biotech) according to manufacturer’s instructions. Sin-
gle-cell suspensions of the tissues were prepared employing the ‘‘Lung Dissociation Kit’’ (130-095-927; Miltenyi Biotech). Briefly,
isolated tissue was rinsed in PBS, cut in 7-10 pieces and incubated in 2.4 mL1x buffer S containing enzyme A and enzyme D for
45min at 37 C. Afterwards, cells were passed through a 100 mmnylonmesh followed by onemore separation through a 30 mmnylon
mesh. Following a centrifugation step, cells were recollected withMicroBeads conjugated tomonoclonal rat anti-mouse CD11b anti-
body (130-049-601, Miltenyi Biotech) and incubated for 15 min at 4 C. CD11b-positive cells were sorted with MS MiniMACS col-
umns and the eluted fraction was seeded onto Poly-L-Lysine coated cover slips and maintained in F12/DMEM containing 20%
FBS, 100 U penicillin/mL, and 100 mg streptomycin/mL. LMF were used for experiments only one day after isolation.
METHOD DETAILS
Transfection and Compound Treatment of Cells
For patch clamp experiments and live cell imaging, cells were plated on 12 mm or 25 mm glass cover slips 24-72 hours before ex-
periments. HEK293 cells were transiently transfected with Turbofect (Fermentas) according to the manufacturer’s protocol and used
for experiments 24-48 hours after transfection. The following N- and C-terminally tagged plasmids were used: TRPML1-YFP,
TRPML3-YFP, Rab5-mCherry, Rab5-mKate, GFP-Rab7, mKate-Rab7, Citrin-Rab11, DsRed-Rab11 and LAMP1-mKate.
For vesicle enlargement, transfected and untransfected cells were treated with either 1 mMvacuolin (HEK293 cells: overnight (o/n);
MF: 1 h), YM201636 (HEK293 cells: 800 nM / 2 h or 400 nM / 12 h; PMF: 400nM / 1-2 h; LMF: 400 nM / 1-3 h), or a combination of
200 nM wortmannin and 10 nM latrunculin B (HEK293 cells: 10-15 min; PMF: 20 min; LMF: 1 h) prior to experimentation. Cells were
treated with compounds at 37 C and 5% CO2. YM201636 was obtained from Chemdea (CD0181), wortmannin and latrunculin B
from Sigma-Aldrich (W1628 and L5288). Compounds were washout before patch-clamp experimentation.
For kinase inhibitor study, HEK293 cells were treated as indicated with Staurosporin (S5921), LY294002 (L9908), Quercetin
(Q4951), AS605240 (A0233) (all from Sigma-Aldrich) or ZSTK474 (Sellckchem).
Confocal Imaging and Antibody Staining
Confocal images were conducted using a Zeiss LSM510 or a Leica SP8 confocal microscope. For live cell imaging, medium was
replaced by unsupplemented medium without phenol red. For videos, HEK293 cells were incubated in a climate chamber for tem-
perature and humidity control (Okolabs, Burlingame, CA, USA) during imaging and compound treatment. For immunocytochemistry,
peritoneal macrophages were stained using anti-LAMP1 (1D4B; Developmental Studies Hybridoma Bank, 1:250) and anti-EEA1
(C45B10) (3288; Cell Signaling Technology, 1:100) or anti-Rab11 (abcam ab3612, 1:200) antibodies, respectively. Briefly, cells
were grown on coverslips and treated as indicated. Cells were then fixed with ice-cold methanol for 10 min at -20C and permeabi-
lised with 0.2% saponin. Alexa488 (Cell Signaling Technology) or Cy3 (Jackson ImmunoResearch Lab) were used as secondary an-
tibodies for detection.
Whole-EE and Whole-LE/LY Manual Patch-Clamp Experiments
Mean capacitance value for EE of HEK293 stable cell lines was 1.0 ± 0.1 pF (n = 54). For EE of primary cells it was 0.4 ± 0.1 pF (n = 26).
For LE/LY of HEK293 stable cell lines it was 1.1 ± 0.3 pF (n = 42). For LE/LY of primary cells it was 0.6 ± 0.1 pF (n = 56). Currents were
recorded using an EPC-10 patch-clamp amplifier (HEKA, Lambrecht, Germany) and PatchMaster acquisition software (HEKA). Data
were digitized at 40 kHz and filtered at 2.8 kHz. Fast and slow capacitive transients were cancelled by the compensation circuit of the
EPC-10 amplifier. All recordings were obtained at room temperature and were analyzed using PatchMaster acquisition software
(HEKA) and OriginPro 6.1 (OriginLab). Recording glass pipettes were polished and had a resistance of 4-8 MU. For all experiments,
salt-agar bridges were used to connect the reference Ag-AgCl wire to the bath solution to minimize voltage offsets. Liquid junction
potential was corrected. For the application of the lipids (A.G. Scientific) or small molecule agonists (ML-SA1), cytoplasmic solution
was completely exchanged by cytoplasmic solution containing agonist. The current amplitudes at -100 mV were extracted from in-
dividual ramp current recordings. Unless otherwise stated, cytoplasmic solution contained 140 mMK-MSA, 5 mMKOH, 4mMNaCl,
0.39 mM CaCl2, 1 mM EGTA and 10 mM HEPES (pH was adjusted with KOH to 7.2). Luminal solution contained 140 mM Na-MSA,
5 mM K-MSA, 2 mM Ca-MSA 2 mM, 1 mM CaCl2, 10 mM HEPES and 10 mM MES (pH was adjusted with methanesulfonic acid to
4.6). In all experiments, 500-ms voltage ramps from -100 to +100 mV were applied every 5 s. All statistical analysis was done using
Origin8 or GraphPadPrism software.Cell Chemical Biology 24, 907–916.e1–e4, July 20, 2017 e3
RT-qPCR
Total RNA was prepared from cultured primary macrophages using RNeasy Plus Mini Kit (Qiagen) according to the manufacturer’s
protocol. cDNA was synthezised from total RNA with RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific) utilizing both
random hexamer primer and oligo(dT)18-primer. qPCR was performed on a StepOne Plus Real-time PCR system (Applied Bio-
systems) using SYBR Select Master Mix (Applied Biosystems). Reactions were carried out in duplicate or triplicate under conditions
according to manufacturer’s recommendations. The following forward and reverse primers were used for TRPML1 (NM_053177),
TRPML2 (NM_026656), TRPML3 (NM_134160), and HPRT (NM_013556): 5’-gccttgggccaatggatca-3’ (sense), 5’-cccttggatcaat
gtcaaaggta-3’ (antisense) (TRPML1), 5’-aatttggggtcacgtcatgc-3’ (sense), 5’-agaatcgagagacgccatcg-3’ (antisense) (TRPML2),
5’-gagttacctggtgtggctgt-3’ (sense), 5’-tgctggtagtgcttaattgtttcg-3’ (antisense) (TRPML3), and 5’-gctcgagatgtcatgaaggagat-3’
(sense), 5’-aaagaacttatagccccccttga-3’ (antisense) (HPRT). Primer efficiencies were between 1.9 and 2.1. Non-template controls
were included to ensure specificity of the primer pairs. Product specificity and amplicon size were controlled by sequencing and
gel analysis of the qPCR products. Relative expression of target gene levels was determined by normalization against HPRT levels.
Samples were run in duplicates using 3-5 biological replicates per group.
QUANTIFICATION AND STATISTICAL ANALYSIS
Details of statistical analyses and n values are provided in the figure legends. Statistical analyses were carried out using Origin 8 and
GraphPad Prism 5. All error bars are depicted as mean ± SEM. Statistical significance was determined via Student’s t-test, unless
stated otherwise. Significance is denoted on figures as outlined in the legends. Statistics were derived from at least three indepen-
dent experiments.e4 Cell Chemical Biology 24, 907–916.e1–e4, July 20, 2017
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Abstract
Metastatic invasion is the major cause of cancer-related
deaths. In this study, we introduce two-pore channels (TPC),
a recently described class of NAADP- and PI(3,5)P2–sensitive
Ca2þ-permeable cation channels in the endolysosomal system
of cells, as candidate targets for the treatment of invasive
cancers. Inhibition of the channel abrogated migration of
metastatic cancer cells in vitro. Silencing or pharmacologic
inhibition of the two-pore channel TPC2 reduced lung metas-
tasis of mammary mouse cancer cells. Disrupting TPC function
halted trafﬁcking of b1-integrin, leading to its accumulation in
EEA1-positive early endosomes. As a consequence, invasive
cancer cells were no longer able to form leading edges, which
are required for adequate migration. Our ﬁndings link TPC
to cancer cell migration and provide a preclinical proof of
concept for their candidacy as targets to treat metastatic cancers.
Cancer Res; 77(6); 1427–38. 2017 AACR.
Introduction
Metastasis is the major cause of cancer-related deaths. The
formation of secondary, metastatic growth includes proliferation
and extensive vascularization of the primary tumor, detachment
and invasionof tumor cells, circulationof single tumor cells, arrest
in distant sites, extravasation, and, ﬁnally, proliferationwithin the
organ (1). Extensive studies in the last decades contributed to a
better understanding of these processes. However, still about 90%
of cancer-associatedmortality is due tometastasis. Therefore, new
strategies to prevent metastasis are urgently needed (1, 2).
To successfully colonize secondary sites, cancer cells gained
the ability to migrate (2, 3). A crucial step in migration is the
binding to ligands of the extracellular matrix (ECM), which is
mediated by integrins. These cell surface receptors display a
diverse family of glycoproteins consisting of 18 a-subunits and
8 b-subunits. Besides mediating cell attachment to the ECM,
integrins are linked to the cytoskeleton through the formation of
clusters with actin-associated proteins such as vinculin. Further-
more, ligation of integrins induces a network of intracellular
signaling pathways including the activation of focal adhesion
kinase (FAK) and Src, altogether regulating cell migration (3).
To fulﬁll the function as migration-promoting receptors, integ-
rins have to be trafﬁcked to the front of the cell for assembly of
focal adhesions. These adhesions act as traction sites for the
movement and are afterwards disassembled at the rear of the cell
for detachment. Hence, integrins need to be dynamically turned
over, which is achieved by endocytic trafﬁcking (4, 5). After
endocytosis, integrins are carried to early endosomes where sort-
ing into recycling and degradative pathways takes place. Under
normal conditions, the larger portion recycles back to the plasma
membrane. Disturbing this process can alter the composition of
focal adhesions, thereby inﬂuencing cell migration (4).
There is increasing evidence that two-pore channels (TPC) are
key players in the regulation of endocytic transport (6–8). It has
been postulated that inhibiting these channels alters Ca2þ sig-
naling during endolysosomal fusion events, resulting in defects in
vesicle trafﬁcking (9–11). TPCs are assigned to the superfamily of
voltage-gated ion channels (8). There are two different TPC
subtypes present in primates, TPC1 and TPC2. TPC1 is primarily
expressed on endosomal membranes while TPC2 dominates on
lysosomal membranes (8, 10, 12). Activation of these channels is
presumably triggered by the second messenger nicotinic acid
adenine dinucleotide phosphate (NAADP) and by phosphatidy-
linositol 3,5-bisphosphate [PI(3,5)P2; refs. 8, 13–15]. Distinct
experiments suggested TPCs as Ca2þ-permeable channels indi-
cating that TPCs might be involved in Ca2þ release from endo-
and lysosomal stores (7–9, 13, 16).
This work unveils that TPCs play a crucial role in the formation
of metastasis as silencing TPC1 and TPC2 reduced the adhesion
and migration of invasive tumor cells in vitro. Similar results
were achieved with Ned-19, an antagonist of NAADP (17), and
tetrandrine, recently shown to inhibit TPC1 and TPC2 (18).
Remarkably, both silencing of TPC2 with siRNA or by pharma-
cologic inhibition showed efﬁcacy in a metastatic in vivo model.
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Inhibition of TPCs led to the accumulation of integrins in endo-
cytic vesicles and impaired formation of leading edges, indicating
that TPCs are signiﬁcantly involved in integrin recycling.
Materials and Methods
Cell lines and reagents
The cancer cell lineT24wasobtained fromDr.B.Mayer (Surgical
Clinic, LMU, Munich, Germany) and recently authenticated by
the DSMZ. HUH7 were purchased from Japanese Collection of
ResearchBioresources and4T1-Luc (4T1) fromPerkinElmer.Meth-
od of cell authentication was short tandem repeat (STR) DNA
typing by using 8 different and highly polymorphic STR loci. T24
cells were grown in McCoy, HUH7 cells in DMEM high glucose,
and4T1 cells inRPMI1640medium.Allmediawere supplemented
with 10% FCS. trans-Ned-19 (Ned-19) was purchased from Tocris
Bioscience, and tetrandrine from Santa Cruz Biotechnology.
qRT-PCR
qRT-PCR of TPC1 and TPC2 was performed as described
previously (19). Following primers were used: TPC2 forward
(fw): 50-GTA CCC CTC TTG TGT GGA CG-3; reverse (rv), 50-GGC
CCT GAC AGT GAC AAC TT-30; TPC1 fw, 50-GGA GCC CTT CTA
TTT CAT CGT-30; rv, 50-CGG TAG CGC TCC TTC AAC T-30; actin
was used as housekeeping gene. The following primers were used:
fw, 50-CCA ACC GCG AGA AGA TGA-30; rv, 50-CCA GAG GCG
TAC AGG GAT AG-30.
Whole-endolysosomal patch clamp
Whole-endolysosomal patch-clamp recordings were per-
formed by modiﬁed conventional patch-clamp. T24 cells were
treated with 1 mmol/L vacuolin-1 for at least 4 hours. Currents
were recorded using an EPC-10 patch-clamp ampliﬁer and Patch-
Master acquisition software (HEKA). Data were digitized at 40
kHz and ﬁltered at 2.8 kHz. Recording pipettes had a resistance of
8–10 MW. Liquid junction potential was corrected. Pipette solu-
tion (corresponding to luminal endolysosomal solution) con-
tained 140 mmol/L sodium methanesulfonate, 5 mmol/L potas-
sium methanesulfonate (KMSA), 2 mmol/L calcium methane-
sulfonate, 1 mmol/L CaCl2, 10 mmol/L HEPES and 10 mmol/L
MES, pH 4.6. Bath solution (corresponding to cytosolic solution)
contained 140 mmol/L KMSA, 5 mmol/L KOH, 4 mmol/L NaCl,
0.39mmol/L CaCl2, 1mmol/L EGTA, and 10mmol/LHEPES, pH
7.2. PI(3,5)P2 was used in a water-soluble diC8 form (A.G.
Scientiﬁc). All compounds including PI(3,5)P2 were prepared as
high-concentration stock solutions, added to the bath solutions to
match the ﬁnal concentration indicated. pH of bath solution and
pipette solution were adjusted with KOH and MSA, respectively.
All recordings were obtained at 21C–23 C and were analyzed
using PatchMaster and Origin 6.1 (OriginLab) software.
Tissue staining
Two-micron thick tissue sections were used. Antigen retrieval
was done with Target Retrieval Solution from Dako and the
sections were heated for 30 minutes in the microwave. Blocking
of endogenous peroxidase was done in 7.5% hydrogen peroxide
for 10 minutes. Anti-TPC2 (atlas antibodies, diluted 1:60) was
applied as primary antibody for 1 hour at room temperature. An
unspeciﬁc control antibody (rabbit IgG isotype, diluted 1:60)was
used under the same conditions as for anti-TPC2 to detect any
background staining of the primary antibody. For antibody detec-
tion, ImmPress reagent anti-rabbit Ig was utilized according to the
manual andDABþ for 3minutes at room temperaturewas used as
a chromogen. Slides were counterstained with hematoxylin for
20 seconds and ﬁnally embedded in mounting medium and
covered with glass coverslips.
Cell transfection
A total of 2105 T24 cellswere transfected using the ScreenFect
A Transfection Kit (Genaxxon bioscience). TPC1 and TPC2 were
silenced using siRNA from Santa Cruz Biotechnology. Nontarget-
ing siRNA was used as a control.
Boyden chamber assay
A total of 1  105 treated or silenced cells were placed on top
of the Transwell chamber (Corning) in media without FCS.
Twenty-four–well plate was ﬁlled with medium with 10% FCS.
Transwell chambers were placed in it and incubated for 16
hours. Migrated cells were ﬁxed and stained with crystal violet/
methanol. The top of the Transwell chamber was cleaned and
pictures were taken. Migrated cells were counted with ImageJ
(NIH, Bethesda, MD).
Endolysosomal preparation
Isolation of endolysosomal proteins was conducted as
described before (20). In short, three 6-well plates of T24 cells
transfected with siTPC1, siTPC2, or siNT were washed with PBS.
Five-hundred microliters of homogenization buffer was added
and the cells were detached with a cell scraper. Homogenization
was performed with a Potter S Homogenizer (B. Braun) at 12 
900 rpm. Homogenized cells were collected into a microcentri-
fuge tube and were centrifuged at 14,000 g, 4C for 15minutes.
Supernatant was collected into a 1.5-mL ultracentrifuge tube
(Beckman), one volume of 16 mmol/L CaCl2 was added and the
preparation was mixed by shaking at 4C for 5 minutes. Ultra-
centrifugation was performed at 18,000  g, 4C for 15 minutes.
Supernatant was removed and the formed pellet was resuspended
in 250 mL wash buffer. After ultracentrifugation at 25,000g, 4C
for 15 minutes, supernatant was removed and pellet was resus-
pended in 50 mL wash buffer. Protein concentration was deter-
mined and 20 mg of endolysosomal preparation was used for
Western blot analysis.
Adhesion assay
A total of 5  104 silenced or stimulated T24 cells were seeded
onto m-slides 8-well ibidiTreat and allowed to attach for 1 hour.
Subsequently, cells were ﬁxed with 4% paraformaldehyde (PFA)
and stained with rhodamine-phalloidin (Molecular Probes) and
Hoechst 33342 (Hoechst; Sigma) for 30 minutes. Cells were
mounted with FluorSave Reagent mounting medium (Merck)
and analyzed with a Zeiss LSM 510 Meta confocal microscope
(Jena).
Chemotaxis
A total of 6  104 T24 cells were seeded on m-Slide Chemotax-
is3D (IBIDI) and allowed to attach for 3 hours. Chemotaxis
experiment (20 hours) was performed as described previously
(21). Cell tracking was performed with ImageJ plugin Manual
tracking (FabriceCordelieres, Institut Curie,Orsay, France). Thirty
cells were tracked per experiment. Data analysis was done with
Chemotaxis andMigration Tool (IBIDI). Rayleigh test was used to
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describe uniformity of distribution of cell endpoints. With P >
0.05, uniformity is rejected (22).
Measurement of cell death
Flow cytometry analysis was performed as described previously
(19). Speciﬁc cell death was calculated as follows: speciﬁc cell
death ¼ [(x – Co) / (100 – Co)]  100
Membrane staining
A total of 2 104 HUH7 cells were seeded onto m-slides 8-well
ibidiTreat. Formembrane labeling, the PKH26 redﬂuorescent cell
linkermini kit was used (Sigma). After silencing or pharmacologic
treatment, cells were incubated with the dye according to the
manufacturer's instructions for 2 minutes. After removal, cells
were incubated with pure FCS for 1 minutes followed by an
incubation of 2 hours in medium. Cells were then ﬁxed with
PFA and stained with Hoechst for 10 minutes. Washed cells were
mounted in FluorSave Reagent mounting medium and the cells
were analyzed by confocal microscopy.
Lysotracker staining
A total of 2  104 T24 cells were seeded onto m-slides 8-well
ibidiTreat and were silenced or stimulated. Thereafter, the cells
were incubated for 30 minutes with 1 mmol/L Lysotracker Red
DND-99 (Molecular Probes) and Hoechst in PBS. After removal,
pictures were taken immediately with a Zeiss LSM 510 Meta
confocal microscope.
b1-integrin internalization
A total of 1  104 T24 cells were seeded onto m-slides 8-well
ibidiTreat and were silenced or stimulated. Cells were starved for
90 minutes and stained with b1-integrin (TS2/16; Santa Cruz
Biotechnology) in cold 0.01% BSA/DMEM without FCS for 45
minutes at 4C. Washed cells were incubated with 0.01% BSA/
DMEM with FCS for 1 hour at 37C. Next, 1 mmol/L phorbol 12-
myristate 13-acetate (Merck) in 0.01% BSA/DMEMwith FCS was
added for 30 minutes at 37C. After washing and ﬁxing cells with
PFA, 0.1% Triton-X100 was added. Alexa Fluor 488-goat-anti-
mouse (Molecular Probes) and Hoechst were used for 1 hour to
stain cells. Washed cells were embedded in FluorSave Reagent
mounting medium and analyzed by confocal microscopy.
Immunocytochemistry
A total of 1  104 T24 cells were seeded onto m-slides 8-well
ibidiTreat (IBIDI). Silenced or treated cells were ﬁxed with PFA
prior to permeabilization with 0.2% Triton X-100/PBS. Hereafter,
unspeciﬁc binding sites were blocked with 1% BSA/PBS contain-
ing 0.1% Triton X-100. Antibodies were diluted in blocking
solution. Used antibodies are given as follows: b1-integrin
(TS2/16), EEA1, LAMP3 (Santa Cruz Biotechnology). Nuclei were
stained with Hoechst. Cells were embedded in FluorSave Reagent
mounting medium and analyzed by confocal microscopy.
Staining of migrating cells
A conﬂuent T24 cell layer was scratched with a pipette tip, after
silencing or treatment. Cells were allowed to migrate for 5 hours
and subsequently ﬁxed with PFA. Samples were stained as
described under the section "Immunocytochemistry." Antibodies
given below were used: b1-integrin (TS2/16), vinculin (Santa
Cruz Biotechnology), pFAKSr732, pSrcpY418 (Invitrogen), Alexa
Fluor 680-goat-anti-rabbit and Alexa Fluor 643-goat-anti-mouse
(Molecular Probes). Rhodamine-phalloidin was used to stain
actin, Hoechst for nuclei.
Western blot analysis
Western blot analysis was performed as described previously
(19). Following antibodies were used: TPC2 (Alomone), LAMP3,
b1-integrin (TS2/16), FAK (Santa Cruz Biotechnology),
pFAKSr732, pSrcpY418 (Molecular Probes), Src (L4A1; Cell Signal-
ing Technology), actin (Millipore), HRP-goat-anti-rabbit (Bio-
Rad), and HRP-goat-anti-mouse (Santa Cruz Biotechnology).
In vivo mouse model
4T1-Luc cells were pretreated with 150 mmol/L Ned-19, 10
mmol/L tetrandrine or DMSO for 24 hours. Alternatively, cells
were silenced with siTPC2 or siNT for 72 hours. Female BALB/
cOlaHsd mice (Envigo) were inoculated with 1  105 4T1-Luc
cells via the tail vein. After ﬁve days, imaging of the mice was
performed using the IVIS Lumina system with Living Image
software 4.4 (Caliper Life Sciences) immediately after intraperi-
toneal injection of 6 mg luciferin (potassium salt, PerkinElmer).
The total signal per deﬁned region of interest was calculated
as photons/second/cm2 (total ﬂux/area). Animal experiments
were approved by the District Government of Upper Bavaria in
accordance with the German Animal Welfare and Institutional
guidelines.
Statistical analysis
GraphPadPrismSoftwarewasused for all statistical analyses. In
some experiments, data were normalized to control or as
indicated.
Results
TPCs in cancer cells
TPCs have been described in different cell types (9, 18, 23);
however, not in cancer cells so far. TPC2 mRNA is distinctly
expressed in T24 (bladder cancer), Jurkat (leukemia), and HUH7
(HCC) cells (Fig. 1A).mRNA levels of TPC1were particularly high
in T24 and HUH7 cells (Fig. 1B). Tumor tissue sections of HCC
patients showed a highly positive staining for TPC2 (Fig. 1C).
Together, these data suggest the presence of TPCs in cancer cells.
To verify TPC functionality in T24 cancer cells, we isolated lyso-
somes and performed endolysosomal patch-clamp experiments.
The applied whole-endolysosmal patch-clamp method is illus-
trated in Fig. 1D. PI(3,5)P2-elicited currents were strongly reduced
after applying tetrandrine (Fig. 1E and F), recently shown to
inhibit TPC1 and TPC2 (18).
TPCs affect cancer cell migration and adhesion
Previous studies in TPC2-deﬁcient MEF cells showed defects in
the endolysosmal degradation pathway (9, 11). As alterations in
this pathway through inhibition of another endolysosome-asso-
ciated protein, the vacuolar ATPase (V-ATPase), have been
described to reduce the ability of invasive cancer cells to migrate
(21), we hypothesized that TPCs affect cancer cell migration.
Silencing TPC1 and TPC2 by siRNA in T24 cells resulted in
signiﬁcantly reducedmigration throughpores inBoyden chamber
assays (Fig. 2A). Knockdown efﬁciency is shown in Fig. 2B and C.
Moreover, these cells showed diminished adhesion after 1 hour of
seeding (Fig. 2D). To get more information about the migratory
defect, movement of the silenced cells exposed to a diffusive
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gradient of FCS (0%–10%)was analyzed. Figure 2E shows control
cells moving clearly toward the highest FCS concentrations,
whereas knockdown cells displayed reduced directional migra-
tion, which is expressed as P value in the Rayleigh test. Not only
directed migration but also cell mobility seems to be affected as
velocity was signiﬁcantly reduced in silenced cells. Thus, TPC1
and TPC2 seem to play a pivotal role in two major steps of
metastasis formation: adhesion and migration.
Pharmacologic inhibitionof TPC1andTPC2 reduces cancer cell
migration and adhesion
To further investigate the potential of TPCs as novel targets
for cancer therapy, two pharmacologic inhibitors of TPC1 and
TPC2 were used. The NAADP antagonist Ned-19 (17) showed
signiﬁcant reduction of migration through pores in T24 and
HUH7 cells (Fig. 3A). Along this line, treatment with tetran-
drine abrogated migration in Boyden chambers in T24, HUH7,
and 4T1 cells (Fig. 3B). Both TPC inhibitors further impaired
adhesion in T24 cells as displayed in Fig. 3C. Importantly, Ned-
19 and tetrandrine had no effect on cell survival in all tested
concentrations and at all tested time points (Fig. 3D). These
results strengthen our ﬁnding that TPC1 and TPC2 are required
for migration of cancer cells.
Accumulation of enlarged acidic vesicles after pharmacologic
inhibition and TPC silencing
As TPC1 and TPC2 are located in the endolysosomal system (8,
10, 12) of cells, investigating this process after inhibition of TPCs
seemed mandatory. First, membranes of cells were stained with
PKH26 ﬂuorescent dye and subsequently allowed to recycle.
As Fig. 4A indicates, cells treated with Ned-19 and tetrandrine as
well as cells silenced with siTPC1 and siTPC2 accumulated up to
2-fold enlarged vesicles compared with control cells, indicating
that general recycling was impaired after TPC inhibition. Staining
with Lysotracker Red DND-99 showed that the accumulated
enlarged vesicles are acidic compartments. This experiment fur-
ther indicates that the acidiﬁcation of endocytic vesicles was
neither affected after pharmacologic inhibition nor after siRNA
Figure 1.
TPCs in cancer cells. A and B, mRNA levels of TPC2 and TPC1 in different cancer cell lines were assessed by qRT-PCR using the SYBR Green PCR Master Mix.
Expression level ofMDA-MB-231 cellswas set at 1. Bars, SEMof three independent experiments performed in duplicate.C,Human liver sections (HCC and surrounding
tissue) were stained with an antibody against TPC2 or with an unspeciﬁc isotype control antibody (Co-IgG). Counterstaining was done with hematoxylin.
One representative specimen is shown. D, Cartoon illustrating whole-endolysosomal patch-clamp method. E, Representative current-voltage relation recorded
from a vacuolin-enlarged endolysosomal vesicle manually isolated from cultured T24 cells. Shown are the effect of 1 mmol/L PI(3,5)P2 and the blocking effect
of 500 nmol/L tetrandrine. F, Population data for current amplitudes at 100 mV obtained from experiments as shown in E.  , P < 0.05, Student t test; data
are shown as mean  SEM.
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silencing (Fig. 4B). To elucidate the connectionbetweendisturbed
recycling and inhibited cell migration, we selected key proteins of
migration that are predominantly trafﬁcked via the endolysoso-
mal system, such as integrins.
Disturbed b1-integrin recycling through inhibition of TPCs
Integrins feature prominently in cancer cell adhesion and
migration. Under normal conditions, these transmembrane
receptors get rapidly recycled through the endolysosomal system
(4). As inhibition of TPCs hampered endocytosis, we checked
whether recycling of b1-integrin is hindered as well. Internaliza-
tion assays of b1-integrin in T24 cells showed an up to 2-fold
enlargement of b1-integrin–positive vesicles after treatment with
Ned-19 or tetrandrine compared with control (Fig. 5A, left). As
shown in the right panel of Fig. 5A, comparable results were
achieved when TPC1 or TPC2 was silenced in the cells. Moreover,
staining of b1-integrin–positive vesicles with EEA1 and LAMP3
displayed a higher overlap of b1-integrin vesicles with EEA1,
indicating an accumulation in early endosomes rather than in
lysosomes (Fig. 5B). In summary, these ﬁndings illustrate that
TPC inhibition or silencing evokes disturbances in b1-integrin
recycling.
Polarization and protrusion of the cell are essential for accurate
cell migration. Protrusions in the direction of migration are
stabilized through integrins linked to the actin cytoskeleton.
Therefore, integrins have to be recycled to the leading edges of
migrating cells (4, 5). To explore the ability to form leading edges,
scratch assays were performed.Under these conditions, Ned-19 as
well as tetrandrine inhibited the formation of wound-directed,
b1-integrin-, pSrc-, pFAK-, and vinculin-positive polarized lamel-
lipodia (Fig. 6A, top). Accordingly, silencing of TPC1 or TPC2
resulted in the same effects (Fig. 6A, bottom). These ﬁndings can
be easily accounted for by disturbed b1-integrin trafﬁcking to the
front of the cell. Consistently, total protein levels of b1-integrin,
FAK, pFAK, Src, and pSrc were not signiﬁcantly altered after Ned-
19 treatment (Fig. 6B), further corroborating an effect on b1-
integrin recycling.
Reduced formation of lungmetastasis in vivo by pharmacologic
TPC inhibition and siRNA silencing of TPC2
To extend the relevance of TPC inhibition on chemotactic
migration and invasion, we investigated whether tetrandrine
was effective in abrogating cancer cell dissemination in a
mouse model. The 4T1-Luc syngeneic metastatic mouse
Figure 2.
Silencing of TPC1 and TPC2 leads to
reduced migration and adhesion in
cancer cells. For all experiments, T24 cells
were silenced with siRNA against TPC1
and TPC2 for 72 hours. A, siRNA-treated
cellswere allowed tomigrate in Transwell
chambers for 16 hours. B, qPCR analysis
of TPC1 and TPC2 mRNA levels were
assessed with the SYBR Green PCR
Master Mix. Bars, SEM of three
independent experiments performed in
duplicate. C, Western blot analysis of
TPC1 and TPC2 protein levels in
endolysosomal preparations. LAMP3
served as loading control and marker for
lysosomes. Bars, SEM of three
independent experiments,  , P < 0.05
(t test). D, After silencing, cells were
allowed to adhere for 1 hour, ﬁxed, and
stained (rhodamine-phalloidin, Hoechst).
Cells were analyzed by confocal
microscopy. Scale bars, 150 mm. Bars
in A and D are the SEM of three
independent experiments,  , P < 0.05
(one-way ANOVA, Dunnett multiple
comparison test). E, Movement of
silenced T24 cells along a FCS gradient
was monitored (20 hours) by live cell
imaging and analyzed for directed
migration (P value) and velocity (ImageJ,
IBIDI software). Dashed line, P ¼ 0.05.
Bars are the SEM of three independent
experiments.  , P < 0.05 (t test).
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mammary cancer model was used for this purpose (24–26).
4T1-Luc cells express a luciferase reporter, which enables for
live imaging. After intravenous injection, 4T1-Luc cells dissem-
inate to distant organs homing preferably to lungs. Along this
line, control animals showed easily detectable lung metastasis
after ﬁve days of 4T1-Luc cell injection. Remarkably, both
pretreatment with Ned-19 or tetrandrine signiﬁcantly dimin-
ished formation of lung metastasis (Fig. 7A and B). The data
were supported by a subsequent in vivo experiment using TPC2-
silenced 4T1-Luc cells, which also formed signiﬁcantly fewer
lung tumors compared with control transfected cells (Fig. 7C).
These ﬁndings strongly support the hypothesis that targeting
TPCs might be a very promising and viable strategy for met-
astatic cancer therapy.
Discussion
This study designates TPCs as promising targets for the treat-
ment of invasive cancers. Disruption of TPC function abrogates
cancer cell migration in vitro and in vivo, resulting from disturbed
integrin trafﬁcking in the endolysosomal system.
TPCs are Ca2þ-permeable cation channels located in the mem-
brane of endosomes and lysosomes (7–10, 12, 13, 16). In recent
years, evidence has accumulated that TPCs are substantially
implicated in the regulation of endolysosomal trafﬁcking pro-
cesses. Thus, a lack of TPC2 in mouse embryonic ﬁbroblasts
resulted in an accumulation of LDL andEGF/EGFR in intracellular
vesicles (9) and led to delayed PDGFRb degradation (11). Phar-
macologic inhibition of TPCs resulted in accumulation of cholera
toxin within endolysosomes, which is normally delivered to the
Golgi, and enlarged lysosomes dramatically (10). Disrupting TPC
function also reduced Ebola virus trafﬁcking through endosomal
vesicles, preventing infection (18). Consistently, we observed an
accumulation of integrins in early endosomes after TPC inhibi-
tion in invasive cancer cells.
When looking at general endocytic trafﬁcking and receptor
recycling, another protein located in the endolysosmalmembrane
of cells comes into focus, the V-ATPase. V-ATPases are multiunit
proton pumps, which actively transport protons from the cyto-
plasm into intracellular compartments thereby regulating its pH
(27). In several reports, it has been observed that altering pH
by inhibition of V-ATPase results in impaired trafﬁcking and
recycling of signaling molecules. Hence, disturbed V-ATPase
function led to the accumulation of Notch in the endolysosomal
system (28) and of cholesterol in intracellular compartments
(29). In cancer cells, inhibition of V-ATPase affected EGF receptor
(21) and transferrin receptor internalization, the latter resulting in
apoptosis (19).
Figure 3.
Ned-19 and tetrandrine inhibit cancer
cell migration and adhesion. A and B,
T24, HUH7, and 4T1 cells were
pretreated with Ned-19 and
tetrandrine for 8 hours (T24: 250
mmol/L Ned-19, 15 mmol/L Tet; HUH7:
150 mmol/L Ned-19, 2,5 mmol/L Tet;
4T1: 150 mmol/L Ned-19, 10 mmol/L
Tet). Cells were allowed to migrate in
Transwell chambers for 16 hours in the
presence of the inhibitor. C, After
24 hours of treatment with inhibitors
used inA andB, T24 cellswere allowed
to adhere for 1 hour, ﬁxed, and stained
(rhodamine-phalloidin, Hoechst). Cells
were analyzed by confocal
microscopy. Scale bars, 150mm.Bars in
A–C are the SEM of three independent
experiments,  , P < 0.05 (t test).
D, Cell death was assessed after
24 hours of treatment with inhibitors
used in A and B by ﬂow cytometry
analysis. Data represent means of
three independent experiments
performed in triplicates  SEM.
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Taken together, targeting the endolysosmal system either
by TPC or V-ATPase inhibition can apparently both impair
adequate endocytic trafﬁcking. As it is quite evident for V-
ATPase inhibition that this is due to altered pH, there is still
an ongoing discussion regarding TPCs. Impaired Ca2þ signaling
may be one reason; however, it has also been postulated that
alkalinizing of the lysosomal pH is responsible for the inhibi-
tion of autophagosomal-lysosomal fusion (30). In our study,
we observed an accumulation of enlarged acidic vesicles after
TPC inhibition, hence no alkalinizing of pH. Other recent
publications have also found no evidence for changes in
endolysosomal pH under basal conditions in TPC-deﬁcient
cells (9, 11, 31).
Alterations in Ca2þ signaling are widely accepted to lead to
impaired trafﬁcking and fusion of endocytic vesicles (9, 10). This
hypothesis is further supported by theﬁnding that Ca2þ chelators,
BAPTAandEGTA-AM, are able to inhibit fusionof late endosomes
and lysosomes (32). In this context, it is interesting to note that
another Ca2þ-permeable endolysosomal channel, TRPML1, has
been proposed to be required for fusion between late endo-
somes and lysosomes in Drosophila (33). In humans, loss or
mutation of this channel leads to the lysosomal storage disorder
mucolipidosis type IV (34–36), further supporting the impor-
tance of Ca2þ signaling.
Regardless of what the main cause of this impairment
is, inhibition of TPC function led to a clear accumulation of
b1-integrins in early endosomes. Integrins link the cell to the
ECM enabling adhesion and migration (37). To migrate, the
cell must be polarized meaning that different molecular pro-
cesses occur at the front and back of a moving cell (5).
Figure 4.
Inhibition of TPCs disrupts endocytic
recycling. A, Membranes were stained
with PKH 26 red in HUH7 cells after
24 hours of Ned-19 (150 mmol/L) and
tetrandrine (2.5 mmol/L) treatment or
after 72 hours of TPC1 and TPC2
silencing. Cellswere allowed to recycle
again for 2 hours. Fixed cells were
analyzed by confocal microscopy.
B, Ned-19 (250 mmol/L, 24 hours),
tetrandrine (15 mmol/L, 24 hours)-
treated or siRNA-silenced (72 hours)
T24 cells were stained with
Lysotracker Red DND-99 and
analyzed by confocal microscopy.
Nuclei in A and B were stained with
Hoechst. Vesicles were analyzed with
ImageJ. Bars, SEM of three
independent experiments,
 , P < 0.05 (t test). Scale bars, 20 mm.
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Therefore, several proteins are trafﬁcked towards the front of
the cell. For example, growth factor receptors and chemokine
receptors are recycled to speciﬁc sites of the leading edge to
mediate promigratory signals. Importantly, adhesive contacts
are regulated by the recycling and degradation of integrins (4).
Hence, the turnover of integrins is crucial for migration. We
Figure 5.
b1-Integrin recycling is hindered after TPC
inhibition. A, Internalized b1-integrin was
stained in T24 cells after 24 hours of Ned-19
(250 mmol/L) and tetrandrine (15 mmol/L)
treatment or after 72 hours of siRNA
silencing. Scale bars, 20 mm (top pictures)
and 10 mm (bottom pictures). Vesicles were
analyzed with ImageJ. Bars, SEM of three
independent experiments,  , P < 0.05
(t test). B, Ned-19 (250 mmol/L, 24 hours)
and tetrandrine (15 mmol/L, 24 hours)-
treated or siRNA-silenced (72 hours) T24
cells were stained for b1-integrin (green),
EEA1, LAMP3 (red), and nuclei with Hoechst
(blue). Scale bars, 10 mm. Pictures of cells in
A and B were taken with a confocal
microscope.
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could observe in our studies, in addition to an accumulation of
b1-integrin in enlarged vesicles, reduced b1-integrin localiza-
tion at the leading edge of migrating cells after TPC inhibition
or silencing. These ﬁndings suggest that disrupted TPC function
alters b1-integrin trafﬁcking, resulting in reduced adhesion to
ECM and insufﬁcient polarization of the cell.
Figure 6.
TPC function is required for the
formation of leading edges. A, T24
cells were scratched and let migrate
for 5 hours after a pretreatment with
250 mmol/L Ned-19 and 15 mmol/L
tetrandrine for 16 hours or after siRNA
silencing for 72 hours. Fixed cells were
stained for actin, b1-integrin, pSrc,
pFAK, and vinculin (white). Nuclei
were stained with Hoechst. One
representative picture out of three
independent experiments is shown.
Scale bars, 20 mm. White arrows,
leading edges. B, Total protein
amounts of b1-integrin, pSrc, Src,
pFAK, and FAK were detected by
Western blot analysis in T24 cells after
treatment with 250 mmol/L Ned-19 for
24 hours. One representative blot is
shown. Quantiﬁcation was done with
ImageJ. Bars, SEM of three
independent experiments.
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Besidesmediating adhesion to ECM, integrins are also essential
for cell migration as they regulate promigratory signaling path-
ways. Thus, integrin ligation induces clustering, resulting in the
activation of FAK. Active FAK recruits Src family kinases to focal
adhesions, altogether promoting cell migration and invasion. In
addition, focal contacts contain different actin-associated pro-
teins, such as vinculin, which links integrin to the cytoskeleton
(3). In our study, inhibition of TPC function or expression clearly
diminished the accumulation of integrin, pFAK, pSrc, and vincu-
lin at the leading edge of migrating cells. This suggests that
adequate b1-integrin trafﬁcking is crucial for the initiation of
promigratory mechanisms.
To fulﬁll these functions, integrins form heterodimeric recep-
tors. Pairing ofa and b subunits decides for the speciﬁc binding of
certain matrix ligands. Previous investigations on the b1-integrin
subunit revealed a central role in adhesion, extravasation, and
migration in T24 cancer cells (38). Moreover, reports show that
b1-integrin and FAK signaling is implicated in the initial prolif-
eration of cancer cells disseminated into the lungs (39). Our own
experiments are consistent with these notions. Further research
Figure 7.
Inhibition of TPC function in 4T1-Luc
cells reduces the formation of lung
metastasis in vivo. A and B, 4T1-Luc
cells were pretreated with 150 mmol/L
Ned-19, 10 mmol/L tetrandrine, or
DMSO for 24 hours. C, 4T1-Luc cells
were silenced with siTPC2 or siNT for
72 hours. A–C, 1  105 cells were
injected intravenously into BALB/
cOlaHsd mice. On day ﬁve after cell
inoculation, bioluminescence signals
weremeasured by imaging themice in
ventrodorsal position. The total signal
per deﬁned region of interest was
calculated as photons/second/cm2
(total ﬂux/area). Bars, SEM of 7
animals.  , P < 0.05 (t test).
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over the last several years led to the development of integrin-
targeted therapeutics, which are now tested in clinical studies
against cancer and other diseases (3). ThemAb volociximab is the
ﬁrst a5b1 integrin antagonist in clinical trials against metastatic
clear cell renal cell carcinoma, metastatic melanoma, non–small
cell lung cancer, and peritoneal cancer among others (40, 41). In
addition, several therapeutic antibodies targeting avb3 integrin
are under development or in clinical phases as antitumor agents
such as Vitaxin and CNTO 95 (40). Taken together, targeting
integrins is a highly promising and viable strategy for the treat-
ment of metastatic cancers.
In summary, our study reveals a potential novel role for TPCs in
the formation of metastasis. Impaired TPC function reduced
adhesion and migration of cancer cells in vitro and diminished
formationofmetastasis in vivo.Most likely, this is due to disturbed
trafﬁcking of integrins known to act promigratory. Here we
link TPCs to fundamental processes in cancer cell migration,
rendering them new and attractive targets for the treatment of
invasive carcinomas.
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Two-pore channels (TPCs) are endolysosomal cation channels. Two
members exist in humans, TPC1 and TPC2. Functional roles associ-
ated with the ubiquitously expressed TPCs include VEGF-induced
neoangiogenesis, LDL-cholesterol trafficking and degradation, phys-
ical endurance under fasting conditions, autophagy regulation, the
acrosome reaction in sperm, cancer cell migration, and intracellular
trafficking of pathogens such as Ebola virus or bacterial toxins (e.g.,
cholera toxin). In a genome-wide association study for variants
associated with human pigmentation characteristics two coding
variants of TPC2, rs35264875 (encoding M484L) and rs3829241
(encoding G734E), have been found to be associated with a shift
from brown to blond hair color. In two recent follow-up studies a
role for TPC2 in pigmentation has been further confirmed. However,
these human polymorphic variants have not been functionally
characterized until now. The development of endolysosomal patch-
clamp techniques has made it possible to investigate directly ion
channel activities and characteristics in isolated endolysosomal
organelles. We applied this technique here to scrutinize channel
characteristics of the polymorphic TPC2 variants in direct comparison
with WT. We found that both polymorphisms lead to a gain of
channel function by independent mechanisms. We next conducted
a clinical study with more than 100 blond- and brown/black-haired
individuals. We performed a genotype/phenotype analysis and
subsequently isolated fibroblasts from WT and polymorphic
variant carriers for endolysosomal patch-clamp experimentation
to confirm key in vitro findings.
TPC | TPC2 | two-pore channel | polymorphism | pigmentation
Two-pore channels (TPCs) are endolysosomal cation channelswhich are distantly related to the endolysosomal TRP chan-
nels of the TRPML subfamily on the one hand and the voltage-
gated calcium channels on the other hand. Two members exist in
humans, TPC1 and TPC2. Functional roles associated with the
ubiquitously expressed TPCs include VEGF-induced neoangio-
genesis (1), endolysosomal LDL-cholesterol trafficking and deg-
radation (2), physical endurance under fasting conditions (3),
autophagy regulation (4, 5), the acrosome reaction in sperm (6),
intracellular trafficking of certain pathogens such as filoviridae
(e.g., Ebola or Marburg virus) (7), bacterial toxins (e.g., cholera
toxin) (8), and a role in cancer cell migration (9). A few years ago,
Sulem et al. (10) presented results from a genome-wide associa-
tion study for variants associated with human pigmentation char-
acteristics among 5,130 Icelanders, with follow-up analyses in
2,116 Icelanders and 1,214 Dutch individuals from which they
claimed that two coding variants of hTPC2 (SNPs), rs35264875
(encoding M484L) and rs3829241 (encoding G734E), were asso-
ciated with a shift from brown to blond hair color. Very recently,
Ambrosio et al. (11) as well as Bellono et al. (12) confirmed a role
for TPC2 in pigmentation by showing that TPC2 regulates the pH
and size of melanosomes, thus controlling the amount of melanin
produced. Consequently, loss of TPC2 activity by knockout or
knockdown leads to a strong increase of melanin production and
melanosomal pH.
Hence, it seemed intriguing to functionally investigate these
polymorphic TPC2 variants. We investigated the activity of WT
hTPC2 side by side with hTPC2(G734E) and hTPC2(M484L) as
well as the double-mutant isoform (M484L/G734E). First, we
applied the endolysosomal patch-clamp technique in combina-
tion with small-molecule activators and blockers of TPC2 to di-
rectly assess channel activity. Second, we performed molecular
dynamics simulations of TPC2 based on the recently published
structures of TPC1 (13, 14) to investigate structural changes due
to the SNPs. These results were corroborated by ion substitution
experiments to assess pore sizes. Furthermore, we genotyped
more than 100 blond- and brown/black-haired human individuals
and isolated fibroblasts from selected donors to confirm key in
vitro findings and the results of the genome-wide association study
by Sulem et al. (10).
Significance
Polymorphisms in the endolysosomal cation channel TPC2 have
been suggested to lead to a shift in human hair color from
brown to blond. In two further studies a role for TPC2 in mel-
anosomal pH regulation was postulated. Electrophysiological
data on how these polymorphisms affect channel gating and
activity are, however, missing. We show here that both poly-
morphisms lead to a gain of channel function by different
mechanisms. In M484L sensitivity to its endogenous ligand
PI(3,5)P2 is strongly increased while in G734E channel in-
activation by ATP is reduced. These findings are corroborated
by molecular dynamics and ion substitution experiments.
Furthermore, >100 blond- and brown/black-haired human in-
dividuals were genotyped and fibroblasts isolated from se-
lected donors to confirm key in vitro findings.
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Results
Human TPC2 WT and Polymorphic Variants Show Comparable
Subcellular Distribution but Differences in Basal Activity and Their
Response to PI(3,5)P2. WT hTPC2 and the polymorphic variants
containing either M484L, G734E, or both M484L and G734E
show similar subcellular distribution when overexpressed in
HEK293 cells (SI Appendix, Fig. S1A). All variants localize to
intracellular vesicular structures which are positively stained with
Lysotracker (SI Appendix, Fig. S1A). A calculation of the Pear-
son correlation coefficients resulted in similar numbers for
colocalization with Lysotracker for all variants (SI Appendix, Fig.
S1B). Western blot analysis demonstrated that expression levels
of the different variants in endolysosomal membranes are not
significantly different (SI Appendix, Fig. S1 C and D). Treatment
with vacuolin increased the size of endolysosomal vesicles to a
similar extent in all variants (SI Appendix, Fig. S1E). Finally,
dimerization efficiencies of TPC2 WT and the polymorphic
variants were comparable as assessed by FRET experimentation
(SI Appendix, Fig. S2).
The two polymorphisms are found in very different parts of the
protein. While M484L resides in the second transmembrane domain
of the second channel domain, G734E is found in the C terminus of
the protein (Fig. 1A), suggesting different functional consequences.
We next performed endolysosomal patch-clamp experiments.
Here, we found striking differences between the respective vari-
ants. The polymorphic variant M484L as well as the double-
polymorphic variant showed, compared with WT, a significantly
increased basal channel activity as well as a significantly increased
channel activity after stimulation with PI(3,5)P2 (3, 15). In contrast,
G734E showed mean basal and stimulated activation levels similar
to those of WT (Fig. 1 B–F and SI Appendix, Fig. S3A). Average
capacitance values were comparable for all variants, indicating that
differences in channel activity were not due to differences in the
size of the patched vesicles (SI Appendix, Fig. S3B). Dose–response
measurements revealed an EC50 of 1,138 ± 376 nM for WT
compared with 216 ± 55 nM for M484L, while G734E was not
significantly different fromWT with an EC50 of 827 ± 183 nM (Fig.
1G; increased potency). In addition, the maximum response level
was increased by two- to threefold, depending on the PI(3,5)P2
concentration, in M484L compared with WT or G734E (Fig. 1G;
increased efficacy).
Differences in ATP Inhibition Between TPC2 WT and Polymorphic
Variants. We next assessed the inhibition of activated TPC2
WT and polymorphic variants by ATP. Block of TPC activity by
ATP has been demonstrated before and was shown to be phys-
iologically relevant during cell starvation (3). We confirm here
that the channel activities of WT TPC2 and also the polymorphic
variants M484L and G734E are efficiently blocked by applying
high concentrations of ATP (1 mM). However, dose–response
measurements revealed significant differences in the IC50 values
which were generated for each variant based on their individual
PI(3,5)P2 EC50 values (Fig. 2). When we used the individual PI
(3,5)P2 EC50 values to activate we obtained the following IC50
values for the ATP block: WT (91 ± 19 μM), G734E (351 ± 37 μM),
and M484L (102 ± 6 μM). These data demonstrate that sig-
nificantly less ATP is necessary to block WT TPC2 or M484L
variant activities compared with the G734E variant. Similar re-
sults were obtained when we used the individual PI(3,5)P2 EC80
values or a fixed concentration of 1 μM PI(3,5)P2 to activate. The
respective IC50 values for the ATP block were as follows: WT
(179 ± 15 μM) and G734E (384 ± 39 μM) for PI(3,5)P2 EC80 as
A D F
B
C
E
G
Fig. 1. Effect of PI(3,5)P2 on endolysosomal vesicles expressing either human TPC2WT or polymorphic variants. (A) Cartoon showing the estimated positions of the
polymorphisms (SNPs) M484L and G734E. (B–E) Shown are representative basal and PI(3,5)P2 (1 μM) activated currents in vacuolin-enlarged endolysosomal vesicles
expressing either hTPC2 WT, hTPC2(M484L), hTPC2(G734E), or hTPC2(M484L/G734E) C-terminally fused to YFP. (F) Statistical summary of data as shown in B–E.
Shown are average current densities at −100 mV. (G) PI(3,5)P2 dose–response curves for hTPC2 WT and hTPC2(M484L) and hTPC2(G734E). In all experiments,
currents were elicited by applying 500-ms voltage ramps from −100 to +100 mV every 5 s. In all statistical analyses mean values of at least 5–10 independent
experiments are shown, each. To test for statistical significance the one-way ANOVA test followed by Tukey’s posttest was applied. ***P < 0.001, **P < 0.01.
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well as WT (4 ± 2 μM) and G734E (133 ± 71 μM) for the fixed
concentration of 1 μM PI(3,5)P2 (SI Appendix, Fig. S4).
In summary, these data suggest that both M484L and G734E
variants are gain-of-function (GOF) polymorphisms.
Effect of mTOR Inhibitors. ATP is known to activate mTOR
(mechanistic target of rapamycin) (16) and mTOR is the
mediator that inhibits TPC2 by direct protein–protein in-
teraction, as recently shown (3). To further investigate the
cross-talk between channel activity and ATP inhibition, we
tested the effect of mTOR inhibitors such as rapamycin and
torin-1 on TPC2 channel activity. Both compounds were found
previously to enhance TPC2 channel activity by blocking the
TPC2 inhibitor mTOR (3). We found that inhibition of mTOR
increased TPC2(G734E) channel activity more efficiently than
WT activity, suggesting a stronger effect of mTOR on WT
compared with G734E. In contrast, the channel activity of the
M484L isoform could not be further enhanced under the same
conditions [for M484L a PI(3,5)P2 concentration of 1 μM is a
saturating concentration; EC50 = 216 ± 55 nM] (Fig. 3 and SI
Appendix, Fig. S5 A and B).
A
B
C
D
Fig. 2. Effect of ATP on human TPC2 WT and polymorphic variants using the respective EC50 values of PI(3,5)P2 as activating concentrations. (A–C) Rep-
resentative PI(3,5)P2 (diC8) activated currents in vacuolin-enlarged hTPC2 WT and hTPC2 SNP expressing endolysosomal vesicles using the respective EC50
values as activating PI(3,5)P2 concentrations and different concentrations of ATP as indicated to block the currents. (D) ATP dose–response curves from ex-
periments as shown in A–C. In all experiments currents were elicited by applying 500-ms voltage ramps from −100 to +100 mV every 5 s. To test for statistical
significance the Student’s t test, unpaired was applied. *P < 0.05.
Fig. 3. Effect of rapamycin and torin-1 on human TPC2 WT and G734E. (A and B) Representative PI(3,5)P2 (1 μM) activated currents in vacuolin-enlarged
hTPC2 WT and hTPC2(G734E) expressing endolysosomal vesicles and the respective blocking effects of 2 μM torin-1 or 1 μM rapamycin. Cells were incubated
with torin-1 for 12 h or with rapamycin for 10 min before experimentation. Currents were measured in the absence of ATP. (C) Statistical summary of data as
shown in A and B including respective basal currents. Shown are average current densities at −100 mV. To test for statistical significance the one-way ANOVA
test followed by Tukey’s posttest was applied to basal and PI(3,5)P2 conditions, respectively. ***,
###P < 0.001, ##P < 0.01.
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Ion Substitution Experiments. To further corroborate the findings
obtained for the M484L variant we performed ion substitution
experiments and molecular dynamics simulations based on the
recently published structures of AtTPC1 (13, 14). In ion sub-
stitution experiments using the endolysosomal patch-clamp tech-
nique we found differences in the estimated pore diameters
between WT and M484L, while there were no obvious dif-
ferences between WT and G734E (Fig. 4 A–E and SI Appendix,
Fig. S5 C–E). We used monovalent cations (sodium, lithium,
rubidium, and cesium) in a concentration of 160 mM, each, to
estimate the pore diameters of TPC2 WT and the M484L variant
(Fig. 4 A–E). We determined permeability ratios relative to Na+
(PX/PNa) from the bionic reversal potentials, which resulted in
estimations of 3.7 Å and 3.9 Å for the minimum pore diameter
of TPC2 WT and the M484L variant, respectively. The estima-
tion for the G734E variant diameter resulted in the same value as
for WT (3.7 Å) (SI Appendix, Fig. 5E). These data suggest that
M484L not only contributes to larger current amplitudes but also
influences channel conformation and the narrowest part of the
pore region.
Molecular Dynamics Simulations Confirm Dilated Pore in hTPC2(M484L)
Variant. Multiple models of the TPC2 channel were submitted to
prolonged molecular dynamics simulations of at least 100 ns, each.
WT and M484L variant were simulated with PI(3,5)P2 resembling
the experimental layout. As each simulation system contained two
channel models a total of over 800 ns was available for analysis. All
models showed a high degree of stability preserving their overall
structure and a continuous water column through the pore. For
one of the two M484L models a dilation of the pore could be
observed in the presence of PI(3,5)P2 for ∼10 ns around position
A272. The pore radii of the dilated M484L pore were compared
with the WT pore (Fig. 4 F–H). This finding suggests that the
M484L mutation affects pore dynamics, further corroborating the
data presented on the estimation of the pore sizes of TPC2 WT
and M484L by ion substitution experimentation. Notably, Schieder
et al. (17) had reported previously that TPC2 mutant isoform
N273A (next to A272) shows a pore block, and Wang et al. (15)
reported that the D276K mutation likewise leads to a pore block
and loss of PI(3,5)P2 response, emphasizing the importance of this
region for channel activity.
A B
C D
E F
G
H
Fig. 4. Ion substitution experiments and molecular dynamics simulations. (A–D) Endolysosomal patch-clamp experiments showing PI(3,5)P2-activated hTPC2
WT (A and B) or hTPC2(M484L) (C and D) currents under biionic conditions with luminal Na+ and bath solutions containing the following monovalent cations,
respectively: Li+, K+, Rb+, and Cs+. (B and D) Expanded view of A and C, showing that the reversal potentials are shifted to negative voltage in M484L variant.
(E) Summary of data as shown in A–D. Shown are the relative permeabilities (PX/PNa) of the different cations plotted against the diameter of cations. The
dashed lines are fitted to Eq. 2 (see Materials and Methods for details). (F) Schematic representation of the TPC2 simulation system. The channel (gray) is
embedded in a fully solvated POPC bilayer (transparent surfaces). As the channel has a conic shape the bilayer is bent locally. To cope with this effect always
two channel models were embedded in antiparallel fashion into a larger bilayer patch. (G) Enlargement of the selectivity filter omitting part of the protein.
D276, N273, and A272, which are present symmetrically on both subunits, are shown in VdW representation. (H) The pore radius of TPC2 is shown at the
height of A272 for WT (blue) and the M484L variant (red) simulated in presence of PI(3,5)P2. A representative window at the end of the independent
simulations was chosen which presumably resembles an opening event. One of two M484L pores showed a dilation of more than 1 Å for almost 10 ns.
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Endogenous TPC2 Channel Activity in Human Donor Fibroblasts. Next,
we screened more than 100 blond- and brown/black-haired human
donors for TPC2 polymorphisms and identified individuals which
were either homozygous for WT, M484L, or G734E, or individuals
which were heterozygous for the respective polymorphisms (Fig. 5 A
and B). The obtained genotyping results were found to correlate well
with the data published by Sulem et al. (10). Thus, the percentage of
DNA samples isolated from blond-haired individuals which are ho-
mozygous for either M484L or G734E was 7.2% and 26.1% (n = 69),
respectively, while DNA samples isolated from brown-, dark brown-,
or black-haired individuals were in only 2.9% of the cases homozy-
gous for M484L and in only 10.4% of the cases homozygous for
G734E (n = 67). Among the blond-haired donors we found only
5.8% to be homozygous for WT. Among individuals with brown/
black hair 23.9% were found to be homozygous for WT (Fig. 5A).
We subsequently isolated fibroblasts from selected individuals
and analyzed them using the endolysosomal patch-clamp technique
(Fig. 5 C–F). While we found only small endogenous PI(3,5)P2
currents in WT or G734E fibroblast endolysosomes, significantly
increased PI(3,5)P2-mediated channel activity was detectable in
endolysosomes isolated from donor fibroblasts homozygous for
M484L, essentially confirming the in vitro findings. For ATP dose–
response measurements the PI(3,5)P2-mediated currents in G734E
endolyosomes were too small. As an activation control we used the
TRPML-channel activator ML-SA1 (18). TRPML channel currents
activated with ML-SA1 were not significantly different between
M484L, G734E, and WT endolysosomes, suggesting that the dif-
ferences in PI(3,5)P2 response are not due to differences in TRPML
channel activity (Fig. 5 C–E). In summary, these data confirm the
strong GOF found for the M484L variant in overexpressing
HEK293 cells and the data further confirm the increased associa-
tion of the M484L and G734E variants with blond hair color
compared with the WT TPC2 isoform.
Discussion
We show here that the TPC2 variants M484L and G734E reported
previously to be associated with a shift in human hair color from
brown to blond display distinct functional differences compared
with WT. We used overexpressing HEK293 cells and endogenously
expressing fibroblasts to functionally characterize the respective
variants. In endolysosomal patch-clamp experiments we found that
both variants show a gain of channel function compared with WT
(SI Appendix, Fig. S6). While basal activity and activation with PI
(3,5)P2 was increased in M484L, affecting both efficacy and
A
B
D
F
C E
Fig. 5. Characterization of human fibroblasts isolated from TPC2 WT donors or donors carrying TPC2 polymorphisms. (A and B) Data summarizing se-
quencing results obtained from human genomic DNA samples. Shown in A is the genotype distribution (in percent) of individuals with either blond hair or
brown/black hair (e.g., 23.9% of the brown/black hair donors but only 5.8% of the blond hair donors are genotype WT). In contrast, 26.1% of the blond hair
donors are homozygous for E (homE) at position 734 while only 10.4% of the brown/black hair donors are homE. Shown in B is the phenotype distribution (in
percent) of all genotyped individuals (e.g., 80% of all individuals with the genotype WT have brown/black hair while only 20% have blond hair). In contrast,
72% of all individuals with the genotype homE at position 734 and 71.4% of all individuals with the genotype L homozygous (homL) at position 484 are
blond. The total numbers of donors were 67 (brown/black hair) and 69 (blond hair), respectively. (C) Examples of human donor genotyping results. Shown are
respective sequences around position 484 (Leu/Met) and 734 (Gly). (D and E) Representative endolysosomal patch-clamp experiments showing PI(3,5)P2
(10 μM) activated currents in vacuolin-enlarged fibroblast endolysosomes isolated from donors homozygous for WT, M484L, and G734E. The TRPML channel
activator ML-SA1 was used to demonstrate that TRPML currents were comparable in size in all fibroblast lines, in contrast to PI(3,5)P2-mediated currents.
(F) Statistical summary of data shown in D and E. Two independent donor fibroblast samples were used for each WT and M484L. One sample was used for
G734E. Shown are the pooled average current densities at −100 mV of at least five independent experiments, each. To test for statistical significance one-way
ANOVA test followed by Tukey’s posttest was applied. ***P < 0.001, *P < 0.05.
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potency of PI(3,5)P2, inhibition of channel activity by ATP was less
sensitive in G734E compared with WT (SI Appendix, Fig. S6). The
M484L polymorphism leads to structural changes affecting the
pore diameter of TPC2. Thus, M484L displays a significant pore
dilation compared with WT as demonstrated by molecular dy-
namics simulations and ion substitution experiments. The G734E
variant is less responsive to ATP and more sensitive to mTOR
inhibitors than WT, the latter suggesting that the weaker ATP
effect may be mediated by mTOR. While torin-1 is a selective
ATP-competitive inhibitor of mTOR which effectively blocks
phosphorylation of mTOR, rapamycin and related inhibitors form
a complex with the intracellular immunophilin FKBP12; the
resulting complex then interacts with and inhibits mTOR (19, 20).
Despite these different mTOR inhibitory mechanisms, both torin-
1 and rapamycin result in a stronger increase in G734E activity
compared with WT, further emphasizing that the differences in
ATP block may be directly mediated via mTOR and downstream
effects. Nevertheless, we cannot fully exclude the possibility of
mTOR-independent ATP effects.
Remarkably, human TPC2 cDNAs used for functional studies in
past publications were often polymorphic variants. For example,
Calcraft et al. (21) had used a TPC2 variant cloned from HEK293
cells containing both polymorphisms: M484L and G734E. Pitt et al.
(22) had used a variant of human TPC2 containing the G734E
polymorphism (GenBank accession no. AY029200) and Brailoiu
et al. (23) had used the IMAGE clone 5214862 (GenBank acces-
sion no. BC063008) which also contains the polymorphism G734E.
Thus, it seems that WT hTPC2, at least in its recombinant form, has
not always been used as a reference in the existing publications.
In accordance with recent findings by Ambrosio et al. (11) as
well as Bellono et al. (12), claiming that loss of TPC2 leads to
increased melanin production, an increase in TPC2 channel ac-
tivity as found here for the two SNPs would be expected to result in
the opposite effect, a decrease in melanin production. Located in
the basal epidermis and in hair follicles, melanocytes of the in-
tegument are responsible for hair coloration through production of
melanin pigments in melanosomes (24). Two types of pigment are
known to give hair its color: eumelanin and pheomelanin. Eume-
lanin has two subtypes, black and brown, which determine the
darkness of the hair color. A low concentration of brown eume-
lanin results in blond hair, whereas a higher concentration of
eumelanin will color the hair brown/black. Melanin production is
strongly dependent on the activity of the enzyme tyrosinase (TYR).
TYR activity is optimal at neutral pH (25–27). To achieve neu-
tralization of melanosomal pH, the proper function of a cascade of
ion transporters seems to be required (27). Consequently, poly-
morphisms in any of such transporters or ion channels rendering
them dys- or malfunctional may lead to changes in melanosome
pH and thus to changes in melanin production, as suggested re-
cently by Ito and Wakamatsu (27). For TPC2 this hypothesis has
now been supported by works published by Ambrosio et al. (11)
and Bellono et al. (12). Thus, loss of TPC2 leads to an increase in
melanosomal pH and melanin production while overexpression of
TPC2 leads to a decrease in melanin production. Like TPC2
overexpression, an increase in TPC2 activity would be expected to
result in a decreased melanosomal pH and thus a decrease in
melanin production. This would consequently explain the shift in
hair color from brown to blond.
In addition to hair coloration, altered TPC2 channel activity may
also impact human health, in particular under challenging condi-
tions such as physical stress or infections. TPC2 knockout mice show
an increased susceptibility to hypercholesterinemia and fatty liver
hepatitis compared with WT when fed with a high-cholesterol diet
(2), they show a decreased physical endurance under fasting con-
ditions (3), and they are less susceptible to distinct viral infections
(7). Migration of cancer cells and the formation of metastases was
recently found to be reduced in TPC2 knockdown cells or after
pharmacological inhibition of TPC2 (9). We therefore speculate
that humans carrying the GOF polymorphisms M484L or G734E,
or both, may have, in particular under stress conditions, an altered
susceptibility for diseases that are associated with the endolysosomal
system. In addition, it may also be possible that changes in
TPC2 activity affect melanosomes differently than lysosomes, for
example due to differences in pH regulatory mechanisms with dif-
ferent consequences for human physiology and pathophysiology.
Materials and Methods
Molecular Biology.All humanTPC2 variantswere generated fromhTPC2(M484L/
G734E)-mCherry, a gift from Michael Zhu, University of Texas Medical School,
Houston. Point mutations were removed from constructs by site-directed mu-
tagenesis using QuikChange (Agilent) according to the procedures outlined in
the manufacturer’s manual or by overlap PCR experimentation. C-terminally
fused YFP versions of WT and the polymorphic TPC2 variants were generated
from the respective mCherry constructs and subcloned into pcDNA3.1 vector.
Constructs used for FRET experiments are described in Materials and Methods
and the figure legends in more detail.
Endolysosomal Membrane Preparations. To evaluate expression levels of TPC2
WT and variants in endolysosomal membranes, HEK293 cells were transfected
with TPC2-constructs (YFP-tagged), respectively. Preparation of endolysosomes
was performed as described previously (17, 28). For immunoblotting, antibodies
were used in the following dilutions: rabbit anti-Rab7, 1:500 (2094S; cell sig-
naling); mouse anti-GFP, 1:2,000; mouse anti-HRP 1:2,000 (sc-2031; Santa Cruz);
and rabbit anti HRP, 1:1,000 (NA934V; GE Healthcare).
Molecular Modeling. Amodel for TPC2was constructed using Schrödinger Prime
based on Protein Data Bank ID code 5E1J (14) with the UniProt sequence
Q8NHX9 (21). Default settings were used using the multichain protocol mod-
eling both subunits simultaneously. Always two of the resulting models were
embedded into a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bi-
layer in antiparallel orientation to reduce lateral stress following protocols
described earlier (29, 30) and solvated with simple point charge water. CaCl2
was added to balance the overall charge and to achieve nearly physiological ion
concentrations. Using GROMACS-5.1 the periodic system was energy-minimized
and constraints on the protein were gradually reduced (31–33). A total of
100 ns each were simulated with a time step of 2 fs for the WT, WT with PI(3,5)
P2, M484L, and M484L with PI(3,5)P2. Two equivalents per pore were placed in
the vicinity of M484L into the bilayer for the corresponding simulations.
Neighbor searching was performed every 40 steps. The particle mesh Ewald
algorithm was used for electrostatic interactions with a cutoff of 1.2 nm and
Verlet cutoff scheme. A reciprocal grid of 192 × 120 × 120 cells was used with
fourth-order B-spline interpolation. A single cutoff of 1.2 was used for van der
Waals interactions. Temperature coupling to 310 K was done with the V-rescale
algorithm. Semiisotropic pressure coupling to 1 bar in the plane and perpen-
dicular to it was done with the Berendsen algorithm. For all simulations the
53a6 force field was used with parameters for POPC adapted from ref. 29 and
adapted for PI(3,5)P2 from ref. 34. The analysis was performed using GROMACS
tools, VMD, Schrödinger, and hole2 (31, 35–37).
FRET Experiments. Measurements of single-cell FRET based on aggregate
(nonspatial) fluorescence recordings were performed and analyzed using the
three-cube FRET method as described previously (38). For measurements, tran-
siently transfected HEK293 cells were maintained in buffer solution composed of
140 mM NaCl, 5 mM KCl, 1 mMMgCl2, 2 mM CaCl2, 10 mM glucose, and 10 mM
Na-Hepes, pH 7.4, at room temperature (RT). Fluorescence intensities of YFP or
the GFP variants Citrine and Cerulean were recorded using a LEICA DMI6000B
inverted epifluorescence microscope and a photomultiplier detection system
(PTI). Excitation was done at 436 nm ± 2.5 or 500 nm ± 2.5 with a DeltaRam
monochromator (Horiba). Epifluorescence emission was detected by a photo-
multiplier (PMT 914) and acquired on a personal computer using FelixGX soft-
ware (Horiba). Three-cube FRET filter cubes were as follows (excitation; longpass
beamsplitter; emission): CFP/Cerulean (ET436/20×; T455lp; ET480/40m), YFP/Cit-
rine (ET500/20×; T515lp; ET535/30m), and FRET (ET436/20×; T455lp; ET535/30m)
(Chrome Technology). The FRET ratio, which is defined as the fractional increase
in YFP emission caused by FRET, was calculated using FR = [SFRET − (RD)(SCer)]/
[(RA)(SCit)]. SFRET, SCer, and SCit denote fluorescence intensities derived from
measurements in individual cells coexpressing Citrine- or Cerulean-tagged pro-
teins with the respective filter cube (excitation, emission): SFRET (436 nm ± 10,
535 nm ± 15), SCFP (436 nm ± 10, 480 nm ± 20), and, SYFP (500 nm ± 10, 535 nm ±
15). RD and RA are experimentally predetermined constants from measurements
applied to single cells expressing only Cerulean- or Citrine-taggedmolecules that
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correct for donor bleed through or acceptor cross-excitation. FRET efficiencies
(EA) can be calculated from FRs using the following equation (39):
EA = ½FR−1 · ecitrineð436Þeceruleanð436Þ. [1]
ecitrine and ecerulean are the setup specific average molar extinction coeffi-
cients for citrine and cerulean, respectively, over the precise bandwidth of
the FRET cube excitation filter. In our setup, the calculated molecular ex-
tinction coefficient ratio is ecitrine (436)/ ecerulean (436) = 0.0563. Data were
analyzed using FelixGX (Horiba PTI) and Microsoft Excel (Microsoft).
Whole-Endolysosomal Patch-Clamp Experiments. For whole-endolysosomal patch-
clamp recordings, isolated intact endolysosomes from HEK293 cells were man-
ually isolated after vacuolin treatment for at least 2 h. Human TPC2 WT and
polymorphic TPC2 variants (C-terminally fused to YFP) were transiently trans-
fected into HEK293 cells using TurboFect Transfection Reagent (ThermoFisher).
Currents were recorded using an EPC-10 patch-clamp amplifier and PatchMaster
acquisition software (HEKA). Data were digitized at 40 kHz and filtered at
2.8 kHz. Cytoplasmic solution contained 140 mM potassium methanesulfonate
(KMSA), 5 mM KOH, 4 mMNaCl, 0.39 mM CaCl2, 1 mM EGTA, and 20 mMHepes
(pH adjusted with KOH to 7.2). Luminal solution was 140 mM NaMSA, 5 mM
KMSA, 2 mM CaMSA, 1 mM CaCl2, 10 mM Hepes, and 10 mMMES (pH adjusted
with MSA to 4.6). For the application of PI(3,5)P2 (A.G. Scientific) and ATP-Mg
(Sigma), cytoplasmic solution was completely exchanged by compound con-
taining solution. Torin-1 and rapamycin were purchased from Tocris and LC
Laboratories, respectively. All recordings were performed at 23–25 °C. For ex-
periments using ATP andmTOR inhibitors, cell density was 50–60% and the time
spent outside the incubator was 30 min.
To estimate the pore diameter of TPC2 WT and M484L, the relative per-
meability ratios of cations relative to Na+ were plotted against the diameter
of the respective monovalent cations as indicated in Fig. 4. The following
equation was applied (40):
PX+
PNa+
= k

1−
a
d
2
, [2]
where a is the diameter of the permeating cation, k is a constant factor, and
d is the pore diameter (41). The ionic radii of Li+, K+, Rb+, and Cs+ are 0.6,
1.33, 1.48, and 1.69 Å, respectively (42). To calculate the permeability ratios
the following equation was used:
PX+
PNa+
=
½Nai
½X + o
e
VF
RT , [3]
where V is the reversal potential, R is the gas constant, F is the Faraday
constant, and T is the temperature in Kelvin. To determine the relative Na+
(PX
+/PNa
+) permeabilities of TPC2 WT and M484L, whole-endolysosome re-
cordings were performed using ramp protocols (+100 to −100 mV with
500-ms increments). The bath solution contained 160 mM (pH 7.2, Hepes
5 mM) of the respective cations (Fig. 4 A–D) and the pipette solutions con-
tained 160 mM NaCl (pH 7.2, Hepes 5 mM). The recordings were started with
symmetric Na+ solutions. The cytoplasmic solution was then exchanged with
the respective monovalent cation-containing solution.
Human Donor DNA Purification and Sequencing. Human genomic DNA was
obtained from adult male and female individuals using the Gentra Puregene
Buccal Cell Kit (Qiagen), according to manufacturer’s instructions. Briefly,
buccal cells were collected by scraping the inside of the mouth 10 times. For
cell lysis, the collection brush was incubated in lysis solution at 65 °C for at
least 15 min. Proteins were precipitated and centrifuged. To precipitate
DNA, the supernatant was added to isopropanol and glycogen solution. The
pellet was washed with 70% ethanol and air-dried before resuspension in
DNA hydration solution. Samples were incubated at 65 °C for 1 h, followed
by incubation at RT overnight to dissolve the DNA. Genomic DNA fragments
were amplified using gene-specific primers [hTPC2(M484L) genomic DNA-
forward: 5′-GGTGTTCCTGGTGCTGGA-3′; hTPC2(M484L) genomic DNA-reverse:
5′-ACAGCCTCTAGTCCTCAGGG-3′; hTPC2(G734E) genomic DNA-forward:
5′-GGCCACCTACCAGATGACT-3′; hTPC2(G734E) genomic DNA-reverse:
5′-CGGACGTCACCTGCACAG-3′]. All DNA sequencing services were done by
Eurofins MWG Operon.
Isolation of Human Fibroblasts. Human genomic DNA sampling and human
fibroblast isolation were approved by the Ludwig-Maximilians-Universität
Ethics Committee (headed by Prof. Dr. Eisenmenger; reference no. 254–16).
Acquisition of human material was performed after obtaining written
informed consent by the donors. Primary fibroblasts were isolated by
Prof. Dr. Carola Berking and colleagues, Department of Dermatology,
Ludwig-Maximilians-Universität München from the skin of healthy adult
donors. Epidermis was separated from dermis using dispase II (10 mg/mL in
PBS, pH 7.2–7.4, D4693; Sigma) and dermis was digested in collagenase
(1 mg/mL in DMEM, C0130; Sigma) for 22 h at room temperature. Fibroblasts
were cultured in DMEM with glutamine (Life Technologies, Inc.) and 10%
FBS (FBS Superior, S0615; Biochrom). They were used for experiments at
passages three to seven.
Statistical Analysis. Details of statistical analyses and n values are provided in
the Materials and Methods or the figure legends. Statistical analyses were
carried out using Origin 7.5 and GraphPad Prism 5. All error bars are depicted as
mean ± SEM. Significance is denoted on figures as outlined in the legends.
Statistics were derived from at least three independent experiments.
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